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Interferon (IFN) is the luteotrophic signal in ruminants and is secreted by bovine blastocysts 
both in vivo and in vitro.  IFN secretion is highly variable and its control is only partly 
understood.  Most studies on the effects of environmental factors on IFN production have 
evaluated IFN production during the time of embryo elongation and attachment.  There is 
less knowledge of how IFN production at the blastocyst stage is modulated.  Therefore, the 
hypothesis of this thesis was that the amounts of IFN expressed and/or secreted by bovine 
blastocysts produced in vitro were modulated by environmental factors. In the first set of 
experiments, bovine embryos were incubated with a cytokine (granulocyte macrophage 
colony stimulating factor, GM-CSF). GM-CSF had been shown previously to promote embryo 
viability in a range of species and to modulate IFN secretion by ovine blastocysts and thus 
was classified as a beneficial environmental factor. Three experiments were conducted to test 
whether GM-CSF stimulated bovine blastocyst development and IFN secretion. Embryos 
were incubated with a range of different concentrations of GM-CSF (2, 5, 10 and 50 ng mL
-1
) 
and at different stages of development (1 to 3 and 1 to 9 days post-insemination).  Bovine 
embryos were unresponsive to GM-CSF in terms of IFN secretion, pyruvate oxidation, rate of 
development, blastocyst yield, morphological quality and apoptotic index, irrespective of 
timing of exposure and/or concentration of GM-CSF.  In the second part of the thesis, bovine 
blastocysts were exposed to a mild heat treatment (42C for four h) to determine whether 
heat stress affected IFN expression by bovine blastocysts.  A novel multiplex reverse-
transcription polymerase chain reaction methodology was validated to detect IFN and heat 
shock protein (HSP)70 mRNA in individual bovine embryos relative to an endogenous gene 
(YWHAZ) and an exogenous mRNA (-globin) and results were expressed both in absolute 
terms and in relation to the endogenous control.  Heat treatment upregulated IFN mRNA 
expression, suggesting that detrimental environmental factors may influence IFN expression.  
Heat treatment also caused an increase in HSP70 mRNA expression but did not affect 
blastocyst morphology, suggesting that the level of stress caused by the heat treatment was 
great enough to activate the cellular stress response, but mild enough not to cause a change 
in morphology.  In addition, the positive correlation between HSP70 and IFN transcript levels 
and the higher IFN expression by embryos which showed signs of degeneration and 
collapse compared to those which progressed in development suggested that IFN 
expression may be indicative of stress. The relationship between IFN expression and 
secretion in vitro with morphology, pyruvate metabolism, apoptotic index and cell number was 
inconsistent, suggesting that IFN production did not correlate with ‘quality’ (defined as an 
index of viability).  Blastocyst yield, day of blastulation and change in morphology index did 
account for at least part of the variation in IFN production, suggesting that some intrinsic 
factors may regulate IFN secretion. These intrinsic factors, however, did not explain all the 
variation in IFN secretion between blastocysts. Therefore, the amount of IFN secreted by 
bovine blastocysts is modulated by both intrinsic and environmental factors.  A model was 
proposed where different levels of stress affect survivability to different extents, and the ability 
to respond to mild levels of stress may be indicative of improved survivability. 
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ANOVA analysis of variance 
AP1 activator protein site of a gene, target binding to PKC 
b bovine  
BAX apoptosis regulator box-2 
Bcl-2 B-cell lymphoma-2 
BSA bovine serum albumin 
Bq becquerel 
BRU blastocyst RNA unit 
C cytosine  
cAMP adenosine 3′,5′-cyclic monophosphate 
cDNA complementary DNA:  single-stranded DNA that is synthesized from a messenger 
RNA template.   
CAT chloramphenicol acetyltransferase 
CCD charge coupled device 
CDX2 caudal-related homeobox protein 2 
CHO chinese hamster ovary cells: cell line often used in studies of genetics, toxicity 
screening, nutrition and gene expression. 
Cl- chloride 
CO2 carbon dioxide 
COCs cumulus oocyte complexes 
COX2 cyclooxygenase-2 
CR1 Charles Rosenkrans medium, as reported in Rosenkrans et al. (1993) 
CSF colony stimulating factor 
CV coefficient of variation, the standard deviation divided by the mean 
Cx connexin 
DLX3 homeobox distal-less 3 
DMEM dulbecco‟s modified embryo medium 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
dpi days post-insemination 
dpm disintegrations per minute 
dpo days post-oestrus  
dUTP deoxyuridine triphosphate 
EDTA ethylenediaminetetraacetic 
ELISA enzyme-linked immunosorbent assay 
ER oestrogen receptor alpha   
ETS E26 transforming sequence 
FBS foetal bovine serum 
FCS foetal calf serum 
FGF fibroblast growth factor 
g gram 
G guanine  
Glut glucose transporter 
GLMM generalised linear mixed model 
GM-CSF granulocyte macrophage colony stimulating factor 
GOI gene of interest 
h hour(s) 
H+ hydrogen ion 
HCO3
- bicarbonate ion 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, an organic chemical buffering 
agent 





      18 
 
  
HSE heat shock element 
HSC heat shock cognate protein 
HSF heat shock transcription factor 
HSP heat stress protein or heat shock protein 
IFN  IFN  
IFN the antiluteolytic protein secreted by a ruminant embryo during maternal recognition 
of pregnancy. Also known as trophoblastin, ovine trophoblast protein-1, and 
bovine trophoblast protein-1. 
IFNs  Interferons: cytokines induced by a viral infection and have antiviral and proliferative 
activities  
IGF Insulin-like growth factor, IGF I, IGF II 
IL interleukin: a type of cytokine produced by leukocytes that influences a variety of 
cells.  IL 1, IL 2, IL 3, IL 5. 
IRF2 IFN regulatory factor 2    
ISG IFN stimulated gene(s) 
IU  international units.  According to Hernendez-Ledezma et al. (1992), 1 IU is 
equivalent to about 0.1 ng of bIFN. 
IVC In vitro Culture 
IVF In vitro Fertilisation 
IVM In vitro Maturation 
IVP In vitro Produced 
JAr human choriocarcinoma cell line 
JAK/STAT janus-activated kinase/signal transducers and activators of transcription 
ex wavelength (excitation) 
em wavelength (emmission) 
LIF leukemia inhibitory factor 
LMM linear mixed model 
LUA laboratory unit of activity 
m  milli 
M molar 
MAPK mitogen-activated protein kinase 
M-CSF macrophage colony stimulating factor 
MDBK  Madin-Darby bovine kidney  
mL millilitre 
Mn-SOD manganese superoxide dismutase 
mOsmo measure of osmolarity 
mRNA messenger RNA 
Mx mini-exon 
Mx/CAT  plasmid containing a human MxA promoter driving a CAT  reporter gene  
n nano 
Na+ sodium ion 
NK cells natural killer cells 




PBS phosphate buffer saline 
PDGF platelet-derived growth factor: a protein that regulates cell growth and division 
PG prostaglandin 
PGF2 prostaglandin F2 
pi post-insemination 
PI3K phosphatidyl-inositol 3-kinases 
PKA protein kinase A 
PKC protein kinase C 
PMA phorbol 12-myristate 13-acetate 
po post-oestrus 
PVA polyvinyl alcohol:  a water soluble polymer 
PVP polyvinylpyrrolidone 
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R  receptor, such as IFNR, progesterone receptor (PR), oxytocin receptor (OR) 
Ras/MAPK Pathway involving the Ras subfamily of proteins and the MAPK signalling pathway, 
involved with cell proliferation 
REML restricted maximum likelihood 
RIA  radioimmunoassay 
RNA ribonucleic acid 
RNase ribonuclease 
RPA RNase protection assay 
RT-PCR  Real Time Polymerase Chain Reaction  
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SOF synthetic oviductal fluid 
SOX sarcoside oxidase 
T thymine 
TBE Tris/Borate/EDTA 
TCA tricarboxylic acid 
TCM tissue culture medium 
TdT Terminal Deoxynucleotidyl Transferase 
TGF transforming growth factor:   growth factors involved in tissue development, cell 
differentiation and embryonic development. 
TNF tumor necrosis factor 
TUNEL Terminal Deoxynucleotidyl Transferase Mediated dUTP Nick End Labeling 
v:v volume per volume 
 micro 
C degrees Celsius 
2D-PAGE two dimensional polyacrylamide gel electrophoresis 
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1 LITERATURE REVIEW 
1.1 Maternal recognition of pregnancy in cattle 
1.1.1 Oestrous cycle 
During a normal oestrous cycle in the bovine, the hypothalamus secretes gonadotropin-
releasing hormone which acts on the cells of the anterior pituitary gland, which in turn secrete 
gonadotropins (follicle stimulating hormone and luteinizing hormone).  Under the influence 
of gonadotropins and growth factors, follicles containing oocytes develop in the ovary 
through the different stages of folliculogenesis:  primordial, pre-antral, antral and Graafian 
follicles.  Graafian follicles are able to undergo ovulation and the cells within the ovulatory 
follicle change into luteal cells which form the corpus luteum.  When fertilisation does not 
occur, new follicles continue to develop in the ovaries and secrete increasing levels of 
oestrogen.  Oestrogen acts on the uterine endometrium to promote oestrogen receptor 
synthesis, which, in turn, stimulates oxytocin receptorsynthesis (Spencer et al., 2008).  
Oxytocin produced by the posterior pituitary gland binds to oxytocin receptors in the uterine 
endometrium, causing the uterine endometrium to secrete prostaglandin (PG) F2 (Asselin et 
al., 1997).  PGF2 acts on the corpus luteum causing its regression (Peters et al., 1985).  
Since the corpus luteum is the source of progesterone, its regression leads to a decrease in 
progesterone concentration (Peters et al., 1985), allowing another Graafian follicle to mature 
and ovulate and another oestrous cycle then begins, 21 days after the previous oestrus.   
1.1.2 Progesterone: the hormone of pregnancy 
Progesterone, secreted by the corpus luteum, has a negative feedback effect on gonadotropin 
secretion by the hypothalamus, thus, preventing development of another Graafian follicle and 
initiation of the next oestrous cycle.  Moreover, progesterone binds to receptors in the uterine 
endometrium changing the pattern of protein secretion by endometrial cells (the 
progestational stage) to maintain the endometrium in an optimal state for embryonic survival 
and development (Mann et al., 1999, Mann and Lamming, 2001).  Therefore, progesterone is 
the hormone of pregnancy through its actions on the hypothalamus and the uterine 
endometrium.   
 
Removal of the corpus luteum by ovariectomy in the first 210 days of gestation terminates 
pregnancy in cattle (Johnson, 1981), emphasizing the importance of the corpus luteum in 
maintaining pregnancy in cattle.  Therefore, the prevention of luteolysis is necessary for 









In eutherian mammals where the length of pregnancy exceeds that of the oestrous cycle, a 
signal is required to prevent luteolysis.  Northey and French (1980) prolonged luteal lifespan 
by infusing homogenates of embryos (17 to 18 days post-insemination, dpi) into the uteri of 
cyclic cows between 14 and 18 days post-oestrus (dpo), suggesting that the embryo may be 
the source of the antiluteolytic signal.  The physiological process in which the embryo signals 
its presence to the maternal system to prolong the lifespan of the corpus luteum and prevents 
the continuation of the oestrous cycle was first termed maternal recognition of pregnancy by 
Short (1969).  
 
Bartol et al. (1985) first identified a prominent, but transient, protein that was secreted by 
embryos from 16 to 24 dpi.  The transient nature of production coincident with the timing of 
establishment of pregnancy suggested a role for this protein in maternal recognition of 
pregnancy.  Since this protein was immunologically related to ovine trophoblast protein-1 (the 
maternal recognition of pregnancy signal in sheep), this protein was later termed bovine 
trophoblast protein-1 by Helmer et al. (1987).   Trophoblast protein-1 was then classified as 
an IFN because of its antiviral activity (Pontzer et al., 1988) and its effectiveness against a 
range of viruses (Roberts et al., 1989) and named interferon (IFN).  Therefore, maternal 
recognition of pregnancy in ungulate ruminants requires that the embryo secretes IFN.  
1.1.3 IFN signalling mechanism  
Using bovine blastocysts, IFN was immunolocalised to the Golgi complex and associated 
clear vesicles (Morgan et al., 1993), where the protein product is concentrated and packaged 
for export, suggesting that IFN is a secretory protein.  Although exocytosis at the cell surface 
was not observed by Morgan et al. (1993), Johnson et al. (2007) captured an IFN positive 
signal inside a vesicle approaching the apical surface of the cell for exocytosis, suggesting 
that IFN is a secretory protein which exits the cell by exocytosis.  Moreover, Morgan et al. 
(1993) observed that the highest level of immunolabelling of the maternal endometrium of 
pregnant cows occurred during the time of maximum IFN production (between 19 and 21 
dpi), indicating that the transfer of IFN from the embryo to the uterus occurred in a paracrine 
manner.  The paracrine action of IFN on the maternal endometrium is thought to occur 
through binding to the Type I IFN receptor (IFNR, Knickerbocker et al., 1986), which, 
through a tyrosine kinase gene transcription pathway, instigates a change in gene expression 
and a subsequent change in the pattern of proteins and hormones secreted by the endometrium 
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1.1.4 IFN stimulated genes 
Genes stimulated by IFN are denominated IFN stimulated genes (ISG, Austin et al., 2004).  
Spencer et al. (2008) outlined endometrial genes whose expression was enhanced during 
pregnancy in cows and sheep, and found that the expression of 19% (51/264) of these genes 
were stimulated by IFN.   The high proportion of ISGs of genes whose expression is 
stimulated by pregnancy highlighted the importance of IFN in establishment of pregnancy.   
 
ISGs are thought to promote pregnancy by reducing PGF2 secretion and subsequent 
luteolysis either (1) by ligating and modifying proteins involved with the release of PGF2 or 
(2) by inhibiting transcription of oestrogen receptor by maternal endometrial cells, therefore 
causing a decrease in oxytocin receptor levels, preventing oxytocin from binding to oxytocin 
receptor and reducing PGF2 secretion (Mann and Lamming, 2001).  The preserved corpus 
luteum then maintains a high concentration of progesterone in the maternal blood.  Therefore, 
by modulating ISG expression, IFN is able to activate a range of endometrial anti-luteolytic 
mechanisms.  Failure of the endometrium to respond to the IFN signal has been implicated 
as a cause for early pregnancy failure in domestic ruminants (Winkelman et al., 1999). 
1.1.5 Pre-attachment embryo development in cattle is modulated by 
genetic and environmental factors 
During the pre-attachment phase of development, the embryo undergoes dramatic changes in 
its physiology in terms of structure, function and size (Figure 1, page 24).  Ovulation occurs 
10 to 12 hours (h) after the onset of heat and fertilisation occurs between 24 and 30 h after the 
end of heat.  After fertilisation (day 0), the viable zygote must undergo cleavage division 
(two-cell by day 1, four-cell by day 2, eight-cell by day 3, 16-cell by day 4) and embryonic 
genome activation (between the two- and eight-cell stage) in the oviduct.  Compaction 
(process where the cells bind tightly to each other, forming a compact sphere) is necessary for 
the formation of the morula as the embryo enters the uterus and cavitation (process where the 
trophoblast secretes water into the morula forming a cavity) and cell differentiation into inner 
cell mass and trophectoderm cells are necessary for the formation of the blastocyst (blastocyst 
development is reviewed by Watson et al., 1992).  The blastocyst then undergoes expansion 
and hatching.  After elongation, the embryo is ready to attach to the uterus, between 30 and 35 
dpi (Gordon, 2003). The viability of the embryo is dependent on the genetic material of the 
gametes from which the embryo was derived as well as the environment meeting the changing 
requirements of the embryo, so that the varied nutritional composition of the fluids of the 
oviduct and the uterus should mirror the changing requirements of the embryo (Gardner and 









Little is known about the regulation of IFN secretion (Martal et al., 1998, Kubisch et al., 
2001a, Neira et al., 2007).  The relative role of the genetic factors inherent in the embryo and 
the environmental factors and the interaction between the two in influencing timing and 
amount of IFN secretion have been investigated.  This review will examine the properties of 
IFN and the methods available for IFN detection, the variation in IFN secretion by bovine 
embryos and how IFN secretion patterns may be regulated by genetic and environmental 
factors to produce discrete patterns of IFN secretion during pre-implantation development.   
1.2 IFN detection 
Protein synthesis involves a multi-step process in which the information coded within a 
sequence of a gene is transcribed into mRNA which in turn is translated into proteins.  IFN 
has been detected in bovine embryos at the mRNA and protein levels.  In this section, the 
techniques used to detect IFN mRNA expression and protein synthesis will be reviewed.    
1.2.1 Detection of IFN mRNA 
1.2.1.1 Properties of embryo mRNA 
On average, a single mammalian cell contains 10 pg of total RNA, of which around 80% is 
ribosomal RNA, 15 to 20% low molecular weight species such as transfer RNA, and only 1 to 
5% mRNA (100 to 500 fg, Wrenzycki et al., 2004).  A bovine morula, which contains around 
100 cells, contains around 700 pg of total RNA (Bilodeau-Goessels and Schultz, 1997a), so 
that the amount of total RNA per blastomere is in the same order of magnitude as in other 
mammalian cells.  However, the total number of cells available for analysis with embryos is 
limited (around 100 cells at the morula to blastocyst stage) compared to cell cultures and 
tissues (generally in excess of 10
6
 cells).  Therefore, the limited quantity of total RNA in 
embryos is one of the main difficulties associated with determining mRNA levels in pre-
attachment embryos.   
 
Murine oocytes contain between 0.35 ng (Piko et al., 1982) and 0.47 ng (Olszanska et al., 
1993) of total RNA, whilst bovine oocytes, which are larger in diameter, contain between 
0.98ng (Olszanska et al., 1993) and 2.4 ng (Bilodeau-Goessels et al., 1997a) of total RNA.  
Therefore, the amount of total RNA in oocytes varies between species.  Between species 
variations may be due to variations in oocyte size, so that it is possible that variation in 
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Figure 1 Events associated with pre-attachment embryo development in cattle (modified and 
supplemented from Spencer and Bazer, 2004).   
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The amount of total RNA in an embryo also varies with stage of development.  Before 
ovulation, the oocyte is in a state of active gene expression, synthesizing maternal RNAs and 
proteins required for early embryonic development.  The competent ooplasm has all the 
mRNA needed for embryonic development up to the eight-cell stage (Barnes and First, 1991).  
Total RNA content of bovine oocytes produced by IVM procedures averages 2.4 ng 
(Bilodeau-Goessels and Schultz, 1997a). Fertilisation initiates a complex series of events 
resulting in fundamental alterations in expression of developmentally important genes in a 
time- and stage-dependent manner.  These events include the first cleavage division, 
embryonic genome activation, compaction, blastocoele formation and cell differentiation into 
inner cell mass and trophectoderm cells. After fertilisation, maternal mRNA and protein 
reserves in the embryo decline with time.  There is a 30% decrease in total RNA content by 
the one- to two-cell stage and a 70% decrease by the morula stage (Table 1, page 26).  
Subsequent development becomes dependent on the embryonic genome becoming 
transcriptionally active.  Early studies indicated that the maternal-embryo transition in bovine 
zygotes began at the four- to eight-cell stage, when major changes were shown to occur in the 
pattern of protein synthesis (Frei et al., 1989), when [
3
H]uridine incorporation into RNA was 
first detected indicating increased transcriptional activity (Camous et al., 1986), and when 
electron-dense nucleolus precursors became transformed into an active fibrillo-granular 
nucleolus during the functional organization of the nucleolus (Kopecny et al., 1989).  A more 
recent study employing more sensitive autoradiography techniques suggested that bovine 
zygotes were transcriptionally and translationally active as early as the two-cell stage (Viuff 
et al., 1996). Currently, it is accepted that the major activation of the bovine embryonic 
genome occurs around the eight-cell stage
 
whereas minor activation occurs at the two-cell 
stage (Memilli and First, 2000).  Therefore, at the eight-cell stage, there is little change in the 
level of RNA since the rate of embryonic RNA synthesis is similar to the rate of decay of 
maternal RNA (Bilodeau-Goessels and Schultz, 1997b).    As cell numbers increase during 
cavitation, blastocyst growth and blastocyst expansion, the rate of RNA synthesis exceeds the 
rate of decay, leading to a seven-fold increase in RNA in blastocysts relative to morulas 
(Table 1, page 26).   Therefore, other than the limiting levels of mRNA in single embryos, the 
variation in total transcription levels during development further hamper experimental design 
for studies assessing mRNA levels in embryos.   
 
Therefore, the method used to detect mRNA levels in embryos must account for the pg levels 
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Table 1 Amounts of total RNA in bovine embryos at different stages of development (Bilodeau-
Goessels and Schultz, 1997a).  Estimated amount of mRNA is calculated as 5% of total RNA.   
 Amount of total RNA (pg) Estimated amount of mRNA (pg) 
Oocyte 2400 120 
two-cell 1700 85 
Morula 700 35 
Blastocyst 5300 265 
1.2.1.2 Techniques available for detection of IFN mRNA 
Techniques used to detect IFN transcript levels have included northern blotting (Stewart et 
al., 1989, Imakawa et al., 1989, Cross et al., 1991), RNase Protection Assays (RPA, Mann et 
al., 1999, Ealy et al., 1998a) and in situ hybridisation (Farin et al., 1989, 1990, Guillomot et 
al., 1990).  These qualitative techniques lacked the sensitivity necessary to detect low RNA 
levels so that large numbers of embryos were pooled or larger embryos (older, 13 dpi 
onwards) were used to give sufficient RNA for analysis.  Reverse transcription polymerase 
chain reaction (RT-PCR) is a technique that allows conversion of small quantities of single-
stranded mRNA to double-stranded cDNA by RT and then amplification of a known 
sequence of interest by enzymatically replicating DNA (Bustin et al., 2002).  As a result of its 
high sensitivity and specificity and the need for only small amounts of material to generate 
data, real time RT-PCR is currently the optimal method for identifying and verifying changes 
at the RNA level in bovine embryos.  Due to the limited quantity of mRNA in embryos, early 
RT-PCR methods (de Sousa et al., 1998a,c, Kawarsky and King et al., 2002, Wrenzycki et al., 
1999) required pooling of large numbers of embryos to give sufficient RNA for analysis.  
Large pools, however, are expensive and time consuming to collect (Bilodeau-Goessels and 
Schultz, 1997).  Moreover, significant variation in total RNA has subsequently been 
demonstrated between blastocysts, both due to natural biological variation due to unique set 
of maternal or paternal DNA, and to the rate of development, so that poolings of embryos 
obscured variation in mRNA expression between individual embryos (Wrenzycki et al., 
2004).  Therefore, it is desirable to estimate mRNA levels at the single embryo level as 
variation between embryos is accounted for and quantified.  Improvements to RT-PCR, such 
as the emergence of real-time PCR, highly specific probes and improvements in nucleotide 
extraction methods, have enabled qualitative analysis of IFN in individual bovine embryos 
(Wrenzycki et al., 2001a, Bertolini et al., 2002), so that methodologies are no longer limited 
to pools of embryos.   
1.2.1.3 Problems with current RT-PCR methodologies used to assess IFN mRNA 
levels 
Quantitative RT-PCR assumes that “the amount of amplification of a target gene transcript is 
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is known” (Lechniak, 2002).   In practice, however, many variables (Table 2, page 28) 
influence the efficiency of RNA extraction, RT processes and PCR amplification, so that the 
amount of product obtained from a sample following amplification may not necessarily reflect 
the initial target concentration.  Therefore, the method by which data are quantified and the 
inherent assumptions can confound experimental results.  Therefore, the variation caused by 
each step of the gene-transcription analysis needs to be controlled to detect true differences in 
transcription levels of a particular gene.  Sources of variations that need to be controlled 
include differences between samples in overall transcriptional activity (differences in number 
of cells or total RNA amount), amount of starting material extracted (some RNA may remain 
trapped inside undisrupted cells, or on the silica gel when using column based RNA 
purification methods), varied efficiency of the reverse transcriptase and DNA polymerase 
(Thellin et al., 1999), varied annealing efficiencies of primer to target sequences, or 
polymerase errors (which occurs in approximately 1 in 10,000 bases, so that, if an error 
occurs in the earlier PCR cycles, it can lead to an alteration of large proportions of the final 
product, Wrenzycki et al., 2004).  The RT reaction should be as efficient as possible in order 
to produce maximum good quality cDNA yield, leading to maximum PCR sensitivity.  
However, several factors affect RT efficiency, including RNA quality (Bustin et al., 2004), 
priming strategy (Stahlberg et al., 2004), enzyme efficiency (Brooks et al., 1995), the duration 
of an RT reaction, the annealing temperature, the length of the target sequences (if using gene 
specific primers), all of which can result in a cDNA population that does not reflect the 
original mRNA population in terms of transcript abundance and complexity (Battaglia et al., 
1998).  Therefore, for meaningful quantification of mRNA levels in bovine embryos, there is 
a need for a method that controls for variations caused by gene-transcriptions analysis and 
variations in overall transcriptional activity among samples.   
 
Another disadvantage of the use of RT-PCR to detect IFN mRNA is that the lack of an IFN 
mRNA standard has meant that there are currently no data available on absolute IFN 
expression from individual embryos.  Also, the use of non-specific DNA binding dyes to 
detect IFN amplicons has meant that PCR artefacts cannot be discriminated from IFN 
amplicons, incurring inaccuracies on the current PCR data available for IFN.  Another 
problem with current techniques for detection of IFN expression is that further developments 
in the RT-PCR technology, such as use of sequence specific probes, have not been applied to 
IFN expression analysis.  Therefore, there is a need for improved methods for detection of 
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Table 2 Endogenous (End), exogenous (Exo) and reference dye controls normalize data for 
different sources of variation during the RT-PCR process.  GOI: gene of interest 
1
Assuming similar RNA extraction between GOI and control 
2
Assuming similar RT efficiency between GOI and control 
3
Assuming similar PCR efficiency between GOI and control 
 
1.2.1.4 Post-transcriptional modulation of IFN 
Roberts et al. (1991) reported 18 distinct polymorphic ovine and 12 different bovine IFN 
cDNA or genomic sequences, whilst Ealy et al. (2001) later identified 24 bovine IFN cDNA 
sequences and Alexenko et al. (2000) reported 43 sequences representing both genes and 
cDNA for IFN, and 33 proteins unique in primary sequence.  Searching through the NCBI 
database, 78 unique IFN proteins are currently registered (Figure 2, page 29).  All cDNAs 
identified had single non-synonymous base changes.  These isoforms have been described and 
categorised by Ealy et al. (2001), Alexenko et al. (2000) and Roberts et al. (1991) based on 
predicted amino acid sequence.   None of the IFN cDNA identified by Ealy et al. (2001) 
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differed by more than 1.8% in nucleotide sequence, although the differences in inferred 
amino-acid sequence were greater than nucleotide sequence (3.5%).  Although many distinct 
transcripts and genes for IFN have been detected in cDNA cloning studies (Imakawa et al., 
1987, 1989, Stewart et al., 1989), not all are transcribed (Demmers et al., 2001).  Moreover, 
each protein isoform is likely to be translated by more than one species of mRNA (Anthony et 
al., 1988).  In fact, Roberts et al. (1991) demonstrated by predicting the protein sequences 
from the nucleotide sequences of different IFN isoform cDNA that these isoelectric variants 
are products of different genes.  However, because sequences for cDNA clones for the ovine 
are derived from mRNA, it is difficult to determine whether different variants represent 
different genes, or allelic forms of the same gene.  Given the similarity between different 
IFN mRNA isoforms, one of the difficulties of detecting IFN mRNA relates to designing 
primers that will detect all the multiple mRNA isoforms or specific isoforms depending on the 

















Bos frontalis (1)  
Figure 2  A phylogenic tree based on amino acid sequence of IFN.  Amino acid sequences were 
inferred from gene and cDNA nucleotide sequences in the NCBI database and aligned using the 
Multiple Alignment Viewer available on www.ncbi.nlm.nih.gov/sutils/alnview.cgi (as of 2 April, 
2008).  The tree for protein sequences was constructed using the Phylogenic Tree option on the 
same website, and then simplified based on species.  100 total proteins were identified, of which 
22 were ‘similar to IFN’ and therefore excluded.  Of the 78 remaining IFN isoforms, 25 are 
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The genetic control from different isoforms of IFN mRNA being transcribed (Demmers et 
al., 2001) coupled with possible post-transcriptional regulation (such as alternative RNA 
splicing, modification, editing, localisation, translation and stability, expression of non-coding 
RNA, antisense RNA and microRNAs, Niemann et al., 2007) and translational regulation 
(affecting efficiency of translation) may lead to discrepancies between total IFN expression 
and secretion levels, as reported by Robinson et al. (2006), so that the assumption that IFN 
mRNA levels reflect IFN protein levels (as suggested by Wrenzycki et al., 2004) may not 
always be true.  Since the known role of IFN as the maternal recognition of pregnancy signal 
occurs at the protein level, there is a need to assess IFN protein levels as well as mRNA 
levels.   
 
1.2.2 Methods for detection of IFN protein synthesis 
IFN protein may be detected within the embryo and outside the embryo.  Since IFN is a 
secretory protein, intracellular IFN protein is present at a very low concentration, so that 
only qualitative immunological methods (within the embryo by immunohistochemistry or 
within the blastomeres by immunocytochemistry) have been used to assess intracellular IFN 
protein.  Most studies assessing IFN protein use methods to assess its concentration in 
culture medium (in vitro) or uterine flushings (in vivo) which rely on its molecular weight, 
isoelectric, antiviral and immunological properties. 
1.2.2.1 Techniques measuring IFN based on molecular weight and isoelectric 
properties 
Bartol et al. (1985) first purified IFN secreted by in vivo produced bovine embryos (16 to 24 
dpi) into culture medium using ion exchange chromatography and observed that IFN was 
more acidic (had a higher net charge) than other proteins secreted by the conceptus.  Bartol et 
al. (1985) then separated the proteins secreted by the embryo using two-dimensional 
polyacrylamide gel electrophoresis (2D-PAGE), and confirmed that IFN was an acidic 
polypeptide with a low molecular weight (molecular weight/isoelectric point, Mr/pI:  22000-
26000/6.5-5.6).   
 
Later, using the 2D-PAGE technique, Anthony et al. (1988) determined that bovine IFN had 
variants differing in molecular mass (between 22000 and 24000 kDa) as well as pI (Anthony 
et al., 1988).    The different sizes are due to differential glycosylation with N-linked 
oligosaccharides (Godkin et al., 1988) through a single potential site for glycosylation: 
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was also shown to have 3 or 4 isoelectric variants using 2D-PAGE (Godkin et al., 1982, 
Imakawa et al., 1987) due to changes in isoelectric properties of different amino acids 
substituted in different IFN isoforms (Roberts et al., 1991).   
 
2D-PAGE has the advantage of being able to differentiate between different isoforms of IFN 
which will have varied size and isoelectric points.  However, 2D-PAGE has the disadvantages 
of being qualitative and insensitive, as this technique has only been reported to assess IFN 
secretion in elongating embryos (10 dpi) which secrete around 10 ng of IFN per day (Bartol., 
1985).  Therefore, methods quantifying the amount of IFN protein based on antiviral activity 
or immunological properties are the preferred methods of measuring IFN protein.   
1.2.2.2 Techniques measuring IFN based on antiviral activity 
One of the characteristics of IFNs is that they have antiviral activity.  Therefore, in 1981, 
Familletti et al. first suggested a cell cytopathic assay for detection of IFNs.  The cell 
cytopathic assay determines the concentration of IFN in the medium as assessed by the ability 
of IFNs to protect cells from viral exposure (Alexenko et al. 1997).   
 
Pontzer et al. (1988) first demonstrated that ovine IFN purified from conceptus culture media 
(12 to 16 dpi) had a high specific antiviral activity of 2 to 3 x 10
8
 international units (IU) 
milligram (mg)
-1
 protein, and was therefore as potent as any known IFN.  Recombinant (r) 




 protein (Klemann et al., 
1990).  Cross et al. (1991) first used the cell cytopathic assay to detect IFN secretion by 
bovine embryos and the cell cytopathic assay has continued to be the commonest technique 
for measuring IFN secretion by ruminant embryos (Roberts et al., 1989, Hernandez-Ledezma 
et al., 1992, 1993, Stojkovic et al., 1995, 1999, de Moraes et al., 1997, Demmers et al., 2001, 
Neira et al., 2007), probably due to the sensitivity of the method (0.12 IU mL
-1
, Hernandez-






 specific activity, 
Pontzer et al., 1988), the ease of reproducing the method in different laboratories and its 
ability to distinguish between different variants of IFN with similar immunological 
properties but varied antiviral activity.  However, antiviral activity measured using the cell 
cytopathic assay may not correspond to biological activity of IFN in maternal recognition of 
pregnancy.  Given that the role of IFN in vivo occurs through receptor binding and not 
though its antiviral activity, use of a technique based on the ability of IFN to bind to its 
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Since the cell cytopathic assay measures antiviral activity, it has the disadvantage of not being 
specific to IFN and will identify other cytokines IFNs.  Moreover, the cell cytopathic assay 
is time-consuming.  Once confluent Madin Darby bovine kidney (MDBK) cell cultures are 
established, the assay takes 3 days (day 1:  exposing cells to sample, day 2: exposing cells to 
virus, day 3: assessing cell survival).  Therefore, despite the cell cytopathic assay being time 
consuming and non-specific, its high sensitivity has led to its common use in quantifying 
IFN secretion.   
 
In 2001, Fray et al. developed a reporter gene assay which uses MDBK cells transfected with 
a plasmid, containing a human mini-exon (Mx) promoter driving a chloramphenicol 
acetyltransferase (CAT) complementary (c) deoxyribonucleic acid (DNA). Mx gene 
transfection is dependent on Type I IFNs and CAT expression allows for quantification in an 
enzyme linked immunosorbent assay (ELISA).  Compared to conventional cell cytopathic 
assay, the Mx/CAT reporter gene assay has the advantage of being specific to Type I IFNs, 
since only Type I IFNs are able to induce gene transcription and synthesis of Mx proteins 
(Ellinwood et al., 1998, Simon et al., 1991).  Moreover, Mx/CAT relies on objective 
quantitation of cell survival, making it more reliable than previous cell cytopathic assays 
which rely on subjective observation of cell survival.  However, the sensitivity of the 
Mx/CAT reporter assay is lower (0.5 IU mL
-1
, equivalent to 5 pg mL
-1
 , Mann et al., 2002) 
than that of the conventional assay  (0.12 IU mL
-1
), which may explain why only one lab has 
reported to use the Mx/CAT method of IFN detection (Fray et al., 2001, Mann et al., 2002).     
1.2.2.3 Techniques measuring IFN based on immunological properties 
In 1988, Vallet et al. developed a radioimmunoassay (RIA) to detect ovine IFN and in 2005, 
Takahashi developed a RIA specific to bovine IFN.  RIAs have the advantage of being faster 
(2 days) than other cell cytopathic assays (3 days) and simpler since RIAs do not require 
maintenance of a permissive cell line or maintenance of viral stocks as required with antiviral 
assays.  Nevertheless, RIAs have the disadvantages of requiring use of radioisotopes and not 
making a distinction between biologically active and inactive IFN.   
 
In 1996, Zhu et al. developed an antigen-competitive ELISA to detect ovine IFN with the 
advantages of being specific to IFN, less time-consuming than previous methods (4 to 5 h), 
and having a lower detection limit (0.005 ng mL
-1
, Zhu et al., 1996 to  0.1 ng mL
-1
, Rooke et 
al., 2005) than RIA (2 ng mL
-1
, Vallet et al., 1988 to  6 ng mL
-1
, Takahashi et al., 2005).   This 
method has been used to detect IFN secreted by bovine blastocysts (J.A. Rooke, personal 
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reproduce in different laboratories due to variation in stability between different batches of 
the rIFN used as an antigen in the ELISA (J.A. Rooke, personal communication).  This may 
explain why the ELISA has not become the current method of choice for IFN protein 
detection and why no studies have been published using the ELISA to detect bovine IFN. 
1.2.2.4 Techniques measuring intracellular IFN synthesis based on immunological 
properties 
Immunohistochemistry and immunocytochemistry detect the localisation of proteins in tissues 
and cells through the principle of antibodies binding specifically to antigens.  There is some 
discrepancy as to the localisation of IFN in bovine embryos.  Neira et al. (2007) observed 
that IFN was detected in both the inner cell mass and trophectoderm.  However, Johnson et 
al. (2006) found IFN protein only in the trophectoderm.  However, in an earlier study 
Johnson et al. (2004) detected IFN in cumulus cell masses of in vitro matured oocytes and in 
morulae (5 to 6 dpi), but not earlier, although it is possible that this was due to non-specific 
staining.     
 
In 1989, Lifsey et al. observed that IFN was more prominent in mononuclear cells, whilst 
binucleate cells stained to a lesser degree.  However, Morgan et al. (1993) observed 
localisation of IFN being specific to uninucleate trophoblast cells.  Despite discrepancies 
between different studies, the general consensus is that the ability to transcribe and translate 
IFN is unique to the uninucleate cells of the trophectoderm of ruminant embryos (Roberts et 
al., 2007).    
 
IFN was immunolocalised to the cytoplasm of trophectoderm cells from bovine conceptus 
tissue (20 dpi), and was not detected in the nuclei or the endoderm (Lifsey et al., 1989).  
Johnson et al. (2006) observed that IFN was immunolocalised to the cytoplasm and IFN 
was not detected in the vacuole, mitochondria or villi.  Morgan et al. (1993) observed that the 
labelling for IFN was consistently located over the Golgi complex and associated clear 
vesicles in the apical third of cell, with no significant labelling over the nucleus, 
mitochondria, endoplasmic reticulum, multivesicular bodies, lysosomes or cytoplasmic 
matrix.  Despite earlier studies (Lifsey et al., 1989, Morgan et al., 1993) failing to note 
nuclear localisation of IFN, Johnson et al. (2006) did localise IFN to the nuclei of 
trophoblast cells of IVP blastocysts (7 dpi).  However, earlier studies detected IFN in tissues 
from embryos much later in development (18-23 dpi, Lifsey et al., 1989, Morgan et al., 1993), 
and used in vivo derived embryos, as opposed to Johnson et al. (2006) who used earlier 
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and may be controlled by factors associated with in vitro culture and /or stage of 
development.    
1.2.2.5 Problems with detecting IFN protein 
1.2.2.5.1 Similarity to other IFNs 
Intramuscular injections or infusions of recombinant bovine (rb) IFN, a Type I IFN, into the 
uteri of cyclic cows between 15 and 21 dpo extended luteal lifespan, so that rIFN mimicked 
some of the biological effects of IFN.  In sheep, IFN was also able to compete with IFN 
for binding to endometrial receptors (Stewart et al., 1989; Hansen et al., 1989) and IFN 
elicited similar effects to IFN on endometrial protein and PGF2 biosynthesis (Thatcher et 
al., 1989).  Similar biological activities between IFN and IFN suggested that IFN had a 
similar structure to Type I IFNs, which include IFN, ,  and .  The similarity between 
IFN and other Type I IFNs was further substantiated by nucleotide substitution analysis, 
which determined that the IFN gene originated from a single duplication of the IFN gene 
around 36 million years ago (Roberts et al., 1997, Figure 3, page 35), when the pecoran 
ruminants originated, which is why IFN is specific to ruminant ungulates, which include 
cattle, sheep, giraffes, antelopes and goats.   The nucleotide sequence differences between 
cDNA for IFN, IFN and IFN are outlined in Table 3 (page 35)  IFN is similar to other 
IFNs in terms of cDNA sequence (85% similar to IFN, and 55-65% similar to ), amino 
acid sequence (70% homology with IFN, 47% homology with IFN, Roberts et al., 1991) 
and length of polypeptide (172 residues, as opposed to 166 in IFN).  The predicted 
hydrophilicity profiles for IFN, IFN and IFN suggest that these molecules have 
approximately the same shapes and dimensions despite minor differences in their architecture 
(Roberts et al., 1990).  The secondary structure of IFN possesses a considerable amount of 
-helical structure (Radhakrishnnan et al., 1996), as with other IFNs which are -helical 
cytokines (Zoom and Wetzel, 1984).  Moreover, IFN adopts the Type I IFN five-helix 
bundle topology, as opposed to four-helix structure observed in non-Type I IFNs (Sprang and 
Bazan, 1993).   Therefore, IFN has a similar structure to other IFNs, and is particularly 






















Figure 3  Evolutionary relationship between the Type I IFNs based on nucleotide substitution 
analysis, as reported by Roberts, et al. (1997).  Numbers refer to timing of the origin of the gene 
(million years ago) which determined the species that different IFNs are specific to.  For instance, 
IFN is only found in birds, IFN is specific to pigs and IFN  is specific to ruminant ungulates.   
Table 3  Comparison of the percentage homology of the base sequences within the coding regions 
of cDNA for ovine IFN, bovine IFN and bovine IFN relative to bovine IFN (Imakawa et 
al.,1987, 1989, Roberts et al., 1991, Yamaguchi et al., 2001).   
 5‟ Non-coding Coding 3‟ Non-Coding 
Predicted amino-acid 
sequence identity 
Ovine IFN 76 90 92 80 
Bovine IFN 72 85 70 70 
Bovine IFN 53 55-65 53 47 
 
Despite the similarity between IFN and other IFNs, secretion of IFN in cattle in the absence 
of a known viral stimulus and the magnitude of its synthesis by an epithelium rather than 
blood cells is different to other IFNs (Roberts et al., 1989).  The primary function of IFN is 
related to reproduction (Roberts et al., 1992), whilst other IFNs provide resistance to 
pathogens (Johnson et al., 1994).  Therefore, there is a need to detect IFN separate from 
other IFNs.  However, techniques available to detect IFN tend to lack specificity due to the 
similarity in biological and chemical properties between IFN and other Type I IFNs (Table 
4, page 37).  The conventional antiviral activity will not differentiate between IFN and other 
IFNs (Hernandez-Ledezma et al., 1992), whilst the more specific Mx/CAT gene reporter 
assay will not differentiate between IFN and other Type I IFNs (Fray et al., 2001).  The 
ELISA uses a specific antibody for IFN (Rooke et al., 2005) whilst the antibody used for the 
RIA was shown to cross-react with IFN (Takahashi et al., 2005).  Differences in the 
specificity of different methodologies may explain some of the discrepancies between 









Due to the high homology between IFN isoforms (more than 85% homologous, Imakawa et 
al., 1989), the only technique available which will differentiate between different isoforms is 
the 2D-PAGE. However, the 2D-PAGE will not distinguish biological activity.   The cell 
cytopathic assays and the Mx/CAT reporter gene assay measure antiviral activity, whilst the 
RIA, ELISA, immunocytochemistry and 2D-PAGE measure amount of protein.  Different 
IFN isoforms vary in antiviral activity (Alexenko et al., 1997), despite having similar amino 
acid sequences (Ealy et al., 1998a; 2001; Winkelman et al., 1999), so that the antiviral activity 
may not correlate to amount of protein.  Therefore, there is no one method available that will 
account for the variation in antiviral activity, sequence, molecular weight and isoelectric point 
between different isoforms of IFN.  Therefore, a method which integrated both a protein-
specific method and an antiviral-specific method should ideally be used to assess embryonic 
IFN secretion to account for differences in biological activity of different isoforms of IFN.   
1.2.2.5.3 Sensitivity 
Occasionally, the level of secretion of IFN by early blastocysts is similar to or even below 
the detection limit of the currently available techniques for measuring IFN protein levels 
(0.001 to 6 ng mL
-1
,Table 4, page 37), so that it is impossible to distinguish between IFN not 
being present or being below the detection limit of the assay.  Therefore, there is a need to 
develop techniques with improved sensitivity in order to assess IFN synthesis during the pre-
blastocyst and post-attachment stages of development, when IFN secretion is not detectable 
(detectable levels of IFN at different stages of development are discussed in 1.3.2, page 39).   
1.2.2.5.4 Accuracy 
One of the problems with the cell cytopathic assay is that it is based on 1:3 serial dilutions of 
the embryo-derived culture medium.   Due to this considerable serial dilution, Kubisch et al. 
(1998) suggested that this method is not accurate, leading to results with large standard 
deviations.  How much of the variation in IFN between different blastocysts is accounted for 
by inaccuracies from the cell cytopathic assay is unclear.   
 
Methods available for detecting IFN secretion by embryos are summarised in Table 4 (page 
37), and can be categorised into methods that measure either antiviral activity or amount of 
IFN secreted.  The ideal method of detection would be specific, rapid, sensitive, quantitative, 
safe and easy to reproduce in different laboratories.  However, because of the nature of IFN 
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reducing the confidence in the accuracy and reliability of these techniques. Therefore, there is 
a need to improve current methods of detection of IFN synthesis. 
 
The confidence of techniques assessing IFN mRNA levels is higher than that of techniques 
assessing protein levels, as primers can be designed to be specific to IFN, whilst antibodies 
are more likely to cross-react with other Type I IFNs.  Moreover, the primers may be 
designed to be specific to certain IFN isoform mRNAs (Ealy et al., 1998a), although non-
specific binding with other isoforms may occur due to the high homology between different 
isoforms (over 85%).    Nevertheless, whether at the protein or at the mRNA level, there is a 
need to develop fast, specific, simple, accurate, precise and sensitive IFN detection systems 
to assess IFN production by the pre-implantation bovine embryo.   
 
Table 4 (next page) Techniques available for detecting IFN secretion.    Yes, X: No, NA: Data 
not available from the literature, : approximation, assuming a specific activity of 1 x 108 mg mL-1 










Assay Cell cytopathic assay 
Mx/CAT reporter 
gene assay 
2D-PAGE Western blotting RIA 
Antigen-competition 
ELISA 
What it measures Antiviral Activity Antiviral Activity 
Protein Size and 
isoelectric point 
Protein sequence Protein sequence Protein sequence 
       
Specificity other IFNs Type I IFN IFN IFN IFN and IFN IFN 
       
Rapidity 3 days 3 days 2 days 2 days 2 days 4-5hrs 
       
Sensitivity  0.001 ng mL-1 A 
 0.003 ng mL-1  B 
 0.005 ng mL-1  C 
NA 1 ng 
2 ng mL-1 D 
6 ng mL-1 E 
0.005 ng mL-1F 
0.1 ng mL-1 G 





NA NA 8.5%E 3.1%G 
       
Distinguish Biological 
Activity 
  X X X X
       
Distinguish between 
different Isoforms 
X X  X Possible Possible 
       
Requires maintenance of a 
permissive cell line 
  X X X X
      
Quantitative/Qualitative Quantitative Quantitative Qualitative Qualitative Quantitative Quantitative 
      
Safety Implications viral stocks viral stocks ethidium bromide ethidium bromide radioisotopes X
       
Ease to reproduce in 
different Labs 
     X 
A
 Hernandez-Ledezma et al.,1992, 
B
 Fray et al., 2001, CMann et al., 2002, D Vallet et al., 1988, E Takahashi et al. 2005, F Lo et al., 2002, 
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1.3 Variation in IFN production 
1.3.1 Variation in amount of IFN production 
There is considerable variation in range of IFN detected between bovine studies (Figure 4, 
page 40), with Hernandez-Ledezma et al. (1992, 1993) and Neira et al. (2007) reporting lower 
IFN amounts secreted (two orders of magnitude) than Kimura et al. (2004a,b) and Kubisch et 
al. (1998, 2001a, 2007).  All four studies used the cell-cytopathic assay to determine IFN 
secretion, and the difference in the magnitude of the amount of IFN detected may be due to 
differences in biological activity of the standards used in different studies.  The specific 









.   Hernandez-Ledezma et al. (1992, 
1993) used a human IFN standard (GA-23-902-530) with specific activity ranging between 
1 x 10
8




 which accounts for the 100 fold difference in amount of IFN 
detected in Hernandez-Ledezma et al. (1992, 1993) relative to Kubisch et al. (1998, 2001a,b, 
2004) and Kimura et al. (2004a,b).  Moreover, Neira et al. (2007) used a human IFN 
standard with specific activity ranging between about 8.8 x 10
8





et al., 2007), which accounts for the ten-fold difference in amount of IFN detected between 
Neira et al. (2007) and Hernandez-Ledezma et al. (1992, 1993).  Therefore, differences in 
specific activity of the standards used in different studies account for the variation in IFN 
secretion reported between studies. 
 
Within studies, IFN secretion by individual blastocysts was also highly variable, with values 
ranging ten-fold (Figure 4, page 40).  Variation of IFN secretion could be caused by 
environmental conditions and/or by intrinsic factors within the embryo.  Although some 
factors have been identified as modulators of IFN secretion, the nature of most of the natural 
variation in IFN secretion is still unknown.  Moreover, unknown variables cause ample 
ranges in standard deviations, which may obscure experimental results and was one of the 
main obstacles in understanding IFN regulation.   
1.3.2 Variation in timing of IFN production 
Generally, IFN protein secretion by bovine embryos has been detected as early as day 8 pi 
(time of blastulation, Larson et al., 1991, Hernandez-Ledezma et al., 1992, de Moraes et al., 
1997, Kubisch et al., 1998, 2001a, Chelmonska Soyta et al., 2001), but not before (day 1, 2, 3 

















































































Figure 4  The range (minimum and maximum) of amount of IFN (pg embryo-1 24h-1) detected in 
culture media as reported in different studies observing ruminant blastocysts.  1:  Hernandez-
Ledezma et al. (1992, 1993), 2:  Kubisch et al. (1998, 2001a, 2004),  3: Kimura et al. (2004b), 4: 
Rooke et al. (2005),  5: Neira et al. (2007). 
43 pi (timing of placentation, Stojkovic et al., 1995) but not after (day 69 pi Bartol et al., 
1985, Godkin et al., 1988, Stojkovic et al., 1995), with maximal IFN secretion occurring 
between 16 and 19 dpi (time when luteolysis needs to be prevented by maternal recognition of 
pregnancy).    IFN transcripts were detected in bovine embryos using RT-PCR from the 
eight-cell stage (3 dpi, Gutierrez-Adan et al., 2004a, Kato et al., 2007) to the elongation stage 
(24 dpi), with maximal IFN transcript levels occurring on 15 to 16 dpi (Farin et al., 1990), 
coinciding with the timing of maximal IFN secretion.  IFN mRNA expression has not been 
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protein secretion suggests that (1) changes in IFN mRNA expression explain, at least in part, 
changes in IFN protein secretion, and that (2) IFN production is modulated at the mRNA 
level.  Also, the transient nature of IFN mRNA expression and protein synthesis during the 
time when luteolysis must be prevented (14 to 17 dpo) further substantiates the role of IFN 
as the maternal recognition of pregnancy signal. 
 
Using 2D-PAGE, IFN secretion was detected in culture medium between 16 and 29 dpi 
(Bartol et al., 1985, Helmer et al., 1987, Godkin et al., 1988, Lifsey et al., 1989, Plante et al., 
1990).   Godkin et al. (1988) did not detect IFN secretion on days 32, or 38, whilst Morgan 
et al., 1993 did not detect intracellular IFN using immunocytochemistry on days 25, 30 and 
37 pi.  Meanwhile, Stojkovic et al. (1995) detected IFN protein secretion as late as day 43 pi 
using the more sensitive cell cytopathic assay, suggesting that some of the variation between 
studies in timing of cessation of IFN protein secretion is due to differences in detection 
limits between different methods of detecting IFN protein.  Using the same method of 
detection of IFN (2D-PAGE), Bartol et al. (1985) did not detect any IFN on day 29 pi, 
whilst Godkin et al. (1988) did, suggesting that differences in detection limits of different 
methods of detection of IFN secretion explain only in part the variation between studies on 
the timing of cessation of IFN secretion. 
 
Detection of IFN by in vivo produced and cultured embryos has not been reported prior to 14 
dpi (Kazemi et al., 1988, Robinson et al., 2006), whilst IFN secretion was detected as early 
as day 7 and 8 pi in in-vitro (Johnson et al., 2006) and ex-vivo (de Moraes et al., 1997) 
produced embryos respectively.  The low volume of fluid in the uterine cavity (around 0.2 
mL, Casslen, 1986) means that direct aspiration of uterine fluid is difficult.  Therefore, the 
uterus is flushed with about 2 mL of saline to collect uterine flushings.  The dilution of the 
endometrial/conceptus secretions may lead to the concentration of IFN protein being below 
the detection limit of the techniques available for detecting IFN secretion.  Therefore, 
differences between studies in the onset of IFN secretion may be due to differences in 
embryo production systems. 
 
Culturing the embryo in smaller volumes in vitro (volume ranging from 0.02 and 0.05 mL, 
compared to 2 mL of saline required for uterine flushings, Hamilton et al., 1998) will lead to 
more concentrated levels of IFN in in vitro culture medium than in uterine flushings.  
Another advantage of detecting IFN in culture medium as opposed to uterine flushings is that 
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representing diluent or actual endometrial/conceptus secretion, which may compromise the 
determination of total protein secreted.  Moreover, Hamilton et al. (1998) reported a high 
inter-individual variation in the volume of flushings retrieved.  Despite the advantages of 
reduced variation and increased sensitivity of methods detecting IFN in culture medium as 
opposed to uterine flushings, the disadvantage is that the change in environment from in vivo 
to in vitro may affect the pattern of IFN secretion.   
 
Nevertheless, the improved sensitivity of methods assessing IFN protein secretion in in vitro 
culture medium have led to detection of IFN protein earlier (as early as 7/8 dpi, Kubisch et 
al., 1998, 2001a) in embryo development than with methods dependent on uterine flushings 
(14 dpi, Robinson et al., 2006).  It could be that bovine embryos are able to secrete IFN 
protein before 7 dpi, but at levels below the detection limit of the cell cytopathic assay (0.12 
IU mL
-1
, equivalent to about 1 pg mL
-1





et al., 2007 and Hernandez-Ledezma et al., 1992, 1993) or isoforms with low antiviral 
activity.  Using a sensitive ELISA, Rooke et al. (2005) detected IFN secretion by ovine IVP 
embryos as early as 3 dpi.    The early detection of IFN protein using the ELISA suggests 
that the onset of IFN protein may occur earlier than is possible to detect IFN protein, given 
the detection limits of the current methods for detecting IFN protein.  Therefore, it remains 
unclear when in development IFN mRNA and protein are first produced by bovine embryos 
and development of more sensitive techniques for detecting IFN mRNA and protein are 
necessary to determine the timing of the onset of IFN secretion by bovine embryos.   
 
The sudden onset and cessation of IFN gene expression during embryo development has 
prompted several studies to identify the sequences responsible for controlling IFN 
expression in order to define the molecular mechanisms by which IFN gene transcription is 
regulated.     
1.4 Molecular control of IFN gene expression 
1.4.1 Molecular control of timing of IFN expression 
Positive and negative regulatory domains have been identified in the promoter region of the 
ovine IFN gene.  Given the homology between ovine and bovine isoforms in the non-coding 
regions of the gene (as discussed in section 1.2.2.5.1 and demonstrated inTable 3, page 35), 
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The duplication events that led to IFN from IFN are thought to have disrupted the promoter 
element of the IFN gene so that the enhancer and promoter regions of IFN are very distinct, 
in contrast with the conserved 5‟non-coding regions of other IFNs (Ezashi et al., 1998).    The 
IFN gene contains a TATA box at base position -27 to -33 (Ezashi et al., 1998, 2001), which 
is the likely transcription start site (Fujita et al., 1987, Raj et al., 1989).  The IFN gene also 
contains a conserved  E26 transforming sequence (ETS) DNA binding domain at base 
position -78 to -70  (Ezashi et al., 1998, 2001), which is characterized by a specific enhancer 
sequence CAGGGAAGTG and is the binding site for transcription factor ETS2.  
Overexpression of ETS2 activated transcription of a luciferase reporter under the control of 
the IFN upstream regulatory region in the human choriocarcinoma cell line (JAr), suggests 
ETS2 is a principal regulator of IFN expression.  Moreover, mutations of the ETS DNA-
binding domain reduced ETS2 induction of IFN (Ezashi et al., 2001).  Also, ovine IFN 
isoforms that are poorly expressed lack an ETS2 binding sequence in the proximal promoter 
region (Ezashi et al., 1998), whilst mutation of the promoter region to incorporate a 22 base 
pair active ETS2 binding site restores the full promoter activity of IFN (Matsuda-Minehata 
et al., 2005).  These data collectively suggest that ETS2, through its interaction with the 
promoter region of the IFN gene, is the key regulator of IFN expression.   
 
The promoter region of the IFN gene also contains two activator protein (AP1) binding sites 
between base pairs -77 and -69 (partially overlapping the ETS2 binding site, Ezashi et al., 
1998, 2004) and -616 and -584 (Yamaguchi et al., 2000) upstream of the transcription start 
site of the IFN gene.   AP1 site is the target of protein kinase C (PKC).  The ETS2/AP1 site 
is mutated in certain ovine IFN genes that seem not to be expressed (Ezashi et al., 1998), 
suggesting that activation of the AP1 site is also required for the onset of IFN expression.   
 
As well as enhancer regions, the 5‟ non-coding region of IFN also contains silencer regions.  
By the time the trophoblast is attached and haematopoiesis (the secretion and development of 
blood cells) begins, IFN secretion is undetectable (discussed in section 1.3.2).   Therefore, 
physical association between the trophoblast and the uterine epithelium may play a role in 
inhibiting expression of the IFN gene.  The decline of IFN production also coincides with 
initiation of secretion of Transforming Growth Factor (TGF) , a cytokine regulating multiple 
post-attachment physiological events such as cell migration, growth and differentiation 
(Imakawa et al., 1998), suggesting that IFN  may not be involved in embryo development 
post-attachment.  Possible silencer elements have been identified in the promoter region of the 
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in the precise timed cessation of gene expression. The ovine IFN contains a nucleotide 
sequence identical to TGF inhibitory element (Yamaguchi et al., 2001) through which TGF 
is thought to negatively regulate various genes (Kerr et al., 1990).  Therefore, the timed 
cessation of IFN production is thought to occur at the transcription level, possibly involving 
the binding of TGF onto its binding site on the promoter region of the IFN gene. 
1.4.2 Molecular control of amount of IFN expression 
ETS2 is the key regulator of IFN expression through its interaction with the ETS binding site 
on the promoter region of the IFN gene (described in section 1.4).  Factors affecting the level 
of IFN expression may be dependent on ETS2 binding to its binding site on the promoter of 
the IFN gene.  For instance, activation of the IFN gene by protein kinase A (PKA) is 
dependent on the ETS binding site (Ezashi et al., 2008), and colony stimulating factor (CSF)1, 
a growth factor present in the uterus (Oshima et al., 2003) and shown to increase IFN 
production by ovine embryos (Martal et al., 1997), enhanced upregulation of IFN promoter 
through activation of ETS2 through the mitogen-activated protein kinase (MAPK) signal 
transduction pathway (Ezashi et al. 2004), suggesting that ETS2 mediates the action of 
cytokines on IFN through the MAPK pathway.   
 
The promoter region of the IFN gene also contains two AP1 sites, which are thought to be 
the target of the PKC protein (described in section 1.4).   Granulocyte macrophage colony 
stimulating factor (GM-CSF), a cytokine shown to modulate IFN expression (to be discussed 




 and an AP-1 site at -654 to 
-555 bp (Imakawa et al., 1993, Yamaguchi et al., 1999). Exposure of embryos to a PKC-
inhibitor removed the GM-CSF effect on IFN mRNA (Yamaguchi et al., 1999).  Phorbol 12-
myristate 13-acetate (PMA) is a PKC activator.  PMA was shown to affect ovine IFN 
transactivation in various cell lines (Yamaguchi et al., 1999).  IFN transcription and 
enhancer regions of the IFN gene (-616 to -584 base pairs) confer PMA response 
(Yamaguchi et al., 2001).  Exposure of PMA mimicked the enhancing effect of GM-CSF and 
interleukin (IL) 3 on IFN expression and secretion (Imakawa et al. 1995, 1997), suggesting 
that GM-CSF and IL 3 enhance upregulation of IFN promoter through a PKC mediated 
pathway.   
                                                   
1 Proto-oncogene is a normal gene that can be altered.   
2 C-jun is a gene which, in combination with c-Fos, forms the AP-1 early response transcription factor. 
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Due to the close homology between IFN and other IFNs, the IFN gene does carry two 
putative viral response elements at base positions -69 to -74 and -88 to -93 (Pontzer et al., 
1993).  Unlike other IFNs, IFN is not induced by viruses (Guesdon et al., 1996), so that these 
viral response elements are likely to be inactive.   
 
Recently, other transcription factors have been identified as modulators of IFN expression.  
The homeobox distal-less 3 (DLX3) is an established contributor to trophoblast function in 
mammals (Berghorn et al., 2005) and recognised a specific sequence with a central TAAT 
core motif (Feledy et al., 1999) located in the IFN promoter (-54 to -46, sequence 
GATAATGAG, Ezashi et al., 2008).  Elimination of the DLX3 and ETS2 binding sites (in 
separate experiments) abolished the enhancing effect of DLX3 on IFN expression (Ezashi et 
al., 2008), suggesting that DLX3 associates with ETS2 to enhance expression of IFN.  IFN 
is also regulated by a blastocyst specific transcription factor called caudal-related homeobox 
protein 2 (CDX2, Imakawa et al., 2006), although the location of its interaction on the IFN 
promoter region has not yet been established.   
 
In summary, the IFN gene possesses a complex of regulatory sequences.  The various 
binding sites identified on the promoter region of the IFN gene suggest that the IFN gene 
may require several sets of transcription factors for full transactivation and that more than a 
single cytokine and intracellular signalling pathway are involved.  Thus, multiple genetic, 
intrinsic and environmental factors may modulate IFN expression. 
1.5 Factors affecting onset and cessation of IFN production 
1.5.1 Genetic factors affecting onset and cessation of IFN production 
After fertilisation, the mRNA and protein required for early embryogenesis are derived solely 
from the maternal oocyte and the paternal genotype is not involved.  Embryonic genome 
activation is the event where the embryonic genome becomes transcriptionally active, thus 
replacing transcription of the maternal genes.  Subsequent embryo development is dependent 
on the timing and the correct activation of embryonic genes.  Ruminant embryos undergo 
embryonic genome activation between the two- and eight-cell stage (Memilli and First, 2000).  
Therefore, genetic factors affecting IFN synthesis may be categorised as maternal, paternal 
and embryonic genotype.   
 
Hernandez-Ledezma et al. (1992) suggested that the onset of IFN production is associated 
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IFN from the blastocyst stage onwards.  Moreover, IFN protein (Johnson et al., 2006) and 
mRNA (Farin et al., 1990) have been localised specifically in the trophectoderm of bovine 
blastocysts (discussed in section 1.2.2.4).  On the other hand, Neira et al. (2007) observed that 
IFN was constitutively synthesized in bovine expanding blastocysts, and Johnson et al., 
(2004) detected IFN in cumulus cell masses of in vitro matured oocytes and in morulae (5 to 
6 dpi), although it is possible that these were due to non-specific staining.  Therefore, the 
onset of IFN production may be associated with the emergence of a functional 
trophectoderm.  However, the detection of IFN secretion at the morula and earlier stages (in 
the ovine, Rooke et al., 2005) suggests that some other event must be responsible for 
triggering the secretion of IFN.  Since cell differentiation between the inner cell mass and the 
trophectoderm occurs after the embryonic genome activation, the embryonic genotype may 
have role in modulating the onset of IFN production. 
 
Parthenotes are unfertilised oocytes that have been activated to initiate cell division.  
Blastocysts derived by parthenogenesis are capable of secreting IFN (Kubisch et al., 2003) 
suggesting that the onset of IFN secretion is largely dependent on maternal factors. 
1.5.2 Environmental factors affecting onset and cessation of IFN 
production 
In vivo embryos are fertilised and developed within the mother during pregnancy, with no 
contact with the in vitro environment.  IVP embryos are fertilised and cultured in vitro, with 
no contact with the in vivo oviductal or uterine environment.  Ex-vivo production of embryos 
involves fertilisation occurring in vivo followed by culture of the embryo in the in vitro 
environment.  Since IFN is a secretory protein and detection of IFN in IVC medium is more 
sensitive and less variable than in uterine flushings (discussed in section 1.3.2), the ex-vivo 
culture system has been used in studies assessing IFN secretion by in vivo embryos (Helmer 
et al., 1987, Godkin et al., 1988, Plante et al., 1990, Stojkovic et al., 1999, Kubisch et al., 
2001b, Kimura et al., 2004a, Neira et al., 2007).  The ex-vitro production system involves 
fertilisation in vitro before transferring the embryo into the in vivo environment.  IFN 
expression and secretion has been detected by embryos produced and cultured in these 
different embryo production systems.   
 
IFN mRNA was detected using RT-PCR in in vivo blastocysts recovered at 7 dpi (Wrenzycki 
et al., 1998, Bertolini et al., 2002) and has not been reported in earlier stages in in vivo 
produced bovine embryos.   In contrast, IVP bovine embryos expressed detectable amounts of 
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same study, IVP bovine embryos transferred into the ewe oviduct 20 hpi and retrieved daily 
between 1 and 4 dpi (Gutierrez-Adan et al., 2004) did not produce detectable amounts of 
IFN mRNA before 4 dpi, suggesting that the in vitro environment advances the temporal 
pattern of transcription of the IFN gene compared to the in vivo environment.   
 
Secretion of  IFN protein by embryos produced in an in vivo production system has not been 
detected before 14 dpi, whilst embryos produced in an ex-vivo production system secreted 
IFN as early as day 8 (Kimura et al., 2004a), earlier than in in vivo developed embryos not 
exposed to the in vitro environment.   Using IVP embryos, Kubisch et al. (1998, 2001a) and 
Hernandez-Ledezma et al. (1992) detected IFN on day 8 pi, thus IVP embryos secreted IFN 
earlier than embryos exposed to the in vivo environment.  Rather than the in vitro 
environment advancing the onset of IFN secretion, it is more likely that the differences in the 
timing of first detection of IFN between different embryo production systems are due to 
differences in detection limits from the different methods used by different studies to detect 
IFN.   
 
The similar timing of onset of IFN secretion (Figure 5, page 49) by IVP (Hernandez-
Ledezma et al., 1992, Neira et al., 2007) and ex-vivo produced embryos (de Moraes et al., 
1997) suggests that IFN secretion occurs at a specific chronological age.  However, 
Hernandez-Ledezma et al. (1992) only detected IFN expression and secretion by blastocysts, 
irrespective of day of blastulation, and did not detect IFN expression or secretion by 
morulae, suggesting that the onset of IFN is developmentally regulated, as opposed to 
chronologically regulated.   
 
In vivo, Godkin et al. (1988) observed that although one variant of IFN  was present up to 22 
dpi, other isoforms were present beyond 24 dpi and up to 29 dpi, but not thereafter, coinciding 
with the time of attachment.  In vitro, Hernandez-Ledezma et al. (1992) found that IVP 
embryos produced IFN  from 8 to 16 dpi, after which the embryos did not survive.  
However, exposure of IVP embryos to the uterine environment in vivo between 8 to 12 dpi 
extended embryo survival to 31 dpi, and the embryos continued to secrete IFN until 31 dpi, 
after IFN  secretion ceases in vivo, suggesting that signalling from the uterine environment is 
necessary to stop secretion of IFN.    
 
Uncertainties remain as to what event triggers and stops IFN secretion during embryonic 
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of IFN secretion does not require uterine factors, so that the onset of IFN expression is 
likely to be a genetically programmed event.  Moreover, the capacity of parthenotes to secrete 
IFN (Kubisch et al., 2003) suggests that the onset of IFN is solely dependent on maternal 
factors.  Alternatively, IFN was detected in IVP embryos at 43 dpi (Stojkovic et al., 1995), 
after the timing of cessation in vivo (25 dpi, Kazemi et al., 1988), suggesting that cessation of 
IFN is dependent on uterine factors.  Therefore, although the onset of IFN secretion is likely 
to be genetically regulated, the cessation of IFN is likely to be environmentally regulated. 
 
Figure 5 The effect of embryo origin and production system on timing (dpi: dpi, the expected 
stage of development) of IFN synthesis in bovine embryos. Maximum IFN secretion by in vivo 
embryos consistently occurs during the timing of maternal recognition of pregnancy (between 17 
and 20 dpi).  IFN secretion by in vivo embryos was not assessed before 14dpi, and was not 
detected during the period of attachment (30 and 37 dpi).  The pattern of secretion by ex-vivo 
embryos followed a similar pattern of secretion than in vivo embryos, with maximum secretion 
between 16 and 19 dpi, reducing to minimal levels by 29 dpi, and not being detected on 32, 38 and 
69 dpi.  The pattern of secretion by in vitro produced (IVP) embryos reported by different studies 
is considerably more inconsistent than by in vivo or ex vivo embryos, possibly due to  
perturbations caused by the in vitro environment and/or lack of maternal signals.    Exposure of 
IVP embryos to the in vivo environment between 8 to 16 dpi changed the pattern of secretion to a 
progressively increasing profile, with IFN secretion extending to 31 dpi, suggesting that the in 
vivo environment is necessary to reduce and stop IFN secretion after the timing of maternal 
recognition of pregnancy.   
x: not detected, : detected,  : maximum level detected in the study,  not assessed.  Compac.: 
compaction, MRP: maternal recognition of pregnancy.  Numbers refer to days post insemination 
(Dpi).  References (Ref.): A. Bartol et al., 1985, B. Godkin et al.,1988, C. Kazemi et al., 1988, D. 
Lifsey et al., 1989, E. Hernandez-Ledezma et al., 1992, F. Hernandez-Ledezma et al., 1992, G.  
Morgan et al., 1993, H. Stojkovic et al., 1995, I. Kimura et al., 2004b, J. Stojkovic et al., 1999, K. 
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1.6 Factors affecting the amount of IFN synthesis 
1.6.1 Genetic factors affecting amount of IFN production 
Ovine blastocysts expressed higher levels of IFN transcript than bovine blastocysts (Rizos et 
al., 2004), suggesting that genetics may play a role in the variation of IFN transcript levels.     
1.6.1.1 Paternal genotype 
Paternal breed differences was shown to significantly influence the ability of bovine oocytes 
to reach the blastocyst stage (Shamsuddin and Larson,1993), suggesting that the paternal 
genotype could be a modulator of IFN secretion.   In fact, paternal genotype significantly 
influenced IFN secretion (Kubisch et al., 2001a), as blastocysts fertilised with Hereford 
semen secreted almost two-fold more IFN than those fertilised with Holstein or Angus 
semen.  This difference was irrespective of differences in penetration given the cleavage rates 
were not affected (Kubisch et al., 2001a).  However, parthenogenic embryos do not contain 
paternal genome and the similarity in the levels of IFN mRNA expressed between in vitro 
fertilised-embryos and parthenotes suggests that IFN expression is not affected by the lack of 
paternal genetic contributions (Kubisch et al., 2003).  Embryo sex is a paternal factor.  
Although no sex bias was observed in IFN secretion by Kubisch et al. (2004), other studies 
have shown that female embryos expressed (Kimura et al., 2003, 2004a,b) and secreted 
(Larson et al., 2001, Kimura et al., 2004a,b) higher levels of IFN (two- to seven-fold) than 
male embryos.  The reasons for discrepancies between studies are unknown, but suggest that 
at least in certain conditions, sex will modulate IFN expression and secretion, along with 
other paternal factors, such as genotype and breed. 
1.6.1.2 Maternal genotype 
Using fewer embryos (43 as opposed to 333 blastocysts used in the paternal genotype study) 
Kubisch et al. (2001a) also evaluated the effect of the maternal genotype on IFN production.  
Using the same batch of sperm from the same sire to artificially inseminate six cows of four 
different breeds (Santa Gertrudis, Angus, Simmental and Holstein cows), embryos were 
flushed after 7 dpi and „maternal factor‟ was a significant determinant of IFN secretion 
(P<0.01).  Unfortunately, this study did not report whether these differences were due to 
different cows or different breeds and the interaction between maternal and paternal factors 
were not evaluated.   
 
The presence of GM-CSF between days 1 and 3 of in vitro culture (one-cell to eight-cell) of 
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suggesting that an event before or at activation of the embryonic genome activation was 
responsible for stimulating IFN secretion at the blastocyst stage (Rooke et al., 2005).  Since 
the maternal genotype is solely responsible for embryo development before the embryonic 
genome activation, then it follows that that the maternal genotype is responsible for at least 
part of the variation in the levels of IFN secreted in this study.   
 
In summary, maternal and paternal genotype may explain some of the individual variation in 
IFN synthesis between embryos cultured in similar conditions.  Although the maternal 
genotype is likely to modulate the onset of IFN production, both the maternal and the 
paternal genotype may affect the amount of IFN synthesized.   
1.6.2 Intrinsic factors affecting amount of IFN production 
Intrinsic factors are defined as characteristics arising from the basic structure of the embryo 
which may have been modulated by both genetic and/or environmental factors, and include 
batch of ovaries, stage of development, rate of development, cell proliferation, morphology, 
size and relative transcript abundance.  Intrinsic factors explain individual variation in IFN 
secretion between embryos exposed to similar conditions.   
1.6.2.1 Batch of ovaries 
Composition of ages, breeds, pregnancy status or stage of oestrous cycles of cows at slaughter 
vary between batches of ovaries, so that it is possible that variation in the proportion of these 
factors between batches may influence IFN secretion.  Therefore, batch of ovaries is a 
determinant modulated by both genetic (such as maternal genotype) and environmental 
factors (such as hormones, temperature, cytokines).  Batch of ovaries was a significant source 
of variation in the amount of IFN secreted (Kubisch et al., 2001a).  Given that overall 
cleavage and development to the blastocyst stage was not affected by batches of ovaries 
suggests that the genetic and environmental factors associated with batches of ovaries are 
modulators of IFN synthesis.   
1.6.2.2 Stage of development 
Secretion of IFN protein increased with development from blastocyst to expanded blastocyst 
to hatching blastocyst (Kubisch et al., 1998, 2001a, Wrenzycki et al., 1999, Hernandez-
Ledezma et al., 1992, 1993).  IVP hatched blastocysts secreted 10-fold more IFN than 
expanding blastocysts (Hernandez-Ledezma et al., 1992).   Similarly, Kimura et al. (2004b) 
observed a 10-fold increase in IFN secretion between 8 and 9 dpi compared to between 9 and 
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embryos (Neira et al., 2007).  Stojkovic et al. (1999) also observed a six-fold linear increase 
in IFN secretion by IVP bovine embryos between days 11 and 23, when elongation and 
attachment occur in vivo.  IFN secreted by IVP embryos exposed to the uterine environment 
in vivo between days 8 and 12 pi increased two fold from day 13 to 15 (when elongation 
occurs), three fold from day 13 to 27 pi (when elongation and attachment occur) and 10-fold 
by day 31 pi (when the chorionic membrane forms, Hernandez-Ledezma et al., 1992).  
Around the time of attachment (day 16 to 18 pi), Robinson et al. (2006) detected between 30 
and 100 mg of IFN in uterine flushings from pregnant cows.  Therefore, stage of 
development explains at least in part the variation in IFN secretion, irrespective of the 
embryo production system.    
1.6.2.3 Speed of development 
Speed of development determines the developmental stage reached at a certain time after 
insemination.  Kubisch et al. (1998, 2001a) observed that the day at which blastocyst 
formation occurs affected the level of IFN secretion, with blastocysts forming on 10 dpi 
secreting six-fold more IFN than blastocysts forming on 7 dpi.  In agreement, Larson et al. 
(2001) observed that blastocysts forming on day 10 pi secreted four-fold more IFN in the 
first 24 h after blastocyst formation than blastocysts forming on day 7 pi and two-fold more 
than blastocysts forming on day 8 pi.  Similarly, earlier forming blastocysts consistently 
expressed less IFN than later forming ones (Wrenzycki et al 2003, Gutierrez-Adan et al., 
2004a), suggesting that the modulation of IFN synthesis by timing of blastulation occurs at 
the transcriptional level.   
 
Given that earlier developing blastocysts are more likely to give rise to pregnancies (Hasler et 
al., 1995), one possible explanation is that the higher IFN secretion by later forming 
blastocysts may, as suggested by Kubisch et al. (1998), be due to a breakdown of the genetic 
control over development caused by a reduction in viability, thus suggesting a negative 
relationship between IFN production and embryo viability.   
1.6.2.4 Ability to hatch 
Blastocysts which hatched by day 8 pi secreted significantly more IFN than non-hatched day 
8 pi blastocysts (Stojkovic et al., 1995).  Similarly, blastocysts which hatched by day 9 pi 
secreted significantly more IFN than non-hatched day 9 pi blastocysts (Neira et al., 2007) 
and blastocysts which hatched by day 10 pi secreted significantly more IFN than non-
hatched day 10 pi blastocysts (Larson et al., 2001).  Therefore, hatched and hatching 
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possible explanations for these findings.  Firstly, hatching ability is an index of developmental 
competence (Rizos et al., 2004, George et al., 2006), and embryos which did not hatch may 
have had reduced viability.  Secondly, embryos which did not hatch may be viable, but have a 
slower rate of development.  This is unlikely to be the case given that increased rate of 
development decreases IFN expression and secretion levels (discussed in section 1.6.2.3).  
Thirdly, and most likely, IFN secretion is developmentally regulated, so that embryos later in 
development (hatched) secrete higher levels of IFN than embryos earlier in development 
(non-hatched), as discussed in section 1.6.2.2.   
1.6.2.5 Cell proliferation 
IFN transcript levels were higher in embryos cultured in tissue culture medium (TCM) with 
serum when compared with bovine serum albumin (BSA) supplemented TCM, and the 
increase in IFN expression was coupled with an increase in cell number (Russell et al., 
2006), suggesting a positive relationship between IFN expression and cell count.  Culturing 
embryos in vitro with polyvinyl alcohol (PVA)-supplemented medium led to fewer cells and 
more IFN secretion per embryo than with BSA supplemented media (Kubisch et al., 2001a), 
suggesting a negative relationship between IFN secretion and cell proliferation.  However, 
these blastocysts also had a delay in development, which probably accounted for the fewer 
cells.  However, other studies assessing IVP (Neira et al., 2007, Kubisch et al., 1998, Larson 
& Kubisch, 1999) or  ex-vivo bovine embryos (Stojkovic et al., 1999) observed no significant 
relationship between IFN secretion and cell numbers.  Therefore, there was no consistent 
relationship between IFN secretion and cell proliferation.  One explanation is that IFN is 
specifically secreted by trophoblast cells (as discussed in section 1.2.2.4), and inner cell mass 
to trophectoderm ratios vary between blastocysts (Neira et al., 2007). Stojkovic et al. (1999) 
estimated trophoblast growth by calculating the surface areas of embryos from their 
diameters.  Although this is only a crude estimation of trophoblast cell number since embryos 
may collapse and re-expand, there was a significant positive correlation between trophoblast 
area and IFN secretion.  Lo and Summers (2001) also observed that embryo diameter was 
positively correlated with IFN secretion, suggesting that IFN secretion may be positively 
correlated to embryo size and number of cells secreting IFN.   
1.6.2.6 Embryo morphology 
 Morphological parameters are used to grade embryos and include characteristics of the 
blastomeres (size, shape, colour and compaction), zona pellucida (rigidity and elasticity), 
perivitelline space (size and presence of cellular debris), presence of extruded cells or cell 
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attachment and pregnancy rate, with blastocysts with good morphological grade yielding 
higher attachment rates than blastocysts with poor morphological grade (Balaban et al., 2000).   
 
Comparison of IFN secretion with embryo morphological grade has not been assessed in 
bovine embryos in vivo.  However, in sheep, IFN activity was higher in uterine flushings (14 
dpi) from embryos with good morphological grade compared to poor morphological grade 
(assessed on day 14pi), although low number of replicates meant that this difference was not 
significant (Abecia et al., 2001).  Therefore, IFN secretion in vivo by ovine embryos may be 
positively correlated to morphological grade.  Moreover, the same study reported that when 
the flushed embryos were cultured in vitro, embryos with good morphological grade secreted 
more (P=0.07) IFN than poor embryos, which could be due to higher numbers of 
degenerating cells in poor embryos.  In agreement, Neira et al. (2007) reported that ex-vivo 
bovine embryos with good morphological grade secreted higher levels of IFN than poor 
embryos, suggesting that IFN secretion in vitro by in vivo derived bovine embryos was 
positively correlated to morphological grade.   
 
Using IVP bovine embryos, Russell et al. (2006) observed that embryos cultured in TCM with 
serum showed greater expansion of the blastocoele and expressed higher levels of IFN 
mRNA than embryos cultured in other media (SOF, or BSA, supplemented TCM) which, in 
turn, were noticeably darker and had reduced expansion of blastocoelic cavity, suggesting that 
IFN secretion may be associated with morphological grade at the transcriptional level.  
Using IVP embryos, Hernandez-Ledezma et al. (1993) also reported that hatched blastocysts 
with good morphological grade secreted more IFN than hatched blastocysts with poor 
morphological grade, further suggesting that IFN secretion by in vitro derived bovine 
embryos was positively correlated to morphological grade.  .   
 
On the other hand, Kubisch et al. (1998) reported that IFN secretion was not affected by 
morphological grade and Larson et al. (2001) observed that female embryos, which showed 
poorer morphological grade compared to males, secreted more (two-fold) IFN than males.  
Also, ovine blastocysts that looked morphologically similar had different capabilities to 
secrete IFN and some viable day 10 embryos produced in vitro secreted low amounts of 
IFN (Lo and Summers, 2002), suggesting that other factors may modulate IFN secretion in 
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Different studies investigating the correlation between morphological grade and IFN 
secretion by blastocysts have used different criteria to categorise blastocysts.  Hernandez-
Ledezma et al. (1993) and Neira et al. (2007) used  a criteria (established by Lindner and 
Wright, 1983) to grade embryos into 4 categories (Poor, Fair, Good, Excellent) based on 
embryo shape, size, cellular integrity and appearance of the cytoplasm and nucleus, whilst 
Kubisch et al. (1998, 2001a) graded embryos into 3 categories solely on embryo shape, 
cellular uniformity and integrity, extrusions and collapse, and Lo and Summers (2002) 
assessed viability based on survival in extended culture in vitro and morphology based on the 
presence of the inner cell mass, extent of blastocyst expansion and embryo size.  Therefore, 
discrepancies between studies investigating the correlation between morphological grade and 
IFN secretion by blastocysts may be due to different studies using different criteria and 
different number of categories to segregate embryos according to morphology.    
 
Morphological grade assessment evaluates an embryo according to its appearance at a specific 
time, without any account of the change in appearance during culture.  Neira et al. (2007) 
used only blastocysts on day 7 pi with excellent morphological grade to assess IFN secretion 
for 24 hour individual culture, and then assessed the morphology of the blastocyst after 
individual culture, and observed a positive correlation between IFN secretion and embryo 
morphological grade.  Meanwhile, Kubisch et al. (1998) used embryos with a range of 
morphological grades before individual culture for assessment of IFN secretion, and 
observed no relationship between IFN and morphological grade.  Also, Hernandez-Ledezma 
et al. (1993) assessed the relationship between IFN and embryo morphology within each 
stage of blastocyst development, whilst Lo and Summers (2002) took no account of stage of 
development.  Therefore, differences in homogeneity of the population of embryos may affect 
the relationship between IFN and morphological grade.   
 
Therefore, the relationship between IFN secretion and embryo morphology was inconsistent 
due to variation between studies in criteria used to evaluate embryos according to 
morphology, homogeneity of the population of embryos assessed, and due to the subjective 
nature of morphological grading, so that it remains inconclusive whether IFN secretion is 
associated with embryo morphological grade assessed as morphology.   
1.6.2.7 Viability 
Hernandez-Ledezma et al. (1992) observed a reduction in IFN secretion from an IVP bovine 
embryo from 15 to 16 dpi, when the embryo died, suggesting that the reduction in IFN 
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the ability of the embryo to synthesize IFN as the embryo died.  Although these observations 
are on a single embryo, they suggest that embryo viability may be an intrinsic factor affecting 
amount of IFN produced, with embryo death being a cause for cessation of IFN production.     
1.6.3 Environmental factors affecting amount of IFN production 
Extrinsic factors are environmental determinants that are not transmitted genetically, and 
include the embryo production system, medium composition, embryo density, ambient 
temperature, oxygen, cytokine and hormone levels and embryo manipulation.  Environmental 
factors observed to affect IFN production may be categorised as those which promote 
embryo development (discussed in section 1.7), and those which are detrimental to embryo 
development (discussed in section 1.8). 
1.7 Beneficial environmental factors 
The embryo has certain environmental requirements that must be met for it to develop.  These 
include nutritional needs (pyruvate, glucose, amino-acids, albumin) necessary to maintain the 
embryos metabolism, temperature (around 38.5C), osmolarity (around 290 mOsmo) and pH 
(around 7.2).  Other factors are not essential for embryonic development, but have been 
shown to improve embryo viability (measured in terms of blastocyst rate, pregnancy rate, live 
birth rate).  Beneficial environmental factors shown to affect IFN secretion include 
hormones and cytokines.   
 
Embryos flushed from cows in which the luteal phase had been advanced by administration of 
progesterone between days 1 and 4 in the cycle produced more IFN than controls (Garrett et 
al., 1988, Mann et al., 2006).  Similarly, ewes with a history of an early luteal phase gave rise 
to embryos that secreted more IFN than ewes with delayed luteal phases (Nephew et al., 
1991).  Therefore, IFN secretion is modulated by the timing of the maternal oestrous cycle, 
suggesting that IFN may be modulated by hormones.  In vivo, follicle stimulating hormone 
was shown to affect translocation of IFN into the nucleus, suggesting a role for hormones in 
localisation of IFN in vivo (Johnson et al., 2004).   
 
Bovine embryos cultured in groups secreted more IFN per embryo than embryos cultured 
individually (Larson and Kubsich, 1999), suggesting that compounds secreted by other 
embryos may modulate IFN secretion.  Embryos secrete cytokines which act as intercellular 
communication signals essential for controlling immunological adaptation and tissue 
remodelling processes necessary for successful development.  Therefore, cytokines may be 
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individual culture.  Culturing bovine embryos in the presence of supernatants of leukocytes 
activated with a pathogen caused an increase in IFN production (Chelmonska-Soyta et al., 
2001), suggesting that cytokines secreted by leukocytes are able to modulate IFN secretion.  
In vivo studies on oviductal and uterine tissue from pregnant cows have demonstrated 
expression and translation of cytokines in these tissues, confirming that as the pre-attachment 
embryo moves through the female reproductive tract, it is exposed to a range of cytokines 
(Table 5, page 58).   mRNA expression of interleukins (IL 1; Leung et al., 2000), growth 
factors (leukaemia inhibitory factor; Oshima et al., 2003; insulin-like growth factor (IGF 1), 
fibroblast growth factor (FGF), platelet derived growth factor (PDGF), TGF, Watson et al., 
1992) and CSFs (GM-CSF, macrophage-CSF (M-CSF), CSF1) have been detected in the 
oviduct and the uterine endometrium of pregnant cows.  Given that the timing and amount of 
IFN expression and secretion differ in in vitro relative to in vivo (Gutierrez-Adan et al., 
2004a, Neira et al., 2007) this implies that cytokines may be involved in IFN production (as 
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Table 5  Cytokines implicated or detected in establishment and maintenance of pregnancy in cattle and their suggested roles.  IL: interleukin; GM: granulocyte 
macrophage; CSF: colony stimulating factor; LIF: Leukaemia Inhibitory Factor; IGF:  insulin growth factor; PDGF:  platelet derived growth factor; TGF:  
transforming growth factor; FGF:  fibroblast growth factor; q:  quantitative; RT-PCR: reverse transcription polymerase chain reaction; ELISA: enzyme linked 
immunosorbent assay, pi: post-insemination, po: post-oestrus.  References (Ref): 1. Roberts et al., 1992, 2. Watson et al., 1992, 3. Mathialagan et al., 1992, 4. 
Davidson, 1994, 5. de Moraes et al., 1999, 6. Leung et al., 2000, 7. Oshima et al., 2003, 8. Lee et al., 2003, 9. Michael et al., 2006a. 
Cytokine Tissue Source Timing of Secretion Detection Method Implications in Pregnancy Ref 
IFN Embryo (Trophoblast) ~Day 7-25 pi,  
Peak during luteolysis (days 16-19 pi) 
 
Cell cytopathic assay 
 
Maternal recognition of 
pregnancy 
1 
IL 6 Embryo At time of embryo elongation/attachment 
 
RT-PCR Unknown 3 
IL 1 Endometrium 
 
Day 11-17 po in cyclic and pregnant cows  
Not detected in pregnant cows at days 25-
30 pi 
ELISA Stimulate prostaglandin 
synthesis, prepare 
endometrium for attachment 
4 
IL 1 Endometrium Day 16 po qRT-PCR  6 
 
GM-CSF Endometrium (Uterus)  
Embryo 
 







Endometrium Day 16-17, 20-21, 30-36, 48-49, 74-140.  
Higher during days 74-140. 
 
qRT-PCR Regulate invasion during 
attachment 
7 
CSF 1 Endometrium (Uterus) 
Embryo (Trophoblast) 
Day 14-70 pi 
 




LIF Endometrium Day 16-140 pi 
 
qRT-PCR Attachment 7 
IGF 1, FGF, 
PDGF, TGF 
 
Endometrium (Oviduct)  
Embryo 
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Supplementation of bovine embryo culture medium with leukaemia inhibitory factor (LIF) 
improved development to the expanded blastocyst stage (Fukui et al., 1994), increased 
numbers of cells per blastocyst (Funstun et al., 1997) and improved survival rates after 
thawing of cryopreserved bovine embryos (Han et al., 1995).  FGF2 was shown to increase 
blastocyst yield (Lim and Hansel, 2000).  Using cell lines, FGF2 has also been shown to 
enhance synthesis and secretion of IFN by a trophoblast cell line (Michael et al., 2006 a) 
whilst PGF2 synthesis in endometrial cells was stimulated by IL 1 (Davidson et al., 1995).  
Of these cytokines, only GM-CSF was shown to modulate IFN secretion by bovine embryos 
cultured in vitro (Emond et al., 2004), whilst IL 3 (Imakawa et al., 1995, 1997), IGF-I and 
IGF II (Ko et al. 1991) and GM-CSF (Imakawa et al. 1995) significantly increased IFN 
secretion by ovine embryos cultured in vitro.  Therefore, cytokines present in the oviductal 
fluid may be vital for the processes of oocyte maturation, fertilisation and early embryonic 
development before the embryo reaches the uterus.    
1.7.1 GM-CSF 
GM-CSF is a major CSF
3
 which belongs to the „short chain 4-helical bundle family‟ of 
cytokines, consisting of a  monomeric protein with a compact globular shape and secondary 
structures containing both -helix and -sheet structures (Wingfield et al., 1988).   GM-CSF 
stimulates stem cells to produce granulocytes and macrophages, from which its name was 
derived (Burgess and Metcalf, 1980).  In mammals, GM-CSF is produced by immune cells 
(dendritic cells, T cells and macrophages), endothelial cells and fibroblasts (Haig, 1992) and 
modulates proliferation, differentiation and survival of in vitro cell cultures of various 
lineages (such as granulocytes and macrophages).  GM-CSF is also implicated in enhancing 
immune functions of mature cells (Metcalf, 1984) by upregulating Class II major 
histocompatibility antigens (Fischer et al., 1988), increasing the bactericidal activity of 
macrophages (Morissey et al., 1989) and activating neutrophils and macrophages to enhance 
phagocytosis (Clark and Kamen, 1987).  Moreover, GM-CSF was shown to induce 
production of other cytokines, such as IL 1 and tumour necrosis factor (TNF) by cells such 
as monocytes and macrophages (Ihle, 1990).   
 
GM-CSF exerts its autocrine and paracrine effects on target cells by binding to high affinity 
heterodimeric receptor complexes with  and  subunits (Miyajima et al., 1992) which are 
members of the cytokine receptor superfamily, so that only cells expressing GM-CSF 
                                                   
3 Colony stimulating factors are a family of glycoprotein cytokines which were named after their 
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receptors are able to exhibit biological responsiveness to GM-CSF.  The  subunit is unique 
to GM-CSF, whereas the  subunit is shared by other cytokines (IL 3 and IL 5 receptors, 
Groot et al., 1998).  The  subunit is able to bind to GM-CSF on its own with low affinity.  
Although the  subunit cannot bind ligand by itself, when in a receptor complex with the 
subunit, the interaction between the ligand and its receptor becomes high affinity 
(Hayashida et al. 1990).  Binding of GM-CSF to its receptor leads to the activation of signal 
transduction pathways which eventually lead to changes in the gene expression of the target 
cell.  Most research on GM-CSF signalling has focused on the regulation of proliferation, 
differentiation and cellular survival by GM-CSF through the Janus-activated kinase/signal 
transducers and activators of transcription (JAK/STAT), MAPK and phosphatidyl-inositol 
(PI3K) pathways (reviewed in Groot et al., 1998) rather than on its roles in improving 
immune function.  More work is therefore required to understand the cytoplasmic signalling 
route used by GM-CSF to exert its immune effects on the target cell.   
 
Although not assessed in bovine embryos, human and murine embryos express GM-CSF 
receptor (GM-CSFR) (human: Loke et al., 1992, Jokhi et al., 1994a, Sjoblom et al., 2002, 
murine: Robertson et al., 2001), and in murine embryos, GMCSFR mRNA was detected from 
fertilisation, and GMCSFR protein from the two cell stage (Robertson et al., 2001), 
suggesting that the embryo is able to respond physiologically to the presence of GM-CSF 
through binding to its receptor from the two-cell stage.  This was demonstrated in in vitro 
studies where supplementation of culture medium with GM-CSF was shown to promote IFN 
secretion and embryo development.   
 
Although not assessed in the bovine ovary, GM-CSF mRNA expression and protein synthesis 
in the human ovary (Table 6, page 61) has been detected mainly in small and large luteal cells 
and the theca interna of large follicles, which are associated with the later stages of follicular 
development (Zhao et al., 1995).  Therefore, GM-CSF levels close to the ovary would be 
expected to be higher during the late tertiary or preovulatory stages of folliculogenesis, 
suggesting that the amount of GM-CSF in the ovary change as the oestrous cycle progresses.  
The spatial and temporal localisation of GM-CSF in the reproductive tract coupled with 
variation in expression between different tissues of the reproductive tract suggests that, as the 
embryo moves through the reproductive tract it is exposed to different amounts of GM-CSF at 
different stages of development.  Therefore, timing and amount of exposure of GM-CSF may 
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Table 6 Localisation of GM-CSF mRNA and protein in human ovarian tissue measured by RT-
PCR, in situ hybridisation and immunohistochemistry as described in Zhao et al. (1995).  - : not 
assessed, 0 : not detected, 1 : low levels, 2: high levels.   
 GM-CSF 
 mRNA Protein 
Oocyte 0 1 










    
Follicular cells 
large follicles 0 1 
small follicles 0 1 
primary follicles 0 - 










   











1.7.1.1 Effect of pregnancy on production of GM-CSF by the female reproductive 
tract 
In vivo, immunoreactive GM-CSF was detected by western blotting in a greater proportion of 
samples of uterine flushings from pregnant cows (75%, n=4) compared to cyclic cows (50%, 
n=18, de Moraes et al., 1999), suggesting that GM-CSF synthesis was stimulated by the 
presence of the embryo.    
 
In mice, Robertson et al. (1992) observed that GM-CSF was at least 20-fold higher in uterine 
luminal fluids from mated compared to non-mated females, suggesting that GM-CSF was 
produced in the female reproductive tract in response to mating and/or cervical stimulation.  
GM-CSF activity was not detected in secretions from male accessory glands (seminal vesicle, 
epididymis, prostate and coagulating glands) suggesting that stimulation of uterine GM-CSF 
after mating was not due to GM-CSF derived from the ejaculate.  GM-CSF activity was 
detected in uterine fluid of mice mated with vasectomised or syngeneic males, indicating that 
the stimulus for GM-CSF production was not associated with sperm or an allogeneic major 
histocompatibility complex haplotype, although other factors present in seminal plasma may 
have been involved (Robertson and Seamark, 1990).  Tremellen et al. (1998) detected TGF1 
in murine seminal vesicle secretions and found that recombinant TGF stimulated GM-CSF 
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GM-CSF in uterine fluid when instilled into the uterine lumen, implicating TGF as a key 
factor in GM-CSF stimulation by mating.  GM-CSF receptors have been detected in bovine 
and ovine spermatozoa (Rodriguez-Gil et al., 2007), suggesting that sperm are able to respond 
to the GM-CSF secreted by the uterine endometrial cells.  The stimulation of GM-CSF by 
seminal factors coupled with the presence of GM-CSFR on sperm implicates GM-CSF in 
fertilisation. 
 
GM-CSF secretion has been observed in in vitro cultures of GM-CSF secreting cells exposed 
to cytokines which tend to occur at higher levels during pregnancy (pregnancy-related 
cytokines).   GM-CSF secretion by rat ovary cell cultures was increased in a dose-dependent 
manner by stimulation with IL 1 and IL 2 (Brannstrom et al., 1994).  IL 1 also increased the 
level of GM-CSF protein in pre-ovulatory rat ovaries (Brannstrom et al., 1994).   IFN had no 
effect on IL 2 induced GM-CSF, but did antagonize the action of IL 1 by the human first 
trimester trophoblast cells (Jokhi et al., 1994b).  Therefore, some pregnancy-related cytokines 
are able to modulate GM-CSF secretion, suggesting a link between pregnancy and GM-CSF.   
1.7.1.2 Localisation of GM-CSF  
In cows, GM-CSF protein was detected (by western blotting) in uterine flushings from 
pregnant cows and was immunolocalised to the uterus and the oviduct, being most abundant 
in epithelial cells (de Moraes et al. 1999).  Therefore, as the embryo travels through the 
female reproductive tract, it is exposed to GM-CSF.  GM-CSF protein was detected between 
days 18 and 24 of pregnancy in regions of the trophectoderm where attachment was not 
advanced (Emond et al., 2004).  Therefore, the bovine embryo is also capable of secreting 
GM-CSF.   
 
In other mammals, GM-CSF protein was detected in uterine intraluminal fluids from pregnant 
mice by a GM-CSF-dependent cell-line assay (Robertson et al., 1992).  Although GM-CSF 
localisation in ovarian tissue has not been assessed in ruminants, Zhao et al. (1995) 
demonstrated that GM-CSF mRNA and protein were present in human ovaries.  As with 
cows, the epithelial cells were the major site of GM-CSF protein in the human oviduct (Zhao 
and Chegini 1994) and in the uterus of humans (Giacomini et al. 1995), mice (Robertson et 
al., 1996) and sheep (Imakawa et al., 1993).  In the human embryo, GM-CSF protein (Jokhi et 
al., 1994b) and mRNA (King et al., 1995) were localised in villous and extravillous 
trophoblast.    Therefore, the pattern of localisation of GM-CSF in the embryo and 
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1.7.1.3 Beneficial effects of GM-CSF on embryo development  
The evidence of the beneficial effects of GM-CSF on embryo development is more abundant 
in human and murine in vitro studies than in bovine studies.  Exposure of human embryos at 
the two-cell stage to GM-CSF inhibited apoptosis (Sjoblom et al., 2002), whilst in murine 
embryos, GM-CSF facilitated glucose uptake (Robertson et al., 2001) and enhanced glucose 
metabolism (Ko et al., 2002).  GM-CSF also improved blastomere proliferation and viability 
in human (Loke et al., 1992) and murine embryos (Robertson et al., 2001), particularly in the 
inner cell mass (in murine embryos: Sjoblom et al., 2002).  As with the bovine (de Moraes et 
al., 1997), human (Sjoblom et al., 1999) two-cell embryos exposed to GM-CSF were more 
likely to reach the blastocyst stage and murine eight-cell embryos exposed to GM-CSF were 
more likely to hatch and implant than controls (Robertson et al., 2001).  Exposure to GM-CSF 
also led to earlier blastulation and improved ability of the blastocyst to hatch from the zona 
pellucida (in human: Sjoblom et al., 1999).  GM-CSF stimulated DNA synthesis and 
differentiation by the trophoblast (Drake and Head, 1994).  Treatment with GM-CSF 
increased foetal survival for female mice through a T-cell dependent mechanism that may 
have involved inhibition of natural killer (NK) cell activity (Clark et al., 1994), suggesting a 
role for GM-CSF in resistance to maternal immune rejection.  Exposing pre-blastocyst 
embryos to GM-CSF instigated beneficial effects not only in the pre-attachment period of 
development, but also later in gestation (increased attachment success, improved 
morphogenesis of the placental labyrinthine tissue and superior growth and development of 
the foetus), in the postnatal period (increased growth and adiposity in adult progeny), and in 
subsequent generations (increased foetal-to-placental weight ratio) (Robertson et al., 2001).  
Moreover, GM-CSF knockout mice showed reduced proliferation and rate of blastocyst 
formation, decreased foetal size, decreased placental labyrinthae, increased foetal loss and 
greater mortality during postnatal life (Robertson et al., 1999, 2001).  These studies 
collectively suggested that GM-CSF is beneficial to embryo development in mammals.   
Role of GM-CSF in blastulation 
In the bovine, GM-CSF increased the proportion of cultured IVP two-cell embryos that 
developed to the blastocyst stage between days 5 and 7 after fertilisation (de Moraes and 
Hansen, 1997), when the embryo resides in the uterine lumen and the endometrium is under 
the influence of progesterone (de Moraes et al., 1999), suggesting that the beneficial effects of 
GM-CSF on embryo development observed in other species also occur with bovine embryos.  
Similarly, in other mammalian embryos, rGM-CSF exposure was reported to cause a two-fold 
increase in blastocyst development in vitro from human zygotes (Sjoblom et al., 1999) and 
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associated with an increase in blastocyst yield, suggesting that although GM-CSF is not 
essential for blastulation, GM-CSF must modulate one or more of the processes involved in 
blastulation.   
 
Processes involved in blastulation include cell proliferation, cell differentiation into 
trophectoderm and inner cell mass, and cavitation (reviewed by Watson et al., 1992).  Each of 
these mechanisms is regulated by other systems.  For instance, net cell proliferation is 
affected by apoptosis and rate of metabolism.  GM-CSF null mutant mice have fewer cells 
than normal mice (Robertson et al. 2001) and in human embryos, the increase in the size of 
the inner cell mass compartment is associated with a 50% reduction in apoptotic nuclei 
(Sjoblom et al., 2002), suggesting that GM-CSF may be a modulator of cell proliferation and 
apoptosis.  Also, increased blastulation due to exposure of murine embryos to rmGM-CSF, 
was associated with an increase in glucose metabolism (Robertson et al., 1999), reduced DNA 
degradation (Robertson et al., 2001) and enhanced expression of the anti-apoptotic factor B-
cell lymphoma (Bcl)-2 (Behr et al., 2005), suggesting that GM-CSF may increase blastocyst 
yield by increasing metabolism and reducing apoptosis.  However, the effects of rGM-CSF on 
apoptosis and metabolism in bovine blastocysts have not been reported.   
 
The effect of rGM-CSF on glucose metabolism, was observed in the murine system.  
Robertson et al. (2001) associated increased cell number, rate of development and viability of 
murine embryos exposed to rmGM-CSF with an enhanced metabolic activity measured in 
terms of increase in glucose uptake.   However, rmGM-CSF exposure does not affect the 
expression of three major facilitated glucose transporter isoforms involved in glucose uptake 
by murine embryos (Ko et al., 2002), so that the mechanism by which GM-CSF increases 
glucose metabolism is not yet understood.    
1.7.1.4 The relationship between GM-CSF and IFN secretion  
IVP bovine blastocysts transferred in vivo on day 8 pi and recovered on day 12 pi produced 
approximately 500 times more IFN than IVP embryos that were not exposed to the in vivo 
environment (Hernandez-Ledezma et al., 1992), suggesting that in vivo IFN secretion is 
supported by endometrial factors.  In vitro studies have demonstrated that GM-CSF had a 
positive effect on IFN secretion (in ovine embryos: Imakawa et al., 1993, 1997, Rooke et al., 
2005, in bovine trophectoderm cell-lines: Michael et al., 2006b), suggesting that GM-CSF 
may be among the endometrial factors supporting IFN secretion in vivo.  GM-CSF 
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abundance of IFN mRNA (Michael et al., 2006 b), suggesting that GM-CSF alters a 
translational or post-translational mechanism in order to increase IFN secretion.   
 
The involvement of GM-CSF in the mechanism of maternal recognition of pregnancy in cattle 
is summarised in Figure 6 (page 66).  IFN acts through the IFN receptor located on the 
luminal epithelium of the uterus to stimulate expression of the enzyme cyclooxygenase 
(COX)2 (Asselin et al., 1997b).  COX2 subsequently stimulates PGF2 synthesis in the 
uterine stroma (Emond et al., 2000) and luminal epithelium (Asselin et al., 1997a) which in 
turn stimulates GM-CSF expression by endometrial lymphocytes (Emond et al., 1998) and 
luminal epithelial cells (Emond et al., 2000).  In sheep, GM-CSF secreted from the uterus acts 
through the GM-CSFR on the embryo and increases expression of IFN through the PKC 
signalling pathway (Yamaguchi et al., 2001), so that an amplification loop becomes 
established between IFN and GM-CSF (Emond et al., 2000), both upregulating each other.  
In rats, GM-CSF in the luminal epithelium is further stimulated by oestrogen and 
progesterone secreted by the ovaries (Tamura et al., 1999), whilst in the bovine, epithelial 
PGF2 acts on the ovary to maintain the corpus luteum, to avoid immune rejection (Emond et 
al., 1998, 2000).  The amplification loop between IFN and GM-CSF, and between GM-CSF 
and ovarian steroids explains why GM-CSF concentration in the uterine endometrium 
increases during pregnancy (de Moraes et al., 1999).  GM-CSF derived from the embryo 
(Emond et al., 2004) may also have a role in this amplification loop as it binds to maternal 
GM-CSFR, and the GM-CSFR from the embryo itself.   The localisation of GM-CSF in both 
maternal and embryonic tissues, the increase in IFN secretion by the embryo due to GM-
CSF exposure (as reviewed in section 2.1.3) and the increase in GM-CSF concentration 
during maternal recognition of pregnancy further suggests that GM-CSF participates in the 
communication between the female reproductive tract and the embryo. 
1.7.2 Conclusion 
In mammals, the site-specific localisation of GM-CSF in the reproductive tract, the 
localisation of GM-CSF receptors in the embryo, the modulation of GM-CSF by mating and 
pregnancy, and the benefits of GM-CSF to embryonic development are indicative of the 
relevance of GM-CSF to early embryonic development.  In cattle, GM-CSF was localised to 
the reproductive tract and the embryonic trophectoderm, and was shown to be beneficial to 
embryo development, suggesting a similar beneficial function for GM-CSF in bovine 
embryology as described in other mammals.  Moreover, GM-CSF seems to be a factor 
affecting IFN secretion, suggesting a role for GM-CSF in maternal recognition of pregnancy 










Figure 6 The role of GM-CSF in the communication between the embryo and the uterus in cattle.  
 The embryo secretes IFN which acts on the maternal endometrium coupling to the IFNR (Li 
and Roberts, 1994).  IFN exposure causes an increase in COX2 synthesis by epithelial cells 
(Asselin et al., 1997),  and a subsequent increase in prostaglandin F2 (PG) synthesis by 
epithelial cells (Emond et al., 1998, 2000).   PG synthesis causes an increase in GM-CSF by 
endometrial lymphocytes (Emond et al., 1998).   GM-CSF acts on the embryo through its 
receptor (ovine : Yamaguchi et al., 2001),  increasing IFN transcript levels through the PKC 
pathway.   Increase in expression leads to an increase in synthesis of IFN.   IFN is also able 
to bind to IFNR on the embryo itself (ovine :  Imakawa et al., 2002). 
1.8 Detrimental environmental factors 
Stress is a condition in which an organism is subjected to a stressor.  The stressor may cause 
an unfavourable deviation from the normal function of the organism which may be 
detrimental to its survival.  In terms of embryology, stress conditions have been categorised 
(Kiang and Tsokos, 1998) as physiological (such as cycle of cell division, growth factors, cell 
differentiation, tissue development, hormonal stimulation), pathological (such as viral, 
bacterial or parasitic infection) and environmental (such as exposure to heat shock, heavy 
metals, metabolic inhibitors, amino acid analogues, ethanol, antibiotics, radiation, osmotic 
stress, acidic and alkaline environments).  Stressful conditions may cause damage to 
macromolecules, such as protein denaturation and misfolding, which may lead to embryo 
death. To ensure survival, embryos exhibit a degree of plasticity and are able to adapt to 
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Stress response is a defence reaction of cells to stress in order to restore normal function.  As 
outlined in Figure 7 (page 69), the cell may respond to damage that stressful conditions cause 
to macromolecules without regard to the type of stress that causes the damage (cellular stress 
response), or the cell may direct its response at re-establishing homeostasis (homeostatic 
stress response).  Homeostatic stress response is stressor specific and is often activated in 
parallel to cellular stress response (Kultz et al, 2005).  Examples of homeostatic stress 
response in embryos include control of intracellular pH, calcium and amino acid 
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into cells until intracellular pH is restored to below 7.2 (Lane, 1999).  Membrane calcium 
channels allow the embryo to maintain calcium concentrations at around 100 nM in an 
oviductal environment containing 1 to 2mM calcium (Borland et al., 1977).  The embryo is 
able to transport non-essential amino-acids in and out of cells to balance osmotic stress and 
stabilise protein function (Yancey et al., 1982).   
 
Once the stress level becomes higher than the embryo can cope with through homeostasis, 
embryo survival then relies on the cellular stress response.  Cellular stress response involves 
an epigenetic repair system to repair damage caused by stress and involves a sudden increase 
in expression of “Heat Stress Proteins” (HSPs, also known as “Heat Shock Proteins”) and a 
change in gene expression upon exposure to stress (Kiang and Tsokos, 1998, Figure 7, 
page69).  HSPs are also known as stress-induced proteins, as they are stimulated by stressors 
other than heat (Tomasini et al., 2002).  HSP70 are a family of 70 kDa proteins which are the 
most frequently studied and best understood effectors of the cellular stress response.  The role 
of HSP70 is to protect cells against the adverse effects of stress (Kawarsky and King, 2001).  
HSP70 function as molecular chaperones by interacting with other proteins without being part 
of the final protein structure (Becker and Craig, 1994).  In the absence of stress, heat shock 
cognate protein (HSC) is involved in the maintenance of proteins in proper configuration to 
ensure correct biological activity (Morimoto et al., 1997), thus taking part in a wide range of 
physiological processes required for normal growth and proliferation and whose activities are 
affected by other cytokines, such as TNF (Mehlen et al., 1995).  HSP70 protect proteins from 
degradation by (1) preventing inappropriate protein aggregation, (2) ensuring proper folding 
,and (3) mediating transport of immature proteins by guiding protein movements through 
membranes to target organelles for packaging, degradation or repair, thus ensuring proper 
cellular localisation and enhancing cellular repair mechanisms (Martinus et al., 1995).  In the 
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abnormal associations until normal conditions are re-established.  At higher levels of stress, 
HSP70 also has a role in accelerating correct refolding, and tagging damaged protein for 
transport to proteosomes and lysosomes for degradation (Parsell and Lindquist, 1993).  Stress-
inducible HSP70s, therefore, supplement constitutively expressed HSC70 to provide 
protection from adverse conditions for the essential cellular functions to occur.   
 
Increase in HSP70 mRNA expression was observed when embryos were exposed to increased 
levels of stress.  HSP70 transcript levels were higher in in vitro cultured embryos compared to 
in vivo cultured embryos (Wrenzycki et al., 2001b).  As the in vitro environment is considered 
to be more stressful for the embryo than the in vivo environment, then upregulation of HSP70 
mRNA levels in vitro relative to in vivo associates HSP70 synthesis with exposure of embryos 
to stressors.  Moreover, embryos cultured in TCM-199 (Wrenzycki et al., 1999), in the 
presence of 10% serum (Russell et al., 2006 and Wrenzycki et al., 1999) and arsenite (Dix et 
al., 1996), also increased HSP70 transcription.  Dix et al. (1996) found that embryos with 
increased HSP70 transcription survived exposure to arsenite, suggesting that HSP70 was 
involved with the embryonic repair system to protect the cells from DNA (Dong and Luo, 
1994)  and protein damage (Wang and Lazarides, 1984) caused by arsenite.  Dix et al. (1996) 
suggested that the increased requirement for HSP70 to respond to a stressor could reduce the 
levels of HSP70s available for normal development processes, thus impairing embryo 
development in the presence of arsenite, despite the protection of HSP70.  The protective role 
of HSP70 leads towards a decrease in cellular injury due to stress, so that the repaired cells 
are then able to quantify stress and activate apoptosis when tolerance limits are exceeded, 
restoring the integrity of the embryo as a whole.   
 
Besides the cellular stress response pathway, stress may activate other pathways that are 
interactive.  Pathways activated by stress, in increasing lethality, include modified gene 
expression, modified metabolism, apoptosis and necrosis, with the stress level determining the 
degree of perturbation. Modified gene expression and modified metabolism led to modified 
developmental kinetics during embryo development, and maternal/embryo asynchrony when 
in utero, modified foetal/placental metabolism, which can then lead to abnormal foetal 
development and abortion (Thompson et al., 2002).    Apoptosis and fragmentation may lead 
to abnormal compaction, modified inner cell mass to trophectoderm allocation which may 
then lead to modified foetal/placental ratio, leading to abnormal foetal growth and possibly 
abortion (Leese et al., 1998), whilst extensive necrosis will lead to embryo death.  Therefore, 
as suggested by Fleming et al. (2004), because of stress-induced pathologies, stressed 









Figure 7  Mechanism by which stress response leads to cell survival.  There are two types of 
stress response: cellular stress response, whereby the cell may respond to the damage caused by 
the stress or homeostatic stress response, whereby the cell responds directly to the stressor via 
homeostasis.   
 
Therefore, when exposed to a stressor, the first defence system at the cellular level is 
homeostasis.  The embryo is considered to be stressed once the levels of stress are higher than 
the embryo can cope with through homeostatic response, so that the embryo responds to stress 
via induction of HSP70.   If the embryo is unable to respond to stress via cellular stress 
response or if the level of stress is too high for the HSP70s to refold or degrade damaged 
proteins, then apoptosis occurs, followed by necrosis and embryo death.  Therefore, the 
ability of an embryo to respond to stress through the cellular stress response mechanism is 
beneficial to the viability of the embryo.  However, stress-induced pathologies are the 
outcome of pathways activated by stress.  Although the ability of an embryo to respond to 
stress has not been compared with the embryo viability in vitro or in vivo, it is proposed that 
reduced developmental competence is indicative that the embryo is stressed.   
 
The suggestion that elevated IFN secretion could be a stress response to sub-optimal culture 
conditions (Kubisch et al., 1998) has led to a number of studies observing the effect of 
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factors, such as in vitro environment, embryo manipulation, cryogenic stress, oxidative stress 
and thermal stress could give insight into whether IFN secretion is an index of stress.   
1.8.1 Effect of embryo production system on IFN production 
Detrimental culture systems are culture systems shown to reduce embryo development and 
viability and are therefore likely to constitute stressors for embryos.  Studies have compared 
IFN production by embryos cultured in different embryo production systems demonstrated 
to be detrimental to embryo survival.   
 
IVP embryos have significantly poorer morphological grade (Thompson, 1997), blastomere 
survival (Hardy and Spanos, 2002), ultrastructure, physiology, sensitivity to cryoinjury (Holm 
et al., 1998), gene expression (Niemann and Wrenzycki, 2000), metabolism (Khurana and 
Niemann, 2000 a) and foetal and postnatal development (Farin and Farin, 1995) compared to 
their in vivo counterparts, suggesting that the in vitro environment may be a stressor for 
embryos.  Wrenzycki et al. (2000, 2001b) and Lonergan et al. (2001) found that in vitro 
derived blastocysts expressed higher levels of IFN transcripts than blastocysts produced in 
vivo.  The decrease in IFN transcript levels was associated with a decrease in embryo 
viability and an increase in HSP70 expression, indicative of stress, supporting the hypothesis 
that an increased level of IFN mRNA is an indicator that the embryo is stressed.   
 
In in vitro studies, certain protein sources are associated with reduced embryo viability and 
are therefore a stressor to the embryo.  Embryos cultured in the absence of protein (medium 
supplemented with PVA) relative to embryos cultured in BSA-supplemented medium 
(Wrenzycki et al., 1999, Kubisch et al. 2001a) had fewer cells and delayed blastocyst 
formation, both indicators of a decrease in developmental competence.  These embryos also 
had an increase in IFN secretion, suggesting that IFN may be an index of stress.  Embryos 
cultured in serum-supplemented medium had increased transcript levels of LIF, a gene 
associated with attachment and differentiation and increased rate of development with more 
blastocysts developing by day 6 compared to embryos cultured in the absence of serum 
(BSA), indicating improved developmental competence,  which was accompanied by 
decreased levels of IFN transcripts (Rizos et al., 2003). These studies suggest that increased 
IFN expression may be associated with decreased embryo viability caused by stress.    
1.8.2 Effect of embryo manipulation on IFN production 
Embryo manipulation techniques, such as nuclear transfer and embryo splitting, caused 
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stressors.  However effects of these different embryo manipulation techniques on IFN are 
inconsistent.  Nuclear transfer embryos contained more IFN mRNA than IVP embryos 
(Wrenzycki et al., 2001a), and secreted less IFN than in vivo or IVP embryos (Stojkovic et 
al., 1999).  Blastomere biopsy at the eight-cell stage, however, had no effect on IFN protein 
secretion (Kubisch and Johnson, 2007) and split embryos secreted less IFN than embryos 
which remained intact (Stojkovic et al., 1999).  The discrepancy between the three studies in 
terms of an association between IFN secretion and stress induced by embryo manipulation 
suggests that different embryo manipulation techniques affect rate of IFN transcription and 
translation differently.  One possible explanation is that IFN is not an index of stress.  An 
alternative explanation could be that different embryo manipulation techniques cause varied 
levels of perturbation to the embryo, and IFN production is affected differently at different 
levels of stress, depending on the level of stress (homeostatic, HSP70 expression, apoptosis, 
necrosis).  It is, at present, unclear why different embryo manipulation techniques affect IFN 
expression and transcription in different ways and more data are required to explain 
inconsistencies. 
1.8.3 Effect of cryogenic stress on IFN production  
Cryopreservation causes physical lesions in the blastomeres due to formation of ice crystals 
inside and outside the cells (Vajta et al., 1997) and the osmotic effects of the cryoprotectants 
during dehydration and hydration of the embryo (Saha and Suzuki, 1997). Cryopreservation 
also causes cell ultra-structural alterations (such as fragmentation of nuclear membranes, 
Wiemer et al., 1995) and a reduction in cell numbers (Kaidi et al., 1999). Consequently, 
frozen/thawed embryos contained a higher number of apoptotic cells than fresh embryos 
(Marquez-Alvaral et al., 2004) and pregnancy rate following transfer of frozen embryos is 
consistently lower than fresh embryos (Massip et al., 1995, Agca et al., 1998, Ambrose et al., 
1999).  Therefore, cryogenic stress seems to cause a decrease in embryo viability.  Araujo et 
al. (2005) compared IFN secretion in fresh and frozen embryos, 7 days after the blastocyst 
stage, and reported that frozen embryos secreted less IFN than fresh embryos.  As considered 
by Stojkovic et al. (1995), a decrease in IFN production may be due to damage due to 
freezing (physical lesions, or biochemical alterations) affecting the viability of the embryo 
and its capacity to secrete IFN.  However, cryopreserved embryos survived for at least 7 
days after cryopreservation/thawing, suggesting that the viability of the embryo as a whole 
was not compromised, at least for the 7 days.  A more plausible explanation is that 
cryopreservation affected the viability of trophoblast cells and their ability to secrete IFN.  In 
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trophoblast cells compared to fresh embryos.  Therefore, the reduction in IFN secretion in 
cryopreserved embryos compared to fresh embryos may be due to a reduction in numbers of 
cells secreting IFN, rather than a modulation of IFN secretion per cell.  Unfortunately, 
Araujo et al., (2005) did not evaluate cell count.  Therefore, it is unclear whether cryogenic 
stress affects IFN secretion per cell.   
1.8.4 Effect of oxidative stress on IFN production 
Since the oxygen concentration in the mammalian uterus and oviduct was lower than 
atmospheric oxygen levels (20%, Fischer and Bavister, 1993), embryos are usually cultured at 
5% oxygen to imitate the in vivo environment.  Although there was some discrepancy as to 
the benefits of 5% oxygen compared to 20% in terms of blastocyst rate (Khurana and 
Niemann, 2000 b, Booth et al., 2005, Correa et al., 2008) and cleavage rate (Correa et al., 
2008), most studies have reported that reducing oxygen concentration is beneficial to the 
embryonic development (Lim et al. 1999; Yuan et al., 2003; Kitagawa et al., 2004; Petersen et 
al., 2005, Olson and Seidel 2000; Takahashi et al. 2000).  The mechanism by which higher 
oxygen concentrations are stressful to the embryo may be due to accumulation of reactive 
oxygen species (ROS, Thompson et al., 1990) which alter gene expression (Mouatassim et al., 
1999), and eventually lead to a deterioration of embryo grade and survival.  Embryos are able 
to survive oxidative stress due to the activity of antioxidant enzymes (Harvey et al., 1995), 
such as Mn-SOD, which protects cells against toxic oxygen radicals by scavenging 
superoxide radicals, and catalase and glutathione peroxidase, which eliminate hydrogen 
peroxide, the product of Mn-SOD activity (Guerin et al., 2001).  Gene expression for these 
enzymes is induced by stress:  embryos cultured at 20% oxygen had increased transcript 
levels of the Mn-SOD gene (Correa et al.,  2008). 
 
The interest in the association between oxidative stress and IFN production arose because 
female embryos expressed more IFN than male embryos (Kimura et al., 2004a,b), and male 
embryos are more sensitive than female embryos to oxidative stress due to increased glucose-
6-phosphate dehydrogenase (G6PDH) activity and greater pentose phosphate pathway flux in 
females (Kimura et al., 2004b), suggesting that IFN and oxidative stress may be related.   
 
Kimura et al. (2004b) cultured embryos in the presence of 0, 100 and 200µM of hydrogen 
peroxide (a product of superoxide dismutase), and found that oxidative stress had no effect on 
IFN secretion.  Also, IFN expression (Correa et al., 2008) and protein (Kimura et al., 
2004b) levels did not differ between 20 and 5% oxygen concentration despite an increase in 
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related to oxidative stress.  Conversely, Kubisch and Johnson (2007) cultured embryos under 
5 and 20% oxygen and found that embryos cultured at 20% oxygen secreted more IFN 
protein (12.22.8 ng at 20% oxygen vs 5.02.6 ng at 5% oxygen, meanSEM) and had lower 
blastocyst yields (42% blastocyst yield at 20% oxygen vs 25% blastocyst yield at 5% oxygen) 
than embryos cultured at 5% oxygen, so that the reduced IFN secretion at a more stressful 
high oxygen environment indicates that increased IFN levels may be positively associated 
with stress.  Correa et al. (2008) did, however, observe a high variability in IFN expression, 
possibly due to the use of pools of 15 embryos, ranging from early to hatched blastocysts.  
Therefore, the lack of an effect of oxidative stress on IFN expression and secretion, as 
reported by Correa et al. (2008) and Kimura et al. (2004b) may be due to the high variation in 
IFN.  Therefore, there are discrepancies between papers on the effect of oxidative stress on 
IFN expression and secretion, probably due to the variable nature of IFN. 
1.8.5 Effect of maternal heat stress on IFN secretion 
Seasonal studies in subtropical environments where temperatures may be as high as 43ºC in 
the summer and as low as 4ºC in the winter (as in Florida), have consistently reported reduced 
conception rates in summer.  Summer heat stress caused a 20-30% decrease in pregnancy rate 
(based on pregnancy diagnosis 6-8 weeks pi) compared to winter in one study (Cavestany et 
al., 1985) and a 60% decrease in pregnancy rate (based on rectal examination at 36-40 dpi) in 
another (Badinga et al., 1985).  Therefore, summer months are associated with reduced 
pregnancy rates.   
 
A number of studies have confirmed that the seasonal difference is indeed due to elevated 
temperature.  While observing pregnancy loss in cattle, Garcia-Ispierto et al. (2006) collected 
data on a range of variables used to determine which variables caused foetal loss and 
concluded that heat stress was amongst the main factors, with the likelihood of pregnancy loss 
increasing by 1.05-fold for each additional unit of the mean maximum temperature-humidity 
index from days 21 to 30 of gestation.  Dunlap and Vincent (1971) exposed cows to high 
(32.2C) and low (21.1C) temperature for 72 h following artificial insemination and reported 
conception rates of 0 and 48% respectively, confirming that reduced fertility in summer 
months are due to high temperatures.  Increased rectal temperatures in heat stressed cows 
compared to controls (Geisert et al., 1988, Putney et al., 1988a, 1989) suggest that elevated 
ambient temperatures caused an increase in temperatures in the uterus.  The detrimental effect 
of heat stress on embryo development was further emphasized by the correlation between 
increased rectal temperature of pregnant cows (from 39 to 42C) and the increase in the 
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(1969) reported that pregnancy rate of cows with rectal temperatures up to 39.7C at the time 
of insemination was over two-fold higher than of those with rectal temperatures above 
39.7C.  Therefore, the reduced fertility due to maternal heat stress may be caused by an 
increase in the body temperature of the cows.       
 
Al-Katanani et al. (2002) compared in vitro blastocyst development from oocytes derived 
from summer and winter cows and found that the proportion of oocytes that developed to the 
blastocyst stage by day eight was lower in the summer compared with winter.  Putney et al. 
(1989) observed that summer heat stress also affected the rate of development of the embryo 
(increased incidence of slow-developing embryos in the summer compared to winter) and 
morphological grade (fair to poor morphological grade in the summer compared to good 
morphological grade in the winter).  Therefore, maternal heat stress seems to be detrimental to 
embryo development.   
 
Exposure of in vivo produced day 17 pi concepti to 43C for 18 h caused a reduction in 
intracellular incorporation of proteins by embryos as well as a 72% reduction in IFN 
secretion in vitro, as determined by SDS-PAGE and immunoblotting (Putney et al., 1988b), 
so that heat stress caused a reduction in IFN secretion probably due to a reduced capacity of 
the embryo to incorporate other proteins in the medium.  These embryos were further stressed 
from culture at high (47.5%) oxygen concentration so that it could be that the stress levels in 
this study were chronic and that the reduced IFN secretion may be indicative of impaired 
development and reduced survival.  However, this cannot be confirmed, given that the 
embryos were only cultured for 24 h, and that the effect of treatment on the viability was not 
tested.  Exposure of pregnant cows to a milder heat-stress treatment (37C)  between eight 
and 17 dpi caused an increase in IFN in uterine flushings at 17 dpi compared to control cows 
(21C, Geisert et al., 1988).  Increase in IFN was accompanied by increased rectal 
temperatures and increased uterine protein and calcium concentrations, suggesting that 
changes in IFN may be due to altered uterine environment.  The same study observed that 
heat treatment caused a decrease in embryo weight relative to control, suggesting a 
detrimental effect of heat stress on embryo development.  Therefore, increased IFN secretion 
in vivo may be associated with stress.   
 
In vitro, the effects of heat stress (41 to 43C) on embryo development reported have been 
decreased cleavage rate (Sugiyama et al., 2003), decreased development past the eight-cell 
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high temperatures caused decreased viability of pre-attachment bovine embryos.  Synthesis of 
HSP70 in bovine pre-attachment embryos was also induced by high temperatures (Kawarsky 
and King, 2001).  The effect of heat stress on IFN secretion by IVP ruminant embryos has 
not been observed and, therefore, requires further analysis.   
1.8.6 IFN production as an index of stress 
One way to determine whether IFN production is a response to stress is to expose embryos to 
a known stressor and measure IFN expression and/or secretion.  All studies which exposed 
embryos to known stressors reported a positive relationship between IFN expression and 
stress (Table 7, page 76), suggesting that increased IFN expression may be an index of 
stress.  However, there are discrepancies between studies relating IFN secretion and stress 
(Table 8, page 76).  Three studies (Putney et al., 1988b, Stojkovic et al., 1999, Araujo et al., 
2005) observed a negative relationship between IFN secretion and stress which could be due 
to lethal stress levels. These studies also observed no significant relationship between IFN 
production and stress due to high variation in IFN production (Kimura et al., 2004b, Correa 
et al., 2008).   
 
Therefore, factors other than stress may modulate IFN synthesis at the post-transcriptional 
level.  IFN synthesis may also be affected by the level of stress (homeostasis, HSP70 
expression, apoptosis, necrosis, embryo death).   If IFN production is a stress response to 
adverse conditions, it may contribute to an attempt of the embryo to overcome sub-optimal 
conditions in vivo and enhance its own survival by modifying uterine function (Kubisch et al., 









Table 7  Direction of change in IFN transcript abundance in ‘stressed’ compared with ‘non-
stressed’ embryos.   : ‘Stressed’ embryos expressed significantly more IFN mRNA than ‘non-
stressed’ embryos.   ():  Non-significant increase in IFN expression in ‘stressed’ compared to 
‘non stressed’ embryos.   
Stressor IFN Reference 
In vitro environment  Wrenzycki et al., 2000, 2001b 
Lonergan et al., 2001 
   
Protein source  Wrenzycki et al., 1999  
Rizos et al., 2003 
   
Nuclear Transfer   Wrenzycki et al., 2001a 
 
Oxidative Stress () Correa et al., 2008 
   
  Kubisch and Johnson, 2007 
 
Table 8  Direction of change in IFN protein secretion in ‘stressed’ compared with ‘non-stressed’ 
embryos   : ‘Stressed’ embryos secreted significantly more IFN than ‘non-stressed’ embryos.   
:  No significant change between ‘stressed’ and ‘non-stressed’ embryos.  :  ‘Non-stressed’ 
embryos secreted significantly more IFN protein than ‘stressed’ embryos.  
Stressor IFN Reference 
In vitro environment  Kubisch et al., 1998 
   
Protein source  Kubisch et al., 2001a 
 
Nuclear Transfer   Stojkovic et al., 1999 
 
   
Embryo Splitting  Stojkovic et al., 1999 
   
Blastomere Biopsy  Kubisch and Johnson, 2007 
   
Cryogenic Stress  Araujo et al., 2005 
   
Oxidative Stress  Kimura et al., 2004b 
   
  Kubisch and Johnson, 2007 
   
Thermal Stress (in vivo)  
 
Geisert et al., 1988  










IFN secretion by bovine embryos in vivo increases to a maximum during the time when 
luteolysis needs to be prevented by maternal recognition of pregnancy (outlined in section 
1.3, page 39).  IFN expression and secretion by bovine embryos vary, both in terms of timing 
of onset and cessation (section 1.3.2, page 39), and in amount of IFN secreted (section 1.3.1, 
page 1.3.1).  As discussed in sections 1.5 (page 45) and 1.6 (page 50), several intrinsic and 
extrinsic factors have been shown to explain at least part of the variation in IFN secretion 
and, therefore, have a role in controlling the cross-talk between the embryo and the maternal 
system.  The timing of onset of IFN expression and secretion seems to be genetically or 
intrinsically regulated, whilst environmental factors seem to be responsible for controlling the 
timing of cessation and the amount of IFN secreted (reviewed in sections 1.5 and 1.6).  The 
complexity of the control of IFN secretion by intrinsic and extrinsic factors which are only 
partly understood has lead to inconsistencies in the results from different in vivo studies.  
Therefore, there is a need for in vitro studies to simplify and understand the mechanism of 
IFN secretion.  IVP embryos also secrete IFN.  The control of IFN secretion by embryos in 
vitro, in the absence of the maternal system, remains unclear.  Although genetic programming 
seems to be involved in controlling IFN secretion (as discussed in section 1.5, page 45) and 
bovine embryos have been shown to be responsive to some environmental factors (outlined in 
section 1.6.3, page 56), significant variation in IFN secretion by IVP embryos (outlined in 
section 1.3, page 39) remains unexplained.  Most studies assessing factors affecting IFN 
expression and secretion have observed IFN production during the timing of elongation.  
However, different factors may not have the same effect at different stages of development, so 
that there is a need to improve understanding of modulation of IFN at the blastocyst stage.  
Therefore, the hypothesis of this thesis is that  
 environmental factors explain the variation in IFN secretion by IVP bovine 
blastocysts.   
 
Therefore, in order to determine whether beneficial or detrimental environmental factors may 
regulate IFN expression and secretion at the blastocyst stage, two experiments were designed 
to have a positive (exposure to a cytokine, GM-CSF, shown to be beneficial to embryo 
development in vitro) or negative (exposure to elevated temperatures) effect on embryo 
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sections 1.7.1, page 20) and heat stress (section 1.8.5, page 73) have been shown modulate 
IFN secretion by bovine embryos in vivo.  In doing so, the objective of this thesis was: 
 to determine whether IFN production by IVP bovine blastocysts was affected by 
beneficial or detrimental environmental factors 
 
 and the aims were: 
 
(1) To determine whether exposing embryos to a beneficial cytokine, GM-CSF, affects 
IFN secretion in vitro, and whether IFN secretion in vitro correlates with blastocyst 
parameters (Chapter 2); 
 
(2) To determine whether mild heat stress modulates IFN expression in vitro (Chapter 
3).   
 
In order to assess IFN expression, a further aim was to develop an improved method for 
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2 EFFECT OF TIMING AND AMOUNT OF GM-
CSF AT EARLY STAGES OF DEVELOPMENT 
ON SECRETION OF IFN DURING IN VITRO 
CULTURE OF BOVINE EMBRYOS 
2.1 Introduction  
In situ hybridisation and immunohistochemistry demonstrated that GM-CSF and GM-CSFR 
localisation in the ovary, oviduct and uterus (as reviewed in section 1.7.1.1) was site specific.  
In the bovine, the uterine epithelium was the major site of GM-CSF synthesis, with the 
luminal epithelium containing more GM-CSF (de Moraes et al., 1999) than the glandular 
epithelium.  Since the uterus is the site of blastulation and attachment, localisation of GM-
CSF in the uterus suggests a role for GM-CSF during blastulation and attachment.  In the 
bovine oviduct, GM-CSF was immunolocalised to the epithelium in both ciliated and non-
ciliated cells of the ampullary and isthmic sections of the oviduct (de Moraes et al., 1999).  
Given that the oviduct is the major site of fertilisation and early embryo development, the 
presence of GM-CSF in the oviduct suggests that GM-CSF may have a role in embryo 
development before the morula stage.  The ampulla is the site of acrosome reaction and 
fertilisation (Herz et al., 1985), whilst the isthmus is the site of pre-compaction embryo 
development.  The ampulla has a higher concentration of GM-CSF compared to the isthmus 
(de Moraes et al., 1999).  Therefore, as the embryo travels through the oviduct, the embryo (at 
different stages of embryo development) is exposed to different concentrations of GM-CSF. 
2.1.1 Effect of varied concentration of GM-CSF on embryo development 
and secretion of IFN  
Neither 1 or 10 ng mL
-1
 GM-CSF had any effect on IFN secretion by ex-vivo produced 
bovine embryos recovered on days 16 to 18 pi (de Moraes et al., 1997).  In contrast, Imakawa 
et al. (1997) observed an 8.3 fold increase in IFN mRNA abundance and protein secretion by 
ovine embryos recovered on day 16 pi and cultured for 24 h in the presence or absence of 3.3 
ng mL
-1
 of GM-CSF. Imakawa et al. (1993) found that GM-CSF was stimulatory at 3.3 to 6.6 
ng mL
-1
, but had no effect on IFN secretion at 13.2 ng mL
-1
.  Inconsistencies between the 
studies by de Moraes and Imakawa could be due to differences in the concentration of GM-
CSF. 
 
Dose-response studies of GM-CSF have been performed on bovine, ovine, murine and 
porcine embryo development in vitro (Figure 8, page 82). The magnitude of the response was 
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murine embryos (Robertson et al., 2001, Ko et al., 2002, and Behr et al., 2005) for a 
proportion of  the rGM-CSF concentrations tested.  Increased concentration of rGM-CSF after 
the optimum concentration (0.125, 2 and 3.3 ng mL
-1
 in Behr et al., 2005, Robertson et al., 
2001 and Imakawa et al., 1993 respectively) did not further promote embryo development and 
even higher concentrations (13.2 ng mL
-1
, Imakawa et al., 1993 and 10 ng mL
-1
, Robertson et 
al., 2001) caused a reduction in response to GM-CSF in embryo development in terms of 
IFN secretion (Imakawa et al., 1993) and ability to hatch and attach (Robertson et al., 2001).  
Therefore, the response of embryos to GM-CSF is dependent on the species as well as the 
concentration of GM-CSF. 
 
In murine embryos (Figure 8b, page 82),   Ko et al. (2002) and Behr et al. (2005) observed a 
dose-dependent increase in blastocyst formation with rGM-CSF (0, 1, 5, 10 ng mL
-1
 and 0, 
0.0625,0.125 ng mL
-1
 respectively), suggesting that the response of murine embryos to GM-
CSF is also dose-dependent. Conversely, other murine studies observed no effect of embryo 
development at any concentration (Karagenc et al., 2005: 0, 2, 4, 8 and 16 ng mL
-1
 and 
Robertson et al., 2001: 0.4, 2, 10 ng mL
-1
).  Therefore, other factors other than amount of 
rGM-CSF must be affecting the response of the embryos to rGM-CSF. 
2.1.2 Effect of varied timing of exposure to GM-CSF on embryo 
development and secretion of IFN 
A two-fold increase in IFN secretion at the blastocyst stage was detected when ovine zygotes 
were exposed to GM-CSF between 1 and 3 dpi, whereas no response to GM-CSF was 
observed when GM-CSF was included between 5 and 7 dpi (Rooke et al., 2005, Table 9, page 
81), suggesting that timing of exposure affects the response of embryos to GM-CSF.  
Therefore, the lack of a response of bovine embryos exposed to GM-CSF at the elongation 
stage (17 dpi) observed by de Moraes et al. (1997) may be due to there being a window of 
opportunity for embryos to be able to respond to GM-CSF.  de Moraes et al. (1997) suggested 
that GM-CSF may be less able to affect IFN production when IFN secretion is being 
produced at maximal levels.  Therefore, differences in timing of exposure to GM-CSF could 
explain why some studies observed an effect of GM-CSF on IFN, whilst others did not.   
 
Although processes between fertilisation and the initiation of attachment are conserved 
between mammalian species, the duration of the processes varies.  Attachment takes place 4 
dpi in mice, 9 dpi in humans, and 30 dpi in cows (Kimura et al., 2005).  The prolonged pre-
attachment period in ruminants compared to other mammals emphasises the importance of 
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studies on the effects of GM-CSF on embryo development in vitro, measured in terms of 
increase in cell proliferation, blastocyst yield and IFN secretion, may be explained by 
differences between species, as summarised in Table 9 (page 81). 
 
GM-CSFR occurrence has not been investigated in bovine embryos.  In human embryos, 
Sjoblom et al. (2002) detected GM-CSFR protein associated with the cell membrane from the 
eight-cell stage onwards and that GM-CSFR mRNA expression was lower at the third 
cleavage compared to later in development suggesting stage-specific differences in GM-
CSFR transcription and translation.  Therefore, it is possible that a stage-specific response to 
rGM-CSF could be due to stage-specific GM-CSFR transcription and/or translation.   
 
Table 9  Variation in timing of exposure ( O: oocyte, 2: two-cell, 8: eight-cell, M: morula, Bl: 
blastocyst, A: attachment)  of embryos to GM-CSF and response to GM-CSF in terms of cell 
proliferation (C), Blastocyst yield (B) and IFN expression and/or secretion (I).   References are 
1: Imakawa et al., 1993, 2:  de Moraes & Hansen 1997 (a: experiment 1, b: experiment 3, c: 
experiment 4), 3 : de Moraes et al., 1997, 4 : Robertson et al., 2001, 5 : Ko et al., 2002, 6 : Cui et 
al., 2004, 7: Behr et al., 2005, 8: Karagenc et al., 2005, 9: Rooke et al., 2005 (a : experiment 2, b : 
experiment 3).  
Species Timing of Exposure  Response Reference 
O 2 8 M Bl A  C B I 
bovine          = 3 
bovine           2 b 
bovine           2 a 
bovine        =   2 c 
            
murine         =  4 
murine           5 
murine           7 
murine        = =  8 
            
ovine           1 
ovine          = 3 
ovine         = = = 9 b 
ovine         = =  9 b 
ovine          =  9 a 
ovine         = =  9 b 
ovine         = =  9 b 
ovine         = =  9 b 
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Figure 8 Dose response effect of GM-CSF on different parameters of embryo development in (a) 
bovine (de Moraes and Hansen, 1997), ovine (Imakawa et al., 1993), porcine (Cui et al., 2004) and 
(b) murine embryos (Behr et al., 2005, Ko et al., 2002 and Robertson et al., 2001).  The 
parameters measured in each study were as follows:  de Moraes and Hansen (1997), Ko et al. 
(2002), Behr et al. (2005) and Cui et al., (2004)  measured blastocyst formation, Robertson et al. 
(2001) measured hatching and attachment rates, and Imakawa et al. (1993) measured IFN 
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2.1.3 Discrepancies between different studies on the beneficial effects of 
GM-CSF on pre-attachment embryo development   
In vitro studies have demonstrated that GM-CSF, a cytokine secreted by the maternal 
reproductive tract in mammals, was beneficial to pre-attachment embryo development 
(discussed in section 1.7.1.3), although there are differences between studies.  In murine 
embryos, Robertson et al. (1991) and Ko et al. (2002) observed that GM-CSF caused an 
increase in cell proliferation, whilst Karagenc et al. (2005) found that cell proliferation was 
not affected by GM-CSF exposure. In ovine embryos, Rooke et al. (2005) observed an 
increase in cell number in the presence of GM-CSF compared to control in one experiment, 
whilst in another experiment, GM-CSF had no effect on cell number.  Therefore, there are 
discrepancies between studies in terms of the beneficial effect of GM-CSF on embryonic cell 
proliferation.  GM-CSF also caused an increase in blastocyst yield in some studies (bovine: de 
Moraes and Hansen, 1997, de Moraes et al., 1997; murine: Behr et al., 2005, Ko et al., 2002; 
porcine: Cui et al., 2004), but not in others (ovine: Rooke et al., 2005, murine: Robertson et 
al., 2001, Karagenc et al., 2005), so that there are discrepancies between studies in terms of 
the effect of GM-CSF exposure on blastocyst yield.  Moreover, GM-CSF caused an increase 
in IFN mRNA expression (Imakawa et al., 1993) and protein secretion (Imakawa et al., 
1993, Rooke et al., 2005) by ovine embryos, but only for a range of concentration (Imakawa 
et al., 1993) and a range timing of exposure (Rooke et al., 2005), whilst de Moraes et al. 
(1997) found that GM-CSF had no effect on IFN secretion by bovine or ovine embryos.  
Therefore, timing of exposure and amount of exposure of GM-CSF may affect the effects of 
GM-CSF on pre-attachment embryo development.   
2.1.4 Conclusion 
It is important to understand why there are discrepancies between different studies in the 
response of embryos to GM-CSF in terms of embryo development and IFN expression and 
secretion.  Given that the timing and concentration of GM-CSF in the female reproductive 
tract of cows vary, it is plausible that differences between studies in timing of exposure of 
embryos to GM-CSF and concentration of GM-CSF may explain discrepancies between 
studies in terms of effect of GM-CSF on embryo function and development.    Therefore, the 
objective of the experiments described in this Chapter was  
to assess the effects on blastocyst development,of inclusion of different concentrations of 
roGM-CSF in culture medium at different stages of pre-blastocyst development.  
Blastocyst development was assessed by measuring pyruvate metabolism, apoptosis, 
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It was hypothesized that: 
 
(1) exposure of bovine embryos to roGM-CSF is beneficial to bovine embryo 
development, 
(2)  exposure of bovine embryos to roGM-CSF enhances IFN secretion and responses in 
embryo development and IFN secretion to roGM-CSF are dose-dependant, 
(3)  responses in embryo development and IFN secretion to GM-CSF occur before the 
eight-cell stage. 
 
Three experiments were designed to test these hypotheses.   
1. Effects of amount of GM-CSF (2, 5, 10 and 50 ng mL-1) not present or present 
between 1 and 3 dpi on blastocyst development, 
2. Effects of roGM-CSF (50 ng mL-1) not present or present between either 1 and 3 dpi 
or 1 and 9 dpi on blastocyst development, 
3. Effects of exposure of roGM-CSF (2 and 10 ng mL-1) not present or present between 
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2.2 Materials and methods 
2.2.1 IVP of embryos 
 The following methodology for IVP of embryos represented the standard methodology used 
at our laboratory at the time of this study (details of equipment and chemicals used are 
outlined in Appendix 1, page 203).   
2.2.1.1 Collection of cumulus-oocyte complexes (COCs) 
Each replicate represented a batch of ovaries (30-40 pairs) obtained from a local abattoir on a 
different day.  Bovine ovaries were collected, transported to the laboratory in phosphate-
buffered saline (PBS) containing 50 µg mL
−1
 kanamycin sulphate maintained at 38C and 
processed within 2 h of collection. After several washes with PBS at 38C, visible follicles (2-
8 mm in diameter) were aspirated with an 18-gauge needle and the aspirated fluids and tissues 
collected into search medium (HEPES-buffered TCM 199 containing 5% (v/v) Foetal Calf 
Serum (FCS), 50 IU mL
−1
 penicillin and 50 µg mL
−1
 streptomycin, pH 7.3, 290-300 mOsmo), 
and carefully searched for COCs. The quality of COCs was determined on the basis of 
cumulus cell structure, density and cytoplasmic appearance (Table 10) and only category 1 
and 2 COCs were selected.   
 




Cumulus colour & structure Cytoplasm 
1 more than 4 compact, light or transparent clear and even 
    
2 less than 4 compact 
generally homogenous, slightly 
coarse 
    
3 less than 4 
dark cumulus or cumulus 
may be expanded 
Irregular appearance with dark 
patches 
    
4 none - - 
 
2.2.1.2  In vitro maturation (IVM) 
Selected oocytes were placed in maturation medium (TCM 199 without HEPES containing 
0.1 mL mL
-1
 FCS, 10 µg mL
−1
 luteinising hormone, 10 µg mL
−1
 follicle-stimulating hormone, 
0.1 mg mL
-1
 L-glutamine, 50 IU mL
−1
 penicillin and 50 µg mL
−1
 streptomycin, pH 7.3 to 7.4, 
280 to 300 mOsmo). The COCs (approximately 50–60 COCs in 0.5 mL of maturation 
medium) were incubated in an atmosphere of 5% carbon dioxide (CO2) at maximum humidity 
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2.2.1.3  In vitro fertilisation (IVF) 
After 24 h maturation, COCs were removed from maturation medium, washed in wash 
medium (modified Tyrode‟s albumin lactate pyruvate containing 3 mg mL
-1
 fraction V BSA 
pH 7.3 to 7.4, 270 to 290 mOsmo), and gently pipetted to remove expanded cumulus cells, 
leaving behind three to five layers of cumulus cells.  Groups of 50 to 60 oocytes were then 
added (40 L final volume) to 0.46 mL fertilisation medium (modified Tyrode‟s albumin 
lactate pyruvate containing 6 mg mL
-1
 fatty acid-free BSA, 3 g mL
-1
 heparin, 3 g mL
-1
  
penicillamine, 1.1 g mL
-1
 hypotaurine, and 0.3 g mL
-1
 adrenaline, pH 7.8, 290 to 310 
mOsmo). After in vitro capacitation of frozen–thawed spermatozoa using a swim-up 





 was added. Semen from the same bull was used throughout to avoid any sire 
effects. The gametes were co-incubated for 22 h at 38.5C in an atmosphere of 5% CO2 in air 
at maximum humidity. 
2.2.1.4  In vitro culture (IVC) 
At the end of IVF, cumulus cells were removed from the embryos by vigorous pipetting, and 
groups of 50 to 60 putative zygotes transferred to 0.5 mL of SOF (8 mg mL
-1
 fatty acid-free 
BSA, 6.294 mg mL
-1
 sodium chloride, 534 g mL
-1
 potassium chloride, 162 g mL
-1
 
potassium dihydrogen phosphate, 2.101 mg mL
-1
 sodium bicarbonate, 108 g mL
-1
 sodium 
pyruvate, 252 g mL
-1
 calcium chloride dihydrate, 9.9 mM sodium lactate, 100 g mL
-1
 
magnesium chloride hexahydrate, 270 g mL
-1
 glucose, 146 g mL
-1
 L-glutamine, 50 IU mL
-1
 
penicillin, 50 g mL
-1
 streptomycin, 0.5 mg mL
-1
 phenol red, pH 7.4, 270 to 280 mOsmo) and 
incubated at 38.5ºC in 5% CO2, 5% O2 plus 90% N2 at maximum humidity.  Cleaved embryos 
were selected 32 hpi and assigned in groups of ten to drops of SOF (0.05 mL).   Embryos that 
had not cleaved by 32 hpi were not used, as early cleavage is a positive indicator of 
developmental potential (Van Soom et al, 1992, 1997). Embryos were transferred to fresh 
microdrops of their respective media every 48 h. Samples of media (0.045 mL) in which 
embryos had been cultured in between days 7 and 9 of culture were stored at -20ºC until 
assayed for IFN.   
2.2.2 Embryo evaluation 
On 7, 8 and 9 dpi, blastocysts were evaluated in terms of their developmental (Table 11, page 
87) and morphological status (Table 12, page 87) and zona-inclusive diameters measured.     
2.2.2.1 Total cell count 
Blastocysts were fixed in glacial acetic acid and ethanol (3:1 v:v) and stained with a nuclear 
stain:  10 g mL
-1
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sodium citrate in water).  Photographs were taken using a fluorescence microscope and cells 
were counted using ImageJ software (version 1.33u, 2003).    
Table 11  Criteria used to classify blastocysts according to stage of development (modified from 
Gardner and Sakkas, 2003).   
 Stage Characteristics 
1 Early blastocoele less than half of the blastocyst 
   
2 Mid blastocoele more than half of the blastocyst 
   
3 Expanding embryo is enlarged and the blastocoele fills the blastocyst 
   
3.5 Expanded embryo is enlarged and the zona is very thin 
   
4 Hatching zona is cracked, but part of the blastocyst is still enclosed by the zona 
   
5 Hatched blastocyst is separated from the zona 
 
Table 12 Criteria used to classify blastocysts according to morphological grade.   
 Quality Characteristics 
1 Excellent spherical, symmetrical, cells of uniform size, distinct inner cell 
mass, free of fragmented cells  
   
2 Fair few imperfections, such as some granulation, initial signs of 
fragmentation, few extruded blastomeres, or irregular shape 
   
3 Poor several extruded blastomeres and degenerate cells, diffuse inner 
cell mass, collapsed or badly fragmented 
2.2.3 Measurement of IFN protein levels using the cell cytopathic assay 
Media samples collected between 7 and 9 dpi were analysed for IFNconcentration using the 
MDBK cell cytopathic assay described by Alexenko et al. (1997).  MDBK cells (ATCC 
CCL22) were seeded at a density of 5 × 10
5
 cells into each well of 96-well plates in 100 l 
Dulbecco‟s Modified Eagle Medium (DMEM) (containing 10 % v/v Foetal Bovine Serum 
(FBS), 2 mM L-glutamine, 50 IU mL
−1
 penicillin and 50 µg mL- streptomycin, 1 mM sodium 
pyruvate) per well and incubated at 37C. After 16 h, monolayers had formed. The medium 
was removed, and 100 l of medium (as above) added to each well.  Fifty l of DMEM 
containing 300 IU hIFN (Calbiochem) were added to a first-row well, and 50 l containing 
1.5 ng IFN (isoform 1c, Ealy et al., 2001) was added to a separate first-row well.  Forty-five 
l sample and 5 l DMEM were added to the remaining first-row wells.  The first-row wells 
were diluted eight times in series, removing 50l from the first row and mixing into the 
subsequent row (1:3 dilution). At the end of dilution, the concentrations of IFN and IFN in 
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replaced with vesicular stomatitis virus (supplied by Dr. SA Moyer, University of Florida) in 
serum-free DMEM. After 1 h at 37°C, the medium was removed and replaced with medium 
containing 0.1 mL mL
-1
 FBS. After 24 h, surviving cells were fixed with 70% ethanol and 
stained with 5 mg mL
-1
 Gentian violet in 70% ethanol.   
 
Table 13 Final concentrations of IFN and IFN in each dilution after the first-row wells were 
diluted eight times in series in a 1:3 ratio.   
Dilution Well IFN (IU mL
-1
) IFN (pg mL
-1
) 
1 2000 10000 
2 667 3333 
3 222 1111 
4 74 370 
5 25 123 
6 8 41 
7 3 14 
8 1 5 
 
The laboratory unit  of activity (LUA, IU mL
-1
) for each sample was derived from the sample 
dilution corresponding to protection of 50% MDBK cells from lysis by the virus, assessed 
visually, using the following formula: 
)1_%50(3_  welldilutionLUAsample
 
















where the absolute amount of IFN in first dilution was 200 IU.   
 
The sample IFN specific activity (IU ng
-1
) was determined from the LUA for the IFN 
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where the amount of IFN control in the first dilution was 1ng.  The sample IFN specific 
activity was averaged across all plates and was found to be equal to 5259 IU ng
-1
.  The sample 
IFN concentration (ng mL
-1








The interassay coefficient of variation (CV) was 12%, and the intraassay CV was 9%.  The 
limit of detection was 2.2 pg mL
-1
 which equals 11570 IU mL 
-1
.   
2.2.4 Apoptosis detection assay 
To determine the apoptotic index (percentage of apoptotic blastomeres relative to total cell 
number), an apoptosis detection kit (Apoptag Red In situ Apoptosis Detection Kit, S7165, 
Chemicon International), which involves the Terminal Deoxynucleotidyl Transferase (TdT) 
Mediated deoxyuridine triphosphate (dUTP) Nick End Labeling (TUNEL) assay, was used 
according to the manufacturer‟s instructions.  The TUNEL assay analyses DNA 
fragmentation of apoptotic cells by incorporating fluorescein dUTP at the 3‟ DNA ends. 
Briefly, blastocysts were washed in PBS/PVP (0.01M PBS containing 1 mg mL
-1
 PVP) and 
fixed in PBS/PVP containing 0.04 mL mL
-1
 paraformaldehyde for 1 h at room temperature.  
Blastocysts were then transferred into PBS/PVP/Tw20 (1l mL
-1
 Tween20 and 1 mg mL
-1
 
saponin in PBS/PVP) for 30 minutes at room temperature.  After several washes in 20 l 
drops of PBS/PVP/Tw20 using silanised glassware, blastocysts were left in equilibration 
buffer (contained in Apoptag Red In situ Apoptosis Detection Kit) for 10 minutes.  Positive 
control blastocysts were incubated with DNase I solution (1 unit mL
-1
 in PBS) for 10 minutes.  
Blastocysts were incubated in reaction buffer (contained in Apoptag Red In situ Apoptosis 
Detection Kit) containing TdT enzyme for 1 h in a humidified chamber at 37C.  Negative 
control blastocysts were incubated in reaction buffer without TdT.  The embryos were washed 
in stop/wash buffer (contained in Apoptag Red In situ Apoptosis Detection Kit) for 10 
minutes at room temperature and then incubated in 20 l microdrops of a solution containing 
anti-digoxigenin antibody conjugated to rhodamine (contained in Apoptag Red In situ 
Apoptosis Detection Kit) for 1 h in a darkened humidified chamber at room temperature.  The 
blastocysts were then stained in the dark in 10 g mL
-1
 bisbenzimide (Hoechst 33342) in 
sodium citrate solution (2.3 mg mL
-1 
in water) for 15 minutes at room temperature on a 
silanised slide.  The blastocyst was allowed to dry for 3 minutes and then allowed to stand for 
5 minutes in 10 l mounting medium with citifluor antifadent.  After placing the coverslip, 
the slide was allowed to dry overnight in the dark at room temperature. Fluorescence from 
bisbenzimide (ex 350 nm, em 461 nm) and rhodamine (ex 507 nm, em 529 nm) were 
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taken using an Olympus Camera (Figure 9) and positive cells were counted using ImageJ 
software (version 1.33u, 2003; Wayne Rasband National Institutes of Health, USA).  The 
apoptotic index was calculated as a ratio of the number of red (apoptotic) cells to the number 




Figure 9  Apoptotic cells detected using TUNEL assay (for details see section 2.2.4).  (a,d) a 
typical negative control, (b,e) positive control and (c,f) sample blastocysts visualised through the 
blue (a,b,c) and red (d,e,f) filter.  X250 magnification.  Blue is a nuclear stain (bisbenzimide), 
whilst red cells are apoptotic (rhodamine stain).   
2.2.5 Pyruvate oxidation assay 
The rationale behind the pyruvate oxidation assay and a comparison of the methodology used 
in this study with that of other published studies is outlined in Appendix 2 (page 207).  
Pyruvate oxidation was determined using individual blastocysts that formed on days 7 and 8 
pi.  Embryos were washed in pre-warmed modified embryo culture medium ( 4 mg mL
-1
 
Fraction V BSA, 0.18 mg  mL
-1
 glucose, 0.108 mg  mL
-1
 sodium pyruvate, 0.146 mg  mL
-1
 L-
glutamine, 50 IU mL
-1
 penicillin, 50 g mL
-1
 streptomycin in PBS, pH 7.2-7.4, 270-280 
mOsmo) and then transferred in a 3l drop and mixed with 3l of radiolabelled mECM 




C] pyruvate, specific activity 203.5 Bq mmol
-1
) on 
the lid of a 1 mL microtube.  The lids were placed onto microtubes containing 1 mL 0.1 M 
sodium hydroxide.  Blanks were prepared excluding embryos.  The sealed microtubes were 
incubated for 3 h at 38.5C.  Embryos were then washed and fixed in acetic acid and ethanol 
(3:1, v:v), and the contents of the microtubes transferred into scintillation vials containing 4 
mL scintillation fluid (Emulsifier Safe, Packard) and 105 L 0.5 M hydrochloric acid.  The 
rate of carbon dioxide production was estimated from disintegrations per minute (dpm) 
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Readings were corrected for blank variation and converted into picomoles h
-1
, as described in 
the following equations: 


















, where h=3. 
2.2.6 Statistical analysis 
Each batch was replicated on different days, using one or more microdrops of cleaved zygotes 
per treatment on each day.  All parametric data were tested for normality before analysis by 
visual assessment of histograms followed by Anderson-Darling test (Minitab, Fifteenth 
Edition, 2006).    For analysis of developmental efficiency, each microdrop was considered an 
experimental unit, and blastocyst development rates calculated within each drop.  Rates of 
blastocyst formation were analyzed using a restricted maximum likelihood (REML) 
Generalised Linear Model (GLM) with binomial distribution and with batch as a random 
factor followed by Wald‟s test (Genstat, Eighth Edition, 2005).  Parametric data for embryo 
quality (diameter, pyruvate metabolism per cell and cell count) were analysed using a REML 
Linear Mixed Model (LMM) with day of blastocyst formation as a covariate (Genstat, Eighth 
Edition, 2005).  A Dunnett‟s test (Minitab, Fifteenth Edition, 2006) was used to compare 
treatment groups versus control.  Non-parametric data (grade and stage) were analysed with 
Kruskal Wallis method (Genstat, Eighth Edition, 2005).  IFN concentrations in media (pg 
mL
-1
) from group cultures between 7 and 9 dpi and from individual cultures were log-
transformed in order to normalise data.  The relationship between blastocyst yield (percentage 
of blastocysts formed per oocytes in a drop) and IFN secretion in group cultures between 7 
and 9 dpi were assessed using linear regression (Genstat, Eighth Edition, 2005).  Given that 
blastulation was assessed every 24 h, the average time any blastocyst was in the culture 
medium was estimated to be 12 h.  Data on IFN secretion in group culture between 7 and 9 
dpi were analysed in the same way as parametric data for embryo quality, but with blastocyst 
yield as a co-variate.  Data on IFN secretion in individual culture were analysed in the same 
way as parametric data for embryo quality, and day of blastulation, diameter, stage and grade 
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IFN secretion during individual culture from experiments 1 and 3 were compared with other 
parameters.  Regression analysis was used to compare IFN secretion (log transformed) with 
apoptotic index (arcsine transformed) and with total cell count and diameter.  The Kruskal 
Wallis test was used to compare IFN secretion with grade and stage.   Differences were 
considered to be significant at P < 0.05.  Data were displayed as means  standard deviations 
(unless otherwise stated), except for grade and stage which were displayed as medians  95% 
confidence interval.   
2.2.7 Experiment 1 
2.2.7.1 Aim 
The aim of experiment 1 was to determine whether roGM-CSF stimulated bovine blastocyst 
development between 1 and 3 dpi, as reported by Rooke et al. (2005) in ovine embryos.  
Additionally, this experiment aimed to establish whether varying the amount of roGM-CSF 
stimulated the rate of blastocyst formation, improved morphological quality, increased rate of 
development, increased IFN secretion up to the blastocyst stage, or reduced rate of apoptosis.    
2.2.7.2  Experimental design 
Cleaved embryos were selected 32 hpi and assigned in groups of 10 to 0.05 mL drops of SOF 
containing 2, 5, 10 or 50 ng mL
-1
  roGM-CSF (McInnes and Haig, 1991, Entrican et al. 1996) 
or an equal volume of medium supernatant derived from culture of Chinese hamster ovary 
(CHO) host cells (control) in which the roGM-CSF had not been expressed. It was established 
from a preliminary experiment that the CHO medium had no effect on embryo culture (data 
not shown).  After 48 h, all blastocysts were transferred to control medium, so that exposure 
to roGM-CSF occurred only between 1 and 3 dpi.  Blastocysts were removed from group 
culture  on days 7 and 8 pi and transferred to individual 50 l microdrops of SOF for 24 h.  
SOF microdrops were analysed for IFN using the MDBK cell cytopathic assay and the 
blastocysts underwent apoptosis detection.  Blastocysts  recovered on day 9 underwent total 
cell count. This experiment was replicated eight times.   
2.2.7.3  Statistical analysis 
The results were analysed as described in section 2.2.6 with the following modifications.  
After logarithmic transformation of the data, IFN concentrations in media (pg mL
-1
) from 
individual culture were analysed by analysis of variance (ANOVA) with regression contrasts 
(Genstat, Eighth Edition, 2005).  The day a blastocyst was removed from culture, diameter, 
cell count, apoptosis index, stage and grade were all checked as possible covariates and 
included in the analysis when statistically significant.  Apoptotic Index was arcsine 
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transformed in order to normalise the data prior to analysis by ANOVA with regression 
contrasts (Genstat, Eighth Edition, 2005).   
2.2.8 Experiment 2 
2.2.8.1 Experimental design 
In order to determine whether early exposure to roGM-CSF rather than exposure throughout 
IVC affected IFN secretion and blastocyst development, 50 ng mL
-1
 roGM-CSF was absent 
(A) or present (P) during Early (1 to 3 dpi) or Late (3 to 9 dpi) periods of culture in three 
combinations:  AA (no exposure), PA (early exposure only) and PP (early and late exposure), 
as summarized in Table 14. Day 7 and 8 blastocysts were removed from culture and assessed 
for pyruvate metabolism followed by cell numbers, whilst Day 9 blastocysts were only 
assessed for cell numbers.  This experiment was replicated six times. 
Table 14 Summary of the experimental design for Experiment 2.  50 ng mL-1 of roGM-CSF was 
present () or absent (x) in the early (days 1 to 3 post-insemination) and late (days 3 to 9 post-
insemination) stages of embryonic development.     
 
Treatment 
AA PA PP 
Early (Day 1-3) x   
Late (Day 3-9) x x  
 
2.2.8.2 Statistical analysis 
The results were analysed as described in section 2.2.6. 
2.2.9 Experiment 3 
2.2.9.1 Aims 
The aim of experiment 3 was to determine whether lower concentrations of roGM-CSF at 
different stages of development stimulated rate of blastocyst formation, improved 
morphological quality, increased rate of development, increased IFN secretion up to the 
blastocyst stage, and reduced rate of apoptosis.     
2.2.9.2  Experimental design 
Two or ten ng mL
-1
 roGM-CSF were absent or present during early and late periods of culture 
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To assess whether survival of the blastocyst over 24 h individual culture was affecting 
apoptosis or IFN secretion, criteria were set up to categorise blastocysts by visual assessment 
of the change in embryo morphology over the 24 h incubation period.  Pictures were taken of 
the embryo before and after 24 h individual culture and visually analysed in terms of changes 
in developmental stage (Table 11, page 87) and diameter to assess whether the blastocyst 
progressed (category 1), remained the same (category 2) or degenerated/collapsed (3) over the 
individual culture period (Figure 10, page 95): 
(1) category 1: increase in diameter by at least 2m and/or progression by 1 stage in 
development, where morula, early, mid, expanding, expanded, hatching and hatched 
are the sequential stages; 
(2) category 2:  diameter changed by less than 2m and reduced morphological quality 
was not evident; 
(3) category 3:  diameter changed by less than 2m and embryo displayed signs of 
reduced morphological quality (such as cell degeneration or exclusion, or embryo 
collapse).   
 The drops were analysed for IFN as described in section 2.2.3 and the blastocysts underwent 
apoptosis detection as described in section 2.2.4.  This experiment was replicated eight times. 
 
Table 15 Summary of the experimental design for Experiment 3.  0, 2 and 10 refer to 
concentration of roGM-CSF (ng mL
-1
) in culture media during 1 to 3 dpi (early) or 3 to 9 dpi of 
in vitro culture.       
 
  Treatment   
AA 2PA 2PP 10PA 10PP 
Early (Day 1-3) 0 2 2 10 10 
Late (Day 3-9) 0 0 2 0 10 
2.2.9.3 Statistical analysis 
The results were analysed as described in 2.2.6 with the following modifications.  Rates of 
blastocyst formation were analyzed using a REML GLMM with binomial distribution and 
with batch as a random factor where the factors were stage of exposure (early and throughout) 
and concentration of GM-CSF (0, 2 or 10 ng mL
-1
) followed by Wald‟s test of the main 
effects and the interactions (Genstat, Eighth Edition, 2005).  Since numbers of blastocysts 
allocated to each individual culture treatment differed in each replicate, a multivariate linear 
REML model with batch as a random factor was used to analyse the data for IFN secretion, 
diameter, total cell count and apoptotic index, with stage of exposure (early and throughout) 
and concentration of GM-CSF (0, 2 or 10 ng mL
-1
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in morphology were also used as random factors when assessing IFN secretion levels by 
individual blastocysts.  The relationship between morphological change of the blastocyst over 
the 24 h individual culture with IFN secretion (log transformed) and apoptotic index (arcsine 
transformed to overcome scale effects) was analysed using GLM with the day the blastocyst 
was removed from culture as a covariate.  An ANOVA followed by a Dunnett‟s test (Minitab, 
Fifteenth Edition, 2006) was used to analyse retrospectively whether treatment groups 
affected the change in morphology index (percentage of grade 1 embryos per total embryos 
graded in each batch) relative to control.  REML GLMM with binomial distribution and with 
batch as a random factor followed by Wald‟s test of the main effect (Genstat, eleventh 
edition, 2008) was used to analyse the proportion of blastocysts secreting less IFN than the 
detection limit of the MDBK assay, and the proportion of blastocysts with no detectable 





Figure 10 Morphological change over 24 h period, as assessed by change in morphology before 
and after the 24 h individual culture period.   
























2.3.1 Experiment 1 
2.3.1.1 Developmental efficiency 
Varying the concentration of roGM-CSF which the embryo was exposed to during early 
culture had no significant effect on overall blastocysts formed per oocyte or rate of 
development (expressed as blastocyst formed on day 7 pi per overall blastocyst, Table 16, 
page 97).    
2.3.1.2 Blastocyst characteristics 
Varying the amount of roGM-CSF between 1 and 3 dpi did not significantly affect blastocyst 
characteristics, such as grade, diameter, cell number or the proportion of cells undergoing 
apoptosis (Table 17, page 98). 
2.3.1.3 IFN protein concentration in culture drops 
IFN protein concentration in media used to culture groups of embryos between 7 and 9 dpi 
and individual embryos for 24 h was unaffected by concentration of roGM-CSF in the culture 
medium during early culture (Table 18, page 98).   Blastocyst yield explained some of the 
variation in IFN secretion in group culture between 7 and 9 dpi, with IFN levels increasing 
with blastocyst yield (P=0.04, Figure 11, page 97).  Interestingly, IFN was detected in drops 
where no blastocysts were formed, suggesting that pre-blastocyst embryos may be capable of 
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Table 16 Experiment 1: Effect of exposure of bovine IVP embryos to varying amounts of roGM-
CSF between days 1 and 3 pi on blastocyst yield and rate of development.  P=probability 




0 2 5 10 50 P 
Replicate drops 13 16 15 13 12  
       
Cleaved oocytes 130 160 150 130 120  
       
Overall blastocyst per zygote (%) 3319 3616 3716 3419 3317 0.9 
       
Day 7 blastocyst per overall 
blastocyst (%) 










































Figure 11  Experiment 1: Relationship between IFN secretion in culture medium from group 
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Table 17 Experiment 1: Effect of early exposure (1 to 3 dpi) of bovine IVP zygotes in vitro to varying concentrations of roGM-CSF on blastocyst grade, diameter, 
total cell count and apoptotic index as indices of blastocyst characteristics. Values are mean±standard deviation.  Apoptotic index: proportion of cell number which 
are apoptotic.   
Amount of roGM-CSF (ng mL
-1
) 0 n  2 n  5 n  10 n  50 n  probability 
Grade (median) 2.0 50  2.0 56  2.0 50  2.0 46  2.0 44  0.8 
Stage (median) 2 50  2 56  2 51  2 47  2 43  1.0 
Diameter(m) 188±20 48  191±25 56  193±23 49  195±21 44  192±18 40  0.7 
Total cell count 137±30 9  139±38 14  158±53 8  138±42 6  153±61 4  0.3 
Apoptotic Index (%) 9±6 9  9±5 14  10±7 8  8±4 6  10±6 4  0.7 
 
Table 18 Experiment 1: Effect of early exposure (1 to 3 dpi) of bovine IVP embryos to varying amounts of roGM-CSF on IFN concentration.  Values are 
mean±standard deviation.   
Amount of roGM-CSF (ng mL
-1
) 0 (control) 2 5 10 50 probability 
Replicate drops 12 15 14 13 11  
Secretion of IFNin group culture (days 7 to 9 pi, pg mL-1) 5149 7598 5352 4943 6173 0.7 
       
Replicate blastocysts 43 46 39 44 31  
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2.3.2 Experiment 2 
2.3.2.1 Developmental efficiency 
Exposure of bovine IVC embryos to 50 ng mL
-1
 roGM-CSF, whether early (PA) or 
throughout culture (PP), had no significant effect on the overall number of blastocysts formed 
per cleaved zygote compared to control.  When expressed as proportion of day 7 blastocysts 
per total blastocysts, rate of development was also unaffected by treatment (Table 19).   
2.3.2.2 Blastocyst characteristics 
Exposing bovine IVP embryos to 50 ng mL
-1
 of roGM-CSF, whether early (PA) or throughout 
culture (PP), also had no significant effect on blastocyst characteristics such as grade, 
diameter, total number of cells or amount of pyruvate oxidized (Table 20, page 100).  
Pyruvate oxidation was correlated with cell count (P=0.0006, Figure 12, page 101) but not 
with diameter (P=0.5).  The correlation between pyruvate oxidation per cell and IFN 
secretion per cell approached significance (P=0.07, Figure 13, page 101). 
 
Table 19  Experiment 2: Effect of timing of exposure of IVP zygotes to 50 ng mL -1 roGM-CSF on 
blastocyst yield:  Control, Early (1 to 3 dpi) and Throughout ( 1 to 9 dpi).  Blastocyst yield 
expressed as a percentage of cleaved zygotes.  Values are mean±standard deviation.   
Treatment Control Early Throughout probability 
Replicate drops 21 26 23  
Cleaved zygote 210 260 230  
Overall blastocysts per zygote (%) 2013 1913 1714 0.8 
Day 7 blastocysts per total blastocyst (%) 4140 5636 4135 0.7 
 
2.3.2.3 IFN concentration in culture drops 
No IFN was detected in medium from embryo culture before 7 dpi.  Blastocyst yield was not 
a significant factor affecting variation in IFN secretion in group culture between 7 and 9 dpi 
(P=0.2).  As in experiment 1, IFN secretion was detected in drops where no blastocysts were 
formed.  IFN secretion between days 7 and 9 pi was unaffected by exposure to 50 ng mL
-1
 of 
roGM-CSF, whether early or throughout in vitro culture up to the blastocyst stage (Table 20, 












Table 20  Experiment 2: Effect of timing of exposure of IVP zygotes to 50 ng mL
 -1
 roGM-CSF on blastocyst characteristics and IFN secretion:  Control (AA), 
Early (PA, 1 to 3 dpi) and Throughout (PP, 1 to 9 dpi).  Blastocyst characteristics measured included morphological grade, stage of development, diameter, total 
number of cells, pyruvate oxidation per blastocyst and per cell.  Data are presented as mean±standard deviation. 
Treatment Control n  PA n  PP n  probability 
Grade (median) 2.5 43  2.25 45  2.5 37  0.4 
Stage (median) 2 43  2 45  2 37  0.3 
Diameter(m) 16919 43  17518 45  16912 36  0.2 
Total cell count 12343 42  11738 44  11934 33  0.9 
           




) 106 35  95 33  105 26  0.3 




) 0.09±0.05 33  0.08±0.04 32  0.08±0.04 24  0.6 
           
IFNsecretion in group culture (days 7 

















































Figure 12  Experiment 2: Relationship between blastocyst cell number and pyruvate oxidation, 
y=0.06x + 2.77, P<0.001, n=94.   
 
Figure 13  Experiment 2:  Relationship between IFN  secretion per cell and pyruvate oxidation 









2.3.3 Experiment 3 
2.3.3.1 Developmental efficiency 
Timing and amount of exposure of bovine IVC embryos to roGM-CSF had no significant 
effect on overall blastocyst yield or day 7 blastocysts per overall blastocysts compared to 
control (Table 21, page103).     
2.3.3.2 Blastocyst characteristics 
Varying the timing and amount of exposure of bovine IVP embryos to roGM-CSF  had no 
significant effect on blastocyst characteristics, regardless of the day the embryos were 
collected from group culture (Table 22, page 104). 
 
2.3.3.3 IFN secretion 
Varying the amount of roGM-CSF and timing of exposure of bovine IVP embryos at different 
stages of development had no significant effect on IFN secretion, whether in individual 
blastocyst drop (Table 22, page 104) or in group culture (Table 23, page 105).   
 
2.3.3.4 Morphological change of the embryos during 24 h individual culture 
The majority (mean % of total blastocyst per batch  SEM, 454%) of blastocysts progressed 
in development during 24 h individual culture (category 1), whilst 164% seemed unchanged 
(category 2) and 392% seemed to deteriorate (category 3).  Category 1 blastocysts secreted 
significantly more IFN than category 3 and category 2 blastocysts (P<0.05, Figure 14a, page 
106).  A larger proportion of category 3 blastocysts (10%) secreted less IFN than the 
detection limit of the MDBK assay compared with category 1 (2%, P<0.001, Figure 14b, page 
106) and all of the blastocysts categorised as category 2 secreted detectable amounts of IFN.  
There was no significant relationship between apoptotic index and morphological change 
index (P=0.3) and the proportion of blastocysts with no signs of apoptosis did not differ 
between the three categories (P>0.05).  As analysed retrospectively, change in morphology 
index did not significantly vary between treatments (P=0.8). 
 
2.3.3.5 IFN concentration in culture drops 
Blastocyst yield explained some of the variation in IFN secretion in group culture between 7 











Table 21 Experiment 3: Effect of exposure of bovine IVP embryos to varying concentrations of roGM-CSF at different stages of development on blastocyst yield 
and rate of development.  Early:  roGM-CSF present between 1 and 3 dpi.  Throughout: roGM-CSF present between 1 and 9 dpi.  Throughout: roGM-CSF present 
between 1 and 9 dpi. Values are mean±standard deviation      
Stage of Exposure  Control  Early Throughout Probability 
Amount of roGM-CSF (ng mL
-1
) 0 2 10 2 10 Concentration Stage  
Replicate drops 19 14 14 16 17    
Cleaved oocytes 190 140 140 160 170    
Overall blastocyst per zygote (%) 1914 1114 2015 2612 2212 0.5 0.06  












Table 22  Experiment 3: Effect of exposure of bovine IVP embryos to varying concentrations of roGM-CSF at different stages of development  on blastocyst grade, 
diameter, total cell count and apoptotic index. Early:  roGM-CSF present between 1 and 3 dpi.  Throughout: roGM-CSF present between 1 and 9 dpi.  Values are 
mean±standard deviation.   
Stage of Exposure Control  Early  Throughout  Probability 




0 2 10 2 10 Concentration    Stage 
  n  n  n  n  n  
Grade (median) 2 24 2 14 2 23 1.9 34 2 30            0.3             0.3 
Stage (median) 2 24 2 14 2 23 2 34 2 30            0.8             0.4 
Diameter() 19619 24 19222  14 19229  23 19225  35 19318  30            0.9             0.9 
Total cell count 11433 20 11433  7 9435  14 11435  19 11044  22            0.3             0.4 












Table 23  Effect of exposure of bovine IVP embryos to varying concentrations of roGM-CSF at different stages of development on IFN secretion.  Early:  roGM-
CSF present between 1 and 3 dpi.  Throughout: roGM-CSF present between 1 and 9 dpi.  Values are mean±standard deviation.   
Amount of roGM-CSF (ng mL
-1
) 0 2 10 Probability 
Stage of Exposure Control Early Throughout Early Throughout Concentration   Stage 
Replicate drops (days 7 to 9 pi) 19 14 16 14 17  
Secretion of IFNin group culture (days 7 to 
9 pi, pg mL
-1
) 
6880  1212  83105  3470  3944             0.9              0.7 
       
Number of blastocysts 23 14 35 23 30  
Secretion of IFN  per blastocyst in 24 h 
individual culture (pg mL
-1
) 
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Figure 14 Morphological change index as assessed visually before and after 24 hour individual 
culture.  Morphological change index: blastocysts progressed in development (category 1, n=53), 
no visual change in blastocyst development (category 2, n=19), blastocysts showed signs of 
degeneration or collapse (category 3, n=43).  This experiment was replicated eight times 
(blastocysts derived from eight batches of ovaries).  a)  Individual value plot of IFN (pg mL-1) 
versus morphological change index (P=0.03).  Values are mean (pg mL
-1
)  SEM: Category 1:  
234 (n=52), Category 2: 102 (n=19), Category 3: 227 (n=43). b)  Proportion of blastocysts in 
each morphological change category which did not secrete IFN (P<0.001).  Values are mean % 
of total blastocyst per batch  SEM.  Category 1: 22%, Category 2: 0%, Category 3: 104%.  











































Figure 15  Relationship between IFN secretion in culture medium from group cultured 
embryos between 7 and 9 dpi and blastocyst yield, y=7x + 36, P=0.03, n=80.   








2.3.4 Overall: IFN concentration in culture drops 
The relationship between blastocyst yield and IFN secretion in group culture between days 
7 and 9 pi for all three experiments are summarised in Figure 16 (page 107).   When data 
from experiments were combined, IFN secretion was detected in drops where no blastocysts 
were formed, suggesting that pre-blastocyst embryos may be capable of secreting IFN.  The 
trend for IFN concentration to increase with blastocyst yield was observed in all 
experiments, although this increase was not significant in experiment 2.  In all three 
experiments, IFN secretion per blastocyst in group culture medium between 7 and 9 dpi 
decreased with increasing blastocyst yield (P<0.001, Figure 17, page108). 
 
IFN secretion in experiments 1 and 3 did not correlate with apoptotic index (P=0.1), cell 
number (P=0.3), diameter (P=0.2) or grade (P=0.2).  Day of blastulation, however, did affect 
IFN secretion, with embryos that blastulated on day 7 pi secreting less IFN than embryos 










































Figure 16  Relationship between IFN secretion in culture medium from group cultured 





























































Figure 17  Relationship between IFN secretion per blastocyst in culture medium from group 





















Figure 18  Day of blastocyst formation versus IFN secretion in experiments 1 (Effect of dose 
response of GM-CSF on embryo development) and 3 (Effect of concentration and stage of 
development on embryo development).  Different superscripts over data represent differences 









2.4.1 Bovine embryos were unresponsive to roGM-CSF 
Bovine embryos were unresponsive to roGM-CSF in terms of blastocyst yield, rate of 
development to the blastocyst stage, rate of pyruvate oxidation, apoptosis and IFN 
secretion, irrespective of amount and timing of exposure. 
2.4.1.1 Effect of GM-CSF on blastulation 
Control embryos in experiments 1, 2 and 3 developed in the absence of an external source of 
growth factors.  Also, GM-CSF null mutant embryos were capable of forming blastocysts 
(Robertson et al., 1999), suggesting that GM-CSF is not essential for blastulation to occur in 
mammalian embryos. 
 
In experiments 2 and 3, roGM-CSF had no effect on blastocyst yield when embryos were 
exposed to roGM-CSF from cleavage to blastulation, or from cleavage to before compaction.  
In contradiction, in other mammalian embryos, rGM-CSF exposure was repeatedly 
associated with an increase in blastocyst yield (human: Sjoblom et al., 1999, porcine: Cui et 
al., 2004), although not consistently (murine: Robertson et al., 2001).  Discrepancies in 
whether GM-CSF has an effect on blastocyst yield between different studies is unlikely to be 
only due to species differences, given that de Moraes and Hansen (1997) demonstrated that 
addition of rbGM-CSF to culture medium caused a two-fold increase in the proportion of 
IVP bovine zygotes that reached the blastocyst stage.  Therefore, other factors are 
responsible for whether mammalian embryos respond to rGM-CSF in terms of blastulation. 
2.4.1.2 Effect of GM-CSF on pyruvate oxidation 
The level of pyruvate oxidation reported in this study for blastocysts (between 0 and 30 pmol 
h
-1
, with an average of 10 pmol h
-1
) is in the same order of magnitude as pyruvate 
metabolism levels reported with sheep (approximately 38 pmol h
-1
 by Garner and Batt, 1991, 
16 pmol h
-1
 by Thompson et al., 1993 and 12 pmol h
-1 
by Rooke et al., 2005) and with bovine 
embryos (approximately 12 pmol h
-1
; Khurana and Niemann, 2000a).   
 
This is the first study to assess the effect of rGM-CSF on pyruvate oxidation.  In the present 
study, exposure of bovine embryos to roGM-CSF had no effect on pyruvate oxidation.     
Moreover, pyruvate oxidation correlated with total number of cells.  Increased cell 
proliferation and increased rate of development have been positively correlated with 
increased metabolic activity in murine embryos (Robertson et al., 2001).  Therefore, given 
that this study observed no effect of roGM-CSF on total number of cells or rate of 








2.4.1.3  Effect of GM-CSF on apoptosis 
The range of apoptotic index detected in the present study (0 to 10%) is comparable to 
previous results on TUNEL assays on bovine embryos (1 to 10% Byrne et al., 1999, 0 to 
17% Park et al., 2006, 0 to 29% Makarevich and Makkula, 2002).   
 
In experiments 1 and 3, exposure to roGM-CSF did not affect the frequency of apoptotic 
cells per total cells in bovine embryos.  Although the effect of rGM-CSF on apoptosis in 
bovine embryos has not previously been reported, Karagenc et al. (2005) also observed no 
relationship between apoptosis and rGM-CSF exposure in murine embryos.  In contradiction, 
other studies have reported a decrease in apoptosis associated with exposure to rGM-CSF 
(murine: Behr et al., 2005, human: Sjoblom et al., 2002), and both studies have used the 
TUNEL assay, the same method of detection of apoptosis as in the present study.  A possible 
explanation for the inconsistency between different studies is that GM-CSF is not the only 
factor which can affect rate of apoptosis.  Differences in experimental conditions between 
the three studies could lead to different levels of stress, as described in section 2.4.2.1, which 
would subsequently lead to different levels of apoptosis.  Other death factors, such as TNF 
are able to bypass the Bcl-2 family pathway (the apoptosis pathway regulated by GM-CSF) 
by directly activating the caspase cascade (Earnshaw et al., 1999).  Therefore, in the 
presence of TNF, GM-CSF would have no effect on apoptosis.  In similar ways, 
differences in other factors due to differences in experimental conditions, could also account 
for differences on whether GM-CSF has an effect on rate of apoptosis.  Therefore, although 
apoptosis may be modulated by rGM-CSF, it must be recognized that apoptosis may also be 
modulated by other factors, which may explain why some studies report an effect of GM-
CSF on apoptosis, whilst others do not.   
2.4.1.4  Effect of GM-CSF on IFN secretion 
The concentration of IFN detected in individual culture droplets in this study (pg mL
-1
) was 
lower than reported in other studies (Appendix 3, page 208).  This may be due to differences 
in biological activity of the standards used in different studies which used the MDBK cell 
cytopathic assay to measure levels of IFN secretion (as discussed in section 1.2.4.1).  
According to Dr. Alan Ealy (personal communication) the IFN standard used in the MDBK 




) was 10 to 50 times more active than the standards 











Kimura et al., 2004a), which would account for the 100 fold difference in amount of IFN 
detected in these studies relative to the current study.   Moreover, it is possible that MDBK 
assays set up in different labs have different detection limits.  Neira et al. (2007) reported a 










(equivalent to 0.1 pM), which might explain the lower concentrations detected in the current 
study compared to that detected by Neira et al. (2007) and Hernandez-Ledezma et al. (1992, 
1993).   In contrast to the MDBK assay used in the current study, Rooke et al. (2005) used an 
ELISA to detect IFN.  The ELISA measures the amount of protein and makes no distinction 
between biologically active and inactive isoforms of IFN, whilst the antiviral assay 
measures the antiviral activity rather than the amount of protein.  The 100 fold difference in 
amount of IFN detected in the current study which uses antiviral activity and ELISA may 
be explained by the fact that the two assays are measuring different aspects of IFN.    
Therefore, differences in the methodologies used between different studies may account for 
differences in IFN secretion levels between different studies.   
 
According to the present study, exposure of bovine embryos to roGM-CSF had no effect on 
IFN secretion, which is in agreement with de Moraes et al. (1997).  However, in ovine 
embryos, Rooke et al. (2005) and Imakawa et al. (1993) observed that rGM-CSF exposure 
caused an increase in IFN secretion.  It is often assumed that early ovine and bovine 
embryos have similar biochemistry and physiology, so that differences in their response to 
rGM-CSF were unexpected.  Discrepancies between these studies may be due to species 
differences or due to other factors affecting the effect of rGM-CSF on IFN secretion . 
2.4.1.5 Factors affecting IFN secretion 
In the current study, IFN secretion levels varied 100 fold.  High variation in IFN secretion 
has also been reported by Kimura et al. (2004b) who observed variation in three orders of 
magnitude, suggesting that other environmental (discussed in section 1.5.2) and genetic 
(discussed in section 1.5.1) factors affect IFN secretion by blastocysts.  In group cultured 
drops, blastocyst yield explained some of the variation in IFN secretion, so that IFN 
secretion increased with numbers of blastocysts.    However, IFN secretion per blastocyst 
decreased with increasing blastocyst yield.  The cause of this decrease in IFN remains 
unknown, but it is unlikely to be due to a negative feedback given that blastomeres do not 
possess receptors to bind IFN (Han et al., 1997).   
 
In both experiment 1 and 3, day of blastulation affected IFN secretion, with embryos that 
blastulated 7 dpi secreting less IFN than blastocysts that blastulated 8 dpi.  This is in 
agreement with Kubisch et al. (1998) and Larson et al. (2001) who also observed that earlier 
forming blastocysts were lower producers of IFN than later forming blastocysts (as 
discussed in section 1.6.2.3).  One possible explanation is that the secretion of IFN is 








et al., 1998).  In support of this hypothesis, IFN was not detected in culture medium before 
day 7 pi but was detected in drops where no blastocysts were formed, suggesting that pre-
blastocyst embryos may be capable of secreting IFN, but only from 7 dpi.   
 
In order to collect data on IFN secretion per embryo, blastocysts were cultured individually 
for 24 h (as described by Kubisch et al., 2001a and Hernandez-Ledezma et al., 1992).  
However, pre-attachment embryos produce factors which can stimulate their own 
development (O‟Neill, 1997) so that culturing embryos individually, rather than in groups, 
may result in inferior development and reduced cell number, as demonstrated in mice (Lane 
and Gardner, 1992), sheep (Gardner et al., 1994), humans (Jones et al., 1998) and cows 
(O‟Doherty et al., 1997).    However, the beneficial effects of culturing bovine embryos in 
groups on cell number and hatching ability were only observed when embryos were cultured 
in groups prior to blastocyst formation (Larson and Kubisch, 1999), so that the individual 
culture of blastocysts in the current study should not have impaired embryonic development.  
However, Larson and Kubisch (1999) also reported that group cultured blastocysts secreted 
more IFN than individually cultured blastocysts, so that individual culture may impact some 
aspects of development.  In order to assess whether individual culture affected the ability of 
bovine embryos to secrete IFN in the current study, a system was set up to categorise 
blastocysts in terms of progression in development during individual culture based on visual 
assessment of the change in morphology over 24 h (described in 2.2.9.2).  Category 1 
blastocysts (blastocysts that progressed in development during 24 h individual culture) 
secreted more IFN compared to categories 2 (remained the same over 24 h individual 
culture) and 3 (blastocysts showed signs of degeneration during 24 h individual culture), 
whilst a larger proportion of category 3 blastocysts secreted less IFN than the detection 
limit of the MDBK assay, compared to categories 1 and 2, suggesting that the criteria set up 
in this study to assess change in embryo morphology over 24 h may be an indicator of 
embryo viability.  However, IFN secretion was detected in 88% of category 3 blastocysts 
suggesting that either category 3 blastocysts secreted IFN before degrading, or that embryos 
that looked degenerated were not in fact dead.  For instance, collapsed blastocyts have no 
visible cavity giving the impression of being degenerated.  Blastocyst collapse is caused by 
changes in the fluxes of water into and out of blastocysts triggered by the partial breakdown 
of tight junctions necessary for fluid accumulation in the blastocoele (Bigger et al., 1988).  
There is normally a re-expansion phase 1 to 2 h after collapse (Fugger, 1999) so that the 
blastocyst may exhibit a pulsatile activity.  This cyclic collapse and re-expansion of the 
blastocyst in vitro was reported by several studies using cinematography with mice (Cole et 








sufficiently either because of lack of interest or because it is difficult to investigate (Massip, 
2001).  Embryos have been observed to collapse particularly when exposed to temperature 
changes (Farin, 1999) suggesting that collapse is a stress response.  However, Farin also 
observed that pregnancy rates from collapsed blastocysts transferred into cows seemed to be 
similar to those that had not collapsed. Therefore, it is unclear whether the collapse of a 
blastocyst is normal or an indication of its poor quality due to mishandling of the embryos.  
Nevertheless, this phenomenon introduces background noise into the criteria used in this 
study to assess survival of the blastocyst as it is difficult to distinguish a degenerating 
blastocyst from a collapsed blastocyst.  Collapsed blastocysts might account for category 3 
blastocysts which secreted high levels of IFN or that had low levels of apoptosis.  Embryos 
may degenerate functionally, but still be graded as progressing in development based in 
morphology, so that the criteria set up in the current study to assess change in embryo 
morphology over 24 h have the disadvantage of relying on visual assessment of embryos 
which could be deceiving.  Also, it is hard to validate these criteria to differentiate between 
collapsed and degenerated embryos.  However, being a quick, simple and non-invasive 
assessment which does not affect the viability of the embryo suggests that this method could 
be a useful tool for selection of attachment competent embryos.  However, these criteria 
would need to be assessed for future embryo development in vivo before being used as a 
diagnostic tool to select embryos with the best chance of successfully implanting and 
developing into a successful pregnancy.  Despite the pros and cons of using change in 
morphology index as an index of survival, it explains part of the variation in IFN secretion.  
However, since change in morphology index did not vary between treatments in experiment 
3, variation in change of morphology index did not explain the lack of an effect of GM-CSF 
on IFN secretion. 
 
IFN secretion did not correlate with apoptotic index, total cell count, diameter, 
morphological grade or stage of development, suggesting that IFN is not associated with 
embryo viability.   
 
Although day of blastulation, change in morphology index and blastocyst yield were 
identified as sources of variation in IFN secretion, high probability values in the current 
study strongly suggest that GM-CSF was not a factor, irrespective of the timing and amount 
of exposure.  Unexplained variation in IFN secretion levels may be due to factors not 








2.4.2 Possible reasons for discrepancies between studies on the effect of 
GM-CSF on embryo development 
The lack of an effect of GM-CSF on bovine embryo development (blastulation, morphology, 
rate of metabolism, apoptosis and IFN secretion) reported in this study is in contradiction 
with previous studies reporting a dose-dependent response of mammalian embryos to rGM-
CSF (reviewed in section 1.7.1.3).  The current study differs from previous studies in the 
concentration of GM-CSF used and the species homology of the rGM-CSF, the timing of 
exposure to GM-CSF in terms of the stage of embryo development, the embryo production 
system and the species assessed.  
2.4.2.1 Effect of amount of GM-CSF on response of embryos to roGM-CSF 
The range in concentrations of roGM-CSF exposed to embryos in the current study (2 to 50 
ng mL
-1
) had no effect on any of the embryo development parameters measured, which 
contradicts previous studies in mammalian embryos (reviewed in section 1.7.1.3).   
 
Imakawa et al. (1993) found that rhGM-CSF stimulated IFN secretion from ovine embryos 
at lower concentrations (3.3 to 6.6 ng mL
-1
), but not at higher concentrations (13.2 ng mL
-1
).  
Meanwhile, Robertson et al. (2001) observed a 15% decrease in the rate of murine 
blastocysts hatching and attaching at the increased dose of 10 ng mL
-1
 relative to 2 ng mL
-1
 
rmGM-CSF.  In another murine study published after the current study was conducted, Behr 
et al. (2005) found that 0.125 ng mL
-1
 promoted blastulation, but increased concentrations to 
2 ng mL
-1
 in the medium did not further promote development to the blastocyst stage, and 
embryonic development appeared to be inhibited when the rGM-CSF concentrations reached 
2 ng mL
-1
 compared to 0.125 ng mL
-1
.  Loureiro et al. (2008) exposed bovine embryos to 1, 
10 and 100 ng mL 
-1
 roGM-CSF and found that the greatest effect of roGM-CSF on 
blastocyst yield occurred at 10 ng mL 
-1
. As demonstrated by these studies, increased 
concentrations of rGM-CSF after a certain threshold did not further promote embryo 
development, and this threshold may vary from species to species. 
 
The cellular and molecular mechanisms through which an excess concentration of rGM-CSF 
may cause desensitization to the actions of rGM-CSF itself may result from the mechanism 
of internalisation and cellular processing by which GM-CSF normally mediates its effects.  
Both murine (Robertson et al., 2001) and human embryos (Sjoblom et al., 2002) synthesise 
GM-CSFR from fertilisation to the blastocyst stage, with the receptor protein being 
detectable on the cell membrane of both trophectoderm and inner cell mass cells.  The 
process of internalisation of GM-CSFR has not been assessed in embryo studies, but was 








bound to GM-CSFR on the cell membrane, invagination of the plasma membrane formed 
receptosomes which then fused with lysosomes.  GM-CSF then became disassociated from 
the receptor, thus releasing the receptor (Walker and Burgess, 1987).  In a human myeloid 
cell line, by inducing internalisation of its own receptor, rGM-CSF exposure led to a 
decrease in the total number of surface-bound GM-CSFR (Cannistra et al., 1990).  Through 
this negative feedback, GM-CSF significantly down-regulated its own receptor, so that an 
excess of GM-CSF could lead to down regulation of the stimulatory effects of GM-CSF on 
the cell.  In the murine system, the process of receptor internalisation and degradation takes 
approximately 45 minutes and within 1 h from down-regulation of GM-CSFR, around 40% 
of internalised receptors were reacquired to the cell surface by means of recycling of 
internalised receptors to the cell surface (around 15%) and resynthesis (around 25%), rather 
than due to the presence of an intracellular pool of receptors (0%, Walker and Burgess, 
1987).  Walker and Burgess (1987) only followed the fate of the GM-CSFR up to 4 h, after 
which the methodology used caused unacceptable levels of cell death.  In that period, the re-
expression of GM-CSFR continued to increase and did not plateau.  The current study 
exposed embryos to rGM-CSF for a much longer period (two to eight days).  Therefore, it is 
possible that during the 2 to 8 day exposure to rGM-CSF, the recycling and resynthesis of 
GM-CSFR may match or exceed the loss of GM-CSFR due to internalisation. Also, it must 
be considered that there may be differences in the rate of internalisation and reaquirement of 
receptors between different species and/or between different culture systems which might 
help explain discrepancies between different studies. 
 
The range of concentrations assessed in experiment 1 (2 to 50 ng mL
-1
) were within the 
range assessed in previous studies (0.4 to 100 ng mL
-1
, reviewed in section 1.7.1.3).  Doses 
two-fold higher (100 ng mL
-1
) than the dose reported in this study (50 ng mL
-1
) increased 
cell proliferation and IFN secretion in a bovine trophectoderm cell line (Michael et al., 2006 
b) and increased blastocyst yield in bovine embryos (Loureiro et al., 2008).  However, cells 
from a cell culture (Michael et al., 2006 b) and cells in a blastocyst (current study) may have 
different thresholds in concentration for a response to GM-CSF.  Nevertheless, de Moraes 
and Hansen (1997) and Loureiro et al. (2008) observed that bovine embryos responded to 10 
ng mL
-1
 rbGM-CSF, so that it is unlikely that the range in concentration assessed in this 
study (2 to 50 ng mL
-1
) was outside the range of concentrations for rGM-CSF to affect 
bovine embryo development.   
 
Moreover, results from experiments 1 and 3 which exposed embryos to lower concentrations 










) did not account for the lack of a response of bovine embryos to roGM-CSF.  
Therefore, other factors must be responsible for differences between studies in the response 
of mammalian embryos to rGM-CSF.   
2.4.2.2 Effect of timing of exposure of rGM-CSF on response of embryos to rGM-
CSF 
In experiment 1, the embryos were exposed to roGM-CSF between 1 and 3 dpi, when the 
embryos were between the two- and eight-cell stage, whilst in experiment 3 the embryos 
were exposed to roGM-CSF between the two-cell and the blastocyst stage, and neither 
experiment detected a response of bovine embryos to roGM-CSF.  Other studies which 
detected beneficial effects of rGM-CSF exposure on embryo development exposed embryos 
to rGM-CSF later in development (Imakawa et al., 1993 exposed ovine embryos to rhGM-
CSF during elongation, de Moraes et al., 1997 exposed bovine embryos to rbGM-CSF from 
blastulation to attachment, and Robertson et al., 2001 exposed murine embryos to rmGM-
CSF from the eight-cell stage to after blastulation), suggesting that exposure of bovine 
embryos to roGM-CSF in this thesis may have been too early for an effect to be detected.   
 
Exposure of bovine embryos to roGM-CSF from day 5 pi increased blastocyst yield, whilst 
roGM-CSF did not stimulate blastocyst development when exposed from day 1 pi (Loureiro 
et al., 2008).  Similarly, de Moraes and Hansen (1997) observed that exposure of bovine 
embryos from day 5 pi, as opposed to up to day 5 pi, increased blastocyst yield.  Therefore, 
rGM-CSF exerts its effects on bovine embryos at the morula stage or later, mimicking the 
exposure of bovine embryos to GM-CSF in vivo, where GM-CSF concentration is higher in 
the uterus than in the oviduct (de Moraes et al., 1999).   Moreover, exposure of bovine 
embryos to rGM-CSF before day 5pi seems to suppress the response of bovine embryos to 
rGM-CSF.  Further studies are necessary to determine whether bovine embryos differ in the 
level of GM-CSF receptor between different stages of development, and whether exposure to 
GM-CSF earlier in development affects the levels of receptors after day 5pi.     
 
Rooke et al. (2005) observed that exposing ovine embryos to roGM-CSF between 1 and 3 
dpi increased IFN secretion, suggesting that, contrary to bovine studies, roGM-CSF exerts 
an effect on ovine embryos at the two- to eight-cell stage.  Therefore, there seems to be a 
species difference in the stage-specific response of embryos to GM-CSF exposure.   
 
Previous studies which observed an effect of GM-CSF on different aspects of mammalian 








of embryo production system, GM-CSF homology and species, so that one or more of these 
factors may explain the lack of a response of bovine embryos to roGM-CSF.    
2.4.2.3 Effect of culture conditions on response of embryos to rGM-CSF 
de Moraes and Hansen (1997) observed that GM-CSF stimulated blastocyst formation in 
embryos cultured in Charles Rosenkrans medium (CR1, Rosenkrans et al., 1993), whilst in 
the current study, which used modified SOF medium, GM-CSF did not affect blastocyst 
yield.  CR1 contains glutamine, SOF does not, and the concentration of  BSA in SOF is 
higher than in CR1, so that the compositions of CR1 and SOF media differ slightly.    
Sagirkaya et al. (2006) compared bovine embryo development in CR1 and in SOF and found 
that CR1 medium was associated with higher levels of HSP70 transcript levels, a gene 
associated with stress.  Moreover, fewer blastocysts were formed from putative zygotes 
cultured in CR1 compared to SOF.  Although the composition of the SOF used in the current 
study was slightly different to the one used by Sagirkaya et al. (2006) in terms of sodium 
lactate, sodium pyruvate, D-glucose and L-glutamine (Sagirkaya et al., 1999 vs current 
study: 3.3 vs 9.9 mM, 0.4 vs 0.99 mM, 0 vs 1.5 mM, 0 vs 1 mM respectively), these findings 
suggest that different culture medium cause different levels of stress on embryos.  Therefore, 
different levels of stress caused by culture in different media may explain discrepancies 
between different studies on the response of embryos to GM-CSF exposure.   
 
Despite the large volume of studies attempting to optimise current embryo culture media 
compositions, conditions in in vitro culture conditions are still suboptimal to the in vivo 
environment.  Nevertheless, the effect of GM-CSF on embryo development in vitro should 
be examined under culture conditions that would incur minimal stress to the embryo.  
However, studies in other mammals which have reported beneficial effects of GM-CSF on 
embryo development have also employed culture conditions that were sub-optimal.  Kim et 
al. (2001) used a medium throughout culture which was designed to support murine embryos 
in the pre-compaction stage, whilst other studies (Wang et al., 2002, Behr et al., 2005) used 
medium throughout culture designed to support murine embryos in the post-compaction 
stage (Karagenc et al., 2005).  Karagenc et al. (2005) compared the response of murine 
embryos to rmGM-CSF in a range of media formulations (the simple G1 or human tubal 
fluid (HTF), or a more complete G1/G2 sequential media) and found that exposure to 
rmGM-CSF from the eight-cell stage to the blastocyst stage had no beneficial effect on 
murine embryo development when protein (human serum albumin) was present in the media.  
However, when human serum albumin was absent from G1/G2 media, supplementation of 
GM-CSF led to an increase in blastocyst cell number and inner cell mass development.  








blastocyst formation and blastocyst cell number in protein-free culture medium, whilst no 
beneficial effect of rmGM-CSF were observed in the presence of BSA.   Since absence of 
protein is stressful for the embryo (Rizos et al., 2003), it was suggested that the extent of the 
beneficial effects of rGM-CSF on embryos varies with the level of stress an embryo is 
exposed to (Karagenc et al., 2005).   
 
Exposure of embryos to rGM-CSF was shown to be beneficial to human embryos (Sjoblom 
et al., 1999) but not to murine embryos (Karagenc et al., 2005), even though both studies 
used human serum albumin as the source of protein.  Meanwhile, exposure of embryos to 
rGM-CSF was shown to be beneficial to bovine embryos (de Moraes and Hansen, 1997) but 
not to porcine embryos (Cui et al., 2004), even though both studies used BSA as the source 
of protein.  Beneficial effects of rGM-CSF exposure on murine embryo development were 
also detected in culture media containing FCS (Robertson et al., 2001) and serum substitute 
(Kim et al., 2001, Wang et al., 2002, Behr et al., 2005), whereas addition of serum to the 
culture medium, while stimulatory, prevented additional stimulatory effects of rGM-CSF in 
bovine embryos (de Moraes and Hansen, 1997), possibly due to the fact that serum may 
contain GM-CSF, amongst other factors beneficial to embryo development.   Therefore, 
there have been several differences between reports of whether GM-CSF supplementation 
had beneficial effects in medium containing a range of protein sources, so that the type of 
protein supplement added to the media is a key factor in determining the response of 
embryos to GM-CSF supplementation to the culture medium.   
 
Sjoblom et al. (1999) used frozen-thawed embryos, so that the stress induced by the freeze-
thaw process might have contributed to the beneficial effects of rhGM-CSF observed on 
human embryo development (Karagenc et al., 2005).  Therefore, besides differences in the 
composition of the media or the protein source, the general quality of the culture conditions 
may also explain discrepancies between studies.   
 
Karagenc et al. (2005) observed the effect of GM-CSF on embryos derived from two strains 
of mice which were previously shown to have different sensitivities to their culture 
environment and found that GM-CSF only had a beneficial effect on the more sensitive of 
the two strains.  Therefore, the sensitivity of the breed to in vitro culture conditions in 
general has also been shown to have an effect on whether an embryo is responsive to GM-
CSF exposure. 
 
As with GM-CSF, another cytokine involved in embryo development, CSF-1, was shown to 








that CSF-1 is also implicated with varied effectiveness in stimulating development and 
differentiation of embryos under stress.  Therefore, because different culture systems expose 
embryos to varied amounts of stress, the use of different culture systems may affect the 
response of embryos to GM-CSF.  Also, the varied sensitivity of different embryos to stress 
may cause variation in the response of embryos to GM-CSF. 
2.4.2.4  Cross-species homology of rGM-CSF 
It is unlikely that the lack of an effect of roGM-CSF on bovine embryo development 
observed in this study was due to the roGM-CSF used in the current study being biologically 
inactive as the same source of roGM-CSF used here increased ovine IFN secretion when 
included in the medium at 5 ng mL
-1
 (Rooke et al., 2005).   Contrary to the present study that 
used bovine embryos, Rooke et al. (2005) used ovine embryos, so that the discrepancy 
between these studies could be due to differences in species cross-reactivity.  Other studies 
have assessed the effects of rGM-CSF derived from one species on embryo development of a 
different species, as shown inTable 24.  Of these studies, Imakawa et al. (1993) and (1997) 
detected an increase in IFN secretion and expression by ovine blastocysts due to rhGM-CSF 
exposure, which could be explained by similarities in the GM-CSF from different 
mammalian species.  The hydrophobicity profiles, putative glycosylation sites and positions 
of cysteine residues in the GM-CSF coding sequences from different mammalian species, 
including ovine and bovine, are highly conserved (Inumaru and Takamatsu, 1995).  The high 
degree of sequence homology between the ovine and the bovine GM-CSF both at the 
nucleotide (approximately 93%) and amino acid (80%) levels (McInnes and Haig, 1991) 
would suggest that differences in homology should not account for discrepancies between 
the bovine and the ovine (Rooke et al., 2005). 
Table 24 Studies which assessed the effects of rGM-CSF derived from one species on embryo 





GM-CSF homology similarity  
Reference  nucleotide level protein level 
ovine bovine 93% 80% de Moraes et al., 1997 
ovine human 84% 80% Imakawa et al., 1993 
ovine human 84% 80% Imakawa et al., 1997 
bovine ovine 84% 80% Loureiro et al., 2008 
 
However, there are reports of rGM-CSF from different species having similar homologies 
but different biological activities on cells derived from different species.  de Moraes et al. 








GM-CSF was found to have no proliferative effect on ovine bone-marrow cells, as opposed 
to ovine GM-CSF which did (McInnes and Haig, 1991), despite being 80% identical in terms 
of amino acid sequence.  Also, bovine GM-CSF was found to be biologically active in 
bovine bone marrow proliferative assays, but only weakly active in both human and mouse 
bone marrow proliferation assays, whereas human GM-CSF was only weakly active in 
bovine bone marrow proliferation assays (Maliszewski et al., 1988).  The bovine GM-CSF 
precursor was shown to contain a putative amino acid sequence not found in human or 
murine GM-CSF, cleavage of which yields another protein (Maliszewski et al., 1988).  
Therefore, despite the high degree of similarity in the sequence of different homologies of 
GM-CSF from different species, different homologies have varied cross-species biological 
activity, which might explain some of the discrepancies in the response of embryos to GM-
CSF observed in different studies. 
2.5 Conclusion 
In terms of IFN secretion, pyruvate oxidation, rate of development, blastocyst yield, 
morphological grade and apoptotic index, IVP bovine embryos were unresponsive to roGM-
CSF at the concentrations and developmental periods tested.  Discrepancies between this 
study and other studies which observed an effect of rGM-CSF on embryo development may 
be attributed to differences between species, rGM-CSF homologies or different culture 
conditions between studies.  The amount of roGM-CSF and timing of exposure did not seem 
to account for the lack of an effect of roGM-CSF on embryo development.  However, 
exposure of bovine embryos to roGM-CSF from day 5 pi was not assessed in this study, and 
Loureiro et al. (2008) observed that such exposure increased blastocyst yield.  Therefore, 
timing of rGM-CSF exposure may explain some of the discrepancies between studies on the 
effect, or lack of, of GM-CSF on embryo development.   
 
IFN secretion by different embryos in the same treatment was highly variable, suggesting 
that genetic and intrinsic factors may explain individual variation.  IFN secretion did not 
correlate with apoptotic index, total cell count, diameter, morphological grade or rate of 
development, suggesting that these intrinsic factors do not explain the high variation in IFN 
secretion between embryos.  However, blastocyst yield, day of blastulation and change in 
morphology over 24 h did account for at least part of the variation in IFN, suggesting that 
some intrinsic factors may regulate IFN secretion.  Also, exposure of embryos to GM-CSF 
did not account for the variation in IFN secretion between different embryos, irrespective of 
the timing and amount of exposure.  Therefore, further studies are required to assess the 









3 EFFECT OF HEAT STRESS ON THE ABILITY 
OF BOVINE EMBRYOS TO PRODUCE IFN IN 
VITRO  
3.1 Introduction 
3.1.1 Effect of heat stress on the development of in vivo produced 
embryos 
Increased rectal temperatures from 39C in control cows to 42C in heat stressed cows 
suggest that embryos developed in utero in heat stressed cows are exposed to elevated 
temperatures (Putney et al., 1988a).  The detrimental effect of heat stress on embryo 
development in vivo is demonstrated by reduced rate of embryonic development, increased 
abnormal embryo development and reduced conception rates in cows exposed to elevated 
temperatures (reviewed in section 1.8.4), suggesting that in vivo  produced bovine embryos 
are sensitive to heat stress.  
 
Putney et al. (1988b) exposed embryos flushed on 17 dpi to 43C for 18 h and observed a 
decrease in IFN secretion due to heat treatment, whilst Geisert et al. (1988) exposed 
pregnant cows to 37C (heat treatment) and 21C (control) from 8 to 17 dpi and observed an 
increase in IFN detection in heat treated cows.  Therefore, heat stress affected IFN 
secretion by in vivo produced bovine embryos.  Differences between the two studies 
(summarised in Table 25, page 122) in terms of severity of stress levels exposed to the 
embryos (due to variation in periods and temperature of the heat treatment), exposure of 
embryos to the in vitro environment, stage of embryonic development when the embryo was 
exposed to the heat treatment and method of IFN detection may account for discrepancies 
between the two studies.   Moreover, it is important to note that the heat stress treatment to 
the putative mother in vivo (Geisert et al., 1988) exposed the embryo to altered hormones 
and cytokines, as opposed to the direct impact of increased temperatures on a zygote in vitro 
(Putney et al., 1988b) where such factors are absent.  Therefore, the effect of heat stress on 
IFN secretion by in vivo produced embryos remains inconclusive.  Moreover, the effect of 
heat stress on IFN secretion by IVP bovine embryos has not been assessed, and, thus, 








Table 25  Comparison between two studies observing the effect of IFN secretion by in vivo 
produced bovine embryos.   
 Putney et al. (1988b) Geisert et al. (1988) 
Medium used to detect IFN In vitro culture medium uterine flushing 
   
Technique to detect IFN SDS-PAGE and  
immunoblotting 
cell cytopathic assay 
   
Heat Treatment temperature 43C (embryo exposure) 37C (maternal exposure) 
   
Period of heat treatment 17 dpi, for 18 h 8 to 17 dpi 
 
3.1.2 Effect of heat stress on the development of IVP embryos 
IVP bovine embryos have been exposed to elevated temperatures.  Two-cell embryos 
exposed to elevated temperatures (41C or 42C for three h) had decreased subsequent 
embryo development (Ealy et al., 1995).  Similarly, Sugiyama et al. (2003) observed that 
embryos exposed in the first 48 hpi (between one and two-cells) to heat treatment cycles 
mimicking rectal temperature changes in summer heat-stressed cattle (ranging in temperature 
from 39.5C to 41C) also had decreased embryo development in terms of cleavage (28% of 
heat treated embryos cleaved, compared to 45% in control), development past the eight-cell 
stage (2% of heat stressed embryos developed past the eight-cell stage, as opposed to 28% of 
control embryos), and development past the morula stage (0.9% of heat treated embryos 
developed past the morulae stage, compared to 12% in the control group).  Moreover, the 
proportion of embryos developing to the morulae or later stages by 7 dpi were reduced in the 
embryos derived from oocytes heat-stressed for four h, compared to the control group (Ju et 
al., 2005).   Therefore, exposure of embryos to elevated temperatures at the two-cell stage or 
earlier severely impaired embryo development.   
 
The percentage of embryos that developed from the eight-cell stage to the morulae stage was 
similar between the heat stressed and control embryos, whilst the percentage of embryos that 
developed from the two-cell stage to the blastocyst stage was lower in heat-treated embryos 
compared to control (Sugiyama et al., 2003).  This suggests that the effect of heat stress on 
embryo development is stage dependent. 
  
Sugiyama et al. (2003) exposed embryos to heat treatment at four dpi in one experiment and 
between one and two dpi in a second experiment, and found that controls had a two-fold 
higher proportion of embryos reaching the morula stage in the first experiment, as opposed 








first 48 h of culture reaching the morula stage relative to control.  Ealy et al., 1993 observed 
that embryos were sensitive to heat stress one dpi (three h heat treatment at 41C or 42C) 
but were resistant to the same heat stress five dpi (morula stage).  Although there is a 
difference in the length of heat treatment, and although these results refer to separate 
experiments, these results suggest that the ability of the pre-implantation embryo to resist 
heat stress increases as development progresses.    
 
Incubation of two-cell embryos at 40C for three h did not affect blastocyst rate or rate of 
development, but heat treatments of 42C for three h decreased embryo development 
significantly (Ealy et al., 1993).  In another study, in vitro matured bovine oocytes did not 
survive more chronic heat treatments (45 minutes at 43C), but did survive shorter heat 
treatments (0, 15 and 30 minutes)  with no deleterious effect on the matured oocyte being 
exposed to lower temperatures (40.5 and 41.5C for up to one hour, Ju et al., 1999).    
Therefore, the detrimental effects of heat stress on embryo development varied with the 
intensity of the stress and milder heat treatments did not affect embryo development.   
 
Some studies even noted that a mild elevated temperature enhanced the growth rate of 
embryos and postulated that this was due to an increase in the rate of metabolism (Ealy et al., 
1993), suggesting that mild heat treatments may benefit the embryo, possibly by improving 
the ability of the embryo to tolerate heat stress, a mechanism known as thermotolerance.  
Heat stress may enhance the thermotolerance of, or cause detrimental effects on, the embryo 
depending on the duration and intensity of the thermal challenge.  Acquiring thermotolerance 
involves increasing the capacity of the embryo to produce molecules involved in 
thermoprotection such as HSPs or cellular antioxidants (Arechiga et al., 1995).  
Thermotolerance of bovine embryos increased with embryonic stage (Al-Katani and Hansen, 
2002), with substantial thermotolerance developing in vitro around the compacted morula 
stage (Edwards and Hansen, 1997).  The difference in thermotolerance between earlier 
stages and later stages of embryo development may be due to the onset of the embryonic 
genome activation.  
 
Ryan et al. (1992) observed that exposing embryos to 4 h at 40C caused no immediate 
effect to the embryos, but caused embryo death immediately after hatching, 5 days after 
exposure of the embryo to heat stress.  Therefore, the detrimental effects of heat stress may 









Heat stress caused changes in the spindle configuration from oocytes heat stressed during 
IVM for two to four h at 42C (Ju et al., 2005), indicating that heat stress affected 
polymerization of meiotic spindle microtubules.  The mitotic spindle may also be altered by 
heat stress, so that heat stress may cause chromosome dispersion and eventually cell death 
(Streffer, 1984).  Also, alterations in the zona pellucida structure and the microvillus pattern 
of the oolemma were evident when the oocytes were heated to 42C for 30 minutes (Suzuki 
et al., 1998).  Therefore, changes in developmental potential of embryos due to heat stress 
may be due to changes in cellular structure.   
 
Following IVF, the heat treatment at the oocyte level caused a reduced blastocyst rate and 
reduced trophectoderm cell number per blastocyst (82 vs 108 cells) compared to control (Ju 
et al., 2005).  Although heat stress did not affect fertilisation rate, it did increase the rate of 
polyspermy from 16% in embryos heat stressed for four h compared to 36% in control 
embryos.  Apoptosis has also been reported as a cause of heat stress in bovine embryos 
(Paula-Lopes and Hansen, 2002, Roth and Hansen, 2004).  These studies confirm that high 
temperatures are a stressor to IVP bovine embryos.    Changes in the structure and 
development of embryos due to heat stress suggest that heat stress may affect the expression 
patterns of certain genes required for normal function and development.   
3.1.3  Effect of heat stress on expression and synthesis by IVP bovine 
embryos 
HSP70 mRNA was detected in bovine oocytes (Edwards and Hansen, 1996, 1997), two-cell 
embryos (Edwards et al., 1997, Howell and Hansen, 1995), eight-cell embryos (Kawarsky 
and King, 2001) and blastocysts (Kawarsky and King, 2001), suggesting that bovine 
embryos are able to respond to stress at the cellular level.  HSP70 mRNA and protein levels 
increased when two-cell stage embryos were exposed to heat stress (42C for 80 minutes, 
Edwards and Hansen, 1997).  The heat-induced synthesis of HSP70 occured even in the 
presence of an RNA polymerase inhibitor (-amanitin, Edwards et al., 1997), suggesting that 
the increase in HSP70 synthesis at the two-cell stage may be regulated post-transcriptionally.  
Heat inducibility of HSP70 mRNA was also evident at the eight-cell stage and the blastocyst 
stage (Kawarsky and King, 2001).  However, heat stress had no effect on HSP70 synthesis 
by bovine oocytes, as demonstrated by metabolic labelling with 35S-amino acids and two-
dimensional gel electrophoresis (Edwards and Hansen, 1996), suggesting that the ability of 
the embryo to upregulate HSP70 expression and synthesis is stage dependent.   
 
Several mechanisms have been proposed to explain how heat stress upregulates HSP70 








HSP70 mRNA continues to be translated efficiently, whilst other mRNAs are poorly 
translated, so that rather than increasing HSP70, heat stress down-regulates expression of 
other genes.      An alternative theory suggests that heat-induced HSP70 expression could be 
regulated at the level of transcription (Edwards et al., 1997), probably due to heat stress 
displacing bound Heat Shock Elements (HSE) from the specific region of the DNA located 
on the promoter region of the HSP gene (Li et al., 1995), allowing heat shock transcription 
factors (HSF) to bind instead, thus inducing the cellular stress response (Figure 19).   
 
    
Figure 19  Proposed mechanism of stress-induced increase in HSP70 (Kiang and Tsokos, 1998).  
HSP70 in the cytosol is bound to HSF.  Under stress, HSP separate from HSF and HSFs 
become phosphorylated.   Phosphorylated HSFs form trimers and enter the nucleus to bind 
to specific regions of the DNA.  HSF is phosphorylated further.  HSP mRNA is transcribed and 
leaves the nucleus.    In the cytosol, HSP is synthesized.  HSF returns to the cytosol where it 
becomes bound with HSP again.   
 
Studies assessing the effect of stressors on IFN expression have determined that stress 
causes an upregulation in the expression of IFN (Wrenzycki et al., 1999, 2000, 2001a, b, 
Lonergan et al., 2001, Rizos et al., 2003, Kubisch and Johnson, 2007, as discussed in section 
1.8).  However, there are discrepancies between studies on the effect of stress on IFN 
synthesis (as summarised inTable 7, page 76), suggesting that IFN may be regulated by 
stress at the transcriptional level, and other factors may modulate IFN translation.  The 
relationship between IFN and HSP70 expression has not been assessed, and would explain 
whether IFN secretion is a stress response.   
3.1.4 Conclusion 
The effect of heat stress on pregnancy rate in vivo, on embryo development in vitro and on 



























heat stress and, therefore, that heat stress is relevant to early embryonic development and 
IFN secretion.  Therefore, heat stress was selected as the stressor for this study.  The 
objective of this Chapter was to determine whether heat stress affects IFN expression 
by IVP blastocysts. 
 
This experiment was designed to examine the effects of heat stress at the blastocyst stage on 
the ability of IVP blastocysts to produce IFN.  The heat treatment was designed to follow 
the pattern of temperatures used in other studies shown to stress IVP bovine embryos (Ealy 
et al., 1995, Sugiyama et al., 2003, Ju et al., 2005) and shown to induce HSP70 expression  
in bovine IVP blastocysts (Kawarsky and King, 2001).  The control group were maintained 
at a temperature of 38.5C throughout the experiment effectively representing the standard 
IVC in our lab.  The expression of HSP70, a chaperone involved in protein folding and 
stabilization of damaged proteins, was used as the stress indicator.  In order to clarify the 
relationship between IFN and the cellular stress response, this experiment was designed to 
test the following hypotheses: 
1. exposure to 42C for 4 h at the blastocyst stage causes heat stress to 
bovine IVP blastocysts 
2. heat stress up-regulates IFN expression.  
 
In order to assess absolute IFN mRNA levels, a multiplex RT-PCR system using sequence-
specific probes was designed.  To date, there are no other reports of bovine embryos being 
assessed either by multiplex RT-PCR or by a sequence-specific probe detection system.  
Therefore, a further objective was 
to validate a real time RT-PCR method do assess absolute IFN mRNA levels. 
3.2 Materials and methods 
3.2.1 Experimental Design 
The methodology used for IVP of bovine embryos and blastocyst assessment and allocation 
to the different treatments is summarised in Figure 20 (page 127).  Nine batches containing 
546 ovaries were collected at a local abattoir and processed as described in section 2.2.1.  
The average proportion of cleaved from transferred zygotes among the 9 batches was 
5111% (mean ± standard deviation) and the average blastocysts per cleaved zygote was 
145%.  At 186 hpi (n=57) and 210 hpi (n=53) blastocysts were evaluated in terms of their 
developmental stage (Table 11, page 87) and given a quality score based on morphological 
assessment (grade  1: embryos free of fragmented cells, grade 2:  some granulation and 








The diameters of the embryos were also measured in two planes to account for non-spherical 
embryos.  Evaluated blastocysts were transferred in minimum volume (3 L) from group 
culture to 5 L individual culture drops of SOF.  Equal numbers of blastocysts were 
allocated to either the control or heat stress group according to grade and stage of 
development, to ensure that the two treatments were balanced. Embryos from the heat stress 
group were exposed to 42C for 4 h (186 to 190 hpi and 210 to 214 hpi) after which changes 
in the embryo grade or stage of development were noted.  All blastocysts were incubated for 
a further 20 h at 38.5ºC.  At 210 hpi (for blastocysts removed from group culture at 186 hpi) 
and 234 hpi (for blastocysts removed from group culture at 210 hpi blastocysts), 50 L of 
warmed SOF were added to the 5 L individual culture drops and mixed.  The blastocysts 
were assessed for changes in diameter, embryo grade or stage of development at 0, 4 and 24 
h of individual culture and categorised for change in morphological index based on the 
criteria outlined in 2.2.9.2 (category 1: blastocyst progressed, category 2: remained the same, 
category 3: degenerated/collapsed during the individual culture period, Figure 10, page 95).  
At the end of the 24 h individual culture period, 45 L  of SOF was added to each drop and 
mixed.  The blastocysts were transferred in 3l for preservation of blastocysts for mRNA, 
intracellular protein and DNA extraction using the All Prep DNA/RNA/Protein Mini kit 
(Qiagen)  and 40 L of medium in which the individual blastocyst had been cultured in was 
collected and stored at -20C until assayed for IFN protein.  Unfortunately, samples for 
IFN protein analysis were destroyed in transit.   
 
 
Figure 20  Schematic summarising the methodology for IVP and blastocyst assessment and 










3.2.2 Preservation of blastocysts for mRNA, DNA and protein analysis 
Blastocysts (n=90) were transferred in minimum volume (3 L) into PBS (Dulbecco) in a 
four well plate, washed four times and then transferred into 75 L of a buffer containing 
guanidium thiocyanate
4
  (Buffer RLT, part of the RNeasy micro kit) in 0.1 mL thin walled 
PCR tubes.  The PCR tubes were vortexed for 1 minute and stored singly (experimental 
embryos) or in pools (embryos used for validation of the RT-PCR system) at -80C until 
mRNA, DNA and protein extraction. 
3.2.3 Extraction of mRNA, DNA and protein 
Samples were defrosted on ice and vortexed for 1 minute in 275L of Buffer RLT to ensure 
that the embryo was disrupted.  The sample was transferred onto a DNA spin column and 
centrifuged at 8100g for 30 seconds.  The DNA column was kept on ice until assayed for sex 
determination (described in section 3.2.6).  0.075 mL of 80% ethanol was added to the eluate 
(containing the protein and the mRNA) to adjust binding conditions.  The sample was mixed 
by pipetting and transferred into an RNeasy MinElute Spin Column for absorption of RNA 
to the membrane.  The spin column was centrifuged at 8100 g for 30 seconds and the 
flowthrough (containing the protein) was kept on ice until assayed for HSP70 protein 
(described in section 3.2.7).  After adding 0.35 mL of Buffer RW1 (included in the RNeasy 
micro kit), the spin column was centrifuged at 8100 g  for 30 seconds and the flowthrough 
discarded.  The membrane was treated with 0.08 mL of DNase I mix for 15 minutes at room 
temperature and washed with 0.35 mL of Buffer RW1 centrifuged at 8100 g for 30 seconds 
and the collection tube replaced.  The membrane was then washed with 0.5 mL of Buffer 
RPE (included in the RNeasy micro kit) and centrifuged at 8100 g for 30 seconds and the 
flowthrough discarded.  The membrane was then washed with 0.5 mL 80% ethanol (in 
RNase free water) at 8100 g for 2 minutes and the collection tube discarded.  The tube was 
then centrifuged at 16000 g for 5 minutes with the spin column cap open, to allow the 
membrane to dry.   The RNA was then eluted from the membrane with 0.02 mL of water 
centrifuged at 16000 g for 1 minute, producing 0.018 mL of eluate.   
 
In a preliminary experiment, the integrity of the RNA extracted from bovine embryos using 
this methodology was assessed using a bioanalyzer (outlined in Appendix 7, page 215).  All 
samples assessed had an RIN value of 9 or greater, clear and defined peaks for 28S and 18S, 
low noise between the peaks and minimal low molecular weight noise in the 
electropherogram, suggesting limited contamination.  Moreover, the ratio of 28S:18S bands 








this study for RNA extraction and storage of sample RNA provide high yield of good quality 
RNA.   
3.2.4 cDNA synthesis 
Each eluate was reverse transcribed using Qiagen Quantitect Reverse Transcription, as 
described in the manufacturer‟s protocol.  No reverse transcriptase was added in the no 
reverse transcriptase (NRT) controls.  RT was performed in a thermal cycler (Biometra 
thermoblock).  A portion of the RT product (1.8 l as 0.1 equivalent of a single blastocyst) 
was separated from each sample as a no template control (NTC).  Each sample was mixed 
with 1.8 l of gDNA wipeout buffer and incubated at 42C for 2 minutes. The sample was 
then mixed with 6 l of reverse transcriptase, RT buffer and RT Primer Mix (1:4:1) and 
incubated at 42C for 15 minutes followed by 95C for 3 minutes to inactivate the reverse 
transcriptase. 
3.2.5 PCR 
3.2.5.1 Transcript analysis and primer and probe design 
Gene accession numbers for each gene of interest were derived from the literature (Table 26, 
page 134).  The single stranded sequences for each of the genes assessed are outlined in 
Appendix 4 (page 209).  Based on the gene accession numbers for each gene, the 
Quantiprobe design software (Qiagen, https://customassays.qiagen.com/design/inputsequences.asp) 
was used to identify secondary structure-free stretches of the mRNA template long enough to 
accommodate a quantiprobe assay.  The program was set to pick forward and reverse primers 
with melting temperatures around 60ºC, the desired product size was set to 50 to150 bases, 
and default settings were used for all other parameters.  The Quantiprobe design software 
found multiple candidate designs for each target sequence.  Primer Express software (version 
1.0) was used to check the secondary-structure of the candidate primers and probes to predict 
the self-hybridisation of PCR templates.   
 
The exon structure of the mRNA transcripts was derived from the Ensemble Bos taurus 
public database (http://www.ensembl.org/Bos_taurus, as at 03 March 2007).  The 
compatibility of the primers and probes were also checked in the NCBI Entrez Nucleotide 
public database (http://www.ncbi.nlm.nih.gov/sites/entrez?db=nucleotide, as at 03 March 
2007).  Due to minor differences in the sequences recovered in the two public databases, the 
compatibility of all primers and probes were checked in both databases.  Where possible, 
assays were designed to be cDNA specific in order to minimize amplification from genomic 
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templates, by including exon-straddling primers or probes in the assay.  According to 
transcript analysis using Ensembl, there are no introns in the HSP70 and IFN genes, so that 
it was not possible to include exon-straddling primers or probes in the assay for these genes.  
YWHAZ, however, has six exons, and the primers spanned intron boundaries.   
 
The properties of the primers and probes used in the current study are outlined in Table 26 
(page 134). The primers and probes were designed in agreement with the principles of 
primer design (Wittwer et al., 2001), containing more C than G bases, to reduce non-specific 
annealing of the primer, a GC content below 67% (a high GC content promotes non-specific 
binding) and above 39% (a low GC content impedes annealing).  Primer Express software 
determined that none of the primers had primer self-complementarity (ability to form 
secondary structures), and Quantiprobe design software determined that all primers and 
probes were compatible with the PCR cycling conditions.  With all target genes, the priming 
sites were more than 50 nucleotides away from the start of sequencing, thus avoiding any 
bias that may have occurred during RT.  Primer pairs used in a multiplex reaction had similar 
melting temperatures for all the targets amplified in the same reaction and the fluorophore 
used to label different probes in multiplex reactions were spectrally distinct (excitation 
maximum and emission maximum were 494 nm and 518 nm for FAM, 526 nm and 552 nm 
for Yakima Yellow and 587 nm and 607 nm for ROX) so that the cycler could distinguish 
between different target sequences. 
 
The predicted amplicon sequences were then run through BLAST 
(http://www.ncbi.nlm.nih.gov/blast/) against genomic and cDNA databases to ensure that 
they were specific to the genes of interest.  As determined by the NCBI Entrez Nucleotide 
public database, the primers and probes designed were compatible with the target genes 
(results from the BLAST analysis are outlined in Appendix 5, page212).  Matches with high 
scores were assessed to determine whether the primer and probe sets were likely to co-
amplify homologous transcripts or genes along with the primary mRNA target.     The 
predicted amplicon sequences were run through BLAST against genomic and cDNA 
databases for Bos Taurus and most of the hits were relevant to the GOI (Appendix 5, page 
212).  Alternative priming sites had less than 90% identity to the primary site:   IFN was 
detected as the thirteenth hit for IFN amplicon sequence and enoyl-Coenzyme A was 
detected as a BLAST Hit for the YWHAZ amplicon sequence.  In both cases the high gap 
percentage, low expectation value and identity percentage would suggest that the primers 








From all the sequences derived from the Qiagen software, these had the most fitting BLAST 
results.    Therefore, the primer and probe sequences are unique to the target template. 
 
As determined by BLAST and gel electrophoresis (Appendix 8, page 219), the primers and 
probe sequences were compatible with the GOI, were specific to the GOI and led to 
amplicons of the correct size, confirming the identity of the amplicon and the validity of the 
use of the primers and probes in RT-PCR.     
3.2.5.2  PCR 
Real-time PCR was carried out on a Stratagene PCR thermocycler (MX3000P) using the 
Quantitect Multiplex PCR kit (Qiagen) according to the manufacturer‟s instructions.  Gene 
transcripts for the genes of interest IFN, HSP70 and YWHAZ were quantified by real time 
quantitative PCR in duplex reactions with the exogenous housekeeping gene, -globin.  The 
25 l PCR reaction consisted of a cDNA equivalent to 0.05 blastocysts (8% of the overall 
reaction), 50% PCR multiplex mix, 22% RNase free water, 5% -globin primer, 5% -
globin probe, 5%  gene of interest (GOI) primer, 5% GOI probe. Standards and samples 
were run in duplicate reactions, and controls (NTC and NRT) were run in single reactions. 
The same PCR thermocycler was used to analyse all the samples, standards and controls to 
avoid any variation that could arise between different thermocyclers in terms of amount of 
control, accuracy and speed which temperature cycling can be achieved and which could 
affect the kinetics of the PCR reaction (de Sousa and Watson, 2004). 
 
The cycling profile included 2 minutes at 50C, 15 minutes at 95C to activate the 
HotStarTaq DNA Polymerase and 40 cycles of denaturation for 45 s at 94C, annealing for 
45 s at 56C, and extension for 45 s at 76C.  Data were collected during the annealing step.  
The results were quantified using the Stratagene MxPro QPCR Software. 
 
The RT-PCR methodology used in this study was validated as described in Appendix 6 
(page 213).  Briefly, the compatibility and specificity of the primers and probes with the 
genes of interest were assessed using gel electrophoresis (Appendix 8, page 219) and 
assessment of the kinetics of the PCR reaction (Appendix 8, page 219); a standard curve was 
generated by serial dilution (ten-fold) of a positive cDNA template (Appendix 9, page 222);  
and -globin (Appendix 10, page 226) and YWHAZ (Appendix 11, page 233) were assessed 








3.2.5.3 Quantification of mRNA levels 
Expression levels were assessed as absolute values or relative to endogenous control 
(YWHAZ) after correction for variation in exogenous control (-globin).  Before RNA 
extraction, samples were spiked with 20 pg of -globin mRNA, used as an exogenous 
control.  A preliminary experiment (outlined in Appendix 9, page 222) showed that adding 
20 pg of -globin mRNA to the RT reaction gave a range of 5 log dilutions after PCR with a 
similar range of cycle numbers to the genes of interest.  RNA was also extracted from 2 ng 
of -globin mRNA (positive -globin control) and from a blank which was used as a NTC 
during the RT reaction.  Ten samples were run in each PCR plate (5 heat stressed and 5 
control) in duplicate for each gene of interest (IFN, HSP70 and YWHAZ) multiplexed with 
the exogenous control (-globin).  An -globin standard curve derived from duplicate ten-
fold serial dilutions of the cDNA derived from 2 ng of -globin mRNA was present in each 
PCR run to assess the interassay variation.   From the serial dilution, the amount of -globin 











Amount 10 , 
where amount refers to the amount of mRNA in pg, Ct refers to the threshold cycle, c refers 
to the y-intercept of the standard curve and m refers to the slope of the standard curve.  The 
-globin standard curve in each plate was used to convert Ct values into amount of transcript 
(in fg) under the assumption that all the genes of interest had similar efficiencies to that of -
globin.  The amount of each gene of interest was divided by the amount of -globin in each 
well in order to control for differences between samples in RNA recovery, RT and PCR 
efficiencies.  YWHAZ was used as the endogenous housekeeping gene to control for 
differences between samples in total mRNA.    To express transcript levels in relative terms, 
absolute transcript levels of the GOI (corrected for variation in -globin transcript levels) 
were divided by absolute transcript levels of YWHAZ (corrected for variation in -globin 
transcript levels).  In other studies, the two-delta-delta-Ct (2Ct) method (Figure 21a) is 
used to quantify expression relative to one normalizer gene evaluated in a separate well to 
the GOI, taking no account of variation in PCR efficiency or total RNA variation.  The 
multiplex method used in the current study, however, corrects the transcript levels for 
variation in the exogenous control and the endogenous control, so that for each GOI for each 





















Figure 21  Diagrammatic representation of PCR profiles (log of the fluorescence versus cycle 
number) for a) the 2Ct mthod and b) the absolute quantification method used in this study.  
Threshold: ____ 
3.2.5.4 Quality control 
All PCRs were run alongside appropriate controls (positive, NTC, NRT).  The positive 
control was a sample that had been shown to contain the GOI in a previous PCR run.  As 
part of the quality control, replicates that fit the criteria set out in Appendix 12 were re-run.  
Re-run replicates that fit the same criteria were culled from analysis.  Of the 110 blastocysts 
assessed, 20 blastocysts  were excluded from analysis due to errors in the -globin standard 
curve (efficiency too high).  For the analysis for IFN transcript levels, a further 17 
blastocysts were excluded due to non-sensical data (either no Ct value, Ct value above 40, or 
abnormal amplification curve), suggesting that IFN mRNA levels for these samples were 
below the level of detection.     
 
The predicted background fluorescence (PBF) was set by the Stratagene software as the best 
fit line through the fluorescence (R) within the range of cycles during which all contributions 
to fluorescence were linear (i.e. no exponential increase in fluorescence) and the PBF was 
subtracted from the measured fluorescence at each cycle, giving dR.   The software then used 
the reference dye (ROX) in each well to normalise the fluorescence detected in each 
replicate, giving dRn.  Using the software alogarithm, the threshold was set at a point where 
all samples displayed the same rate of increase in the fluorescence intensity.  The standard 
curve for each plate was plotted using the software as the Ct versus the log of initial template 



















Forward Primer ACATGAAGGAGTGGCCTTT 413 - 431 47 64.9 
66 
 












BM446307 FAM or YY 
Forward Primer GACTATTTCCCTCTTCCTATTC 415-436 41 62.4 
78 
 













Forward Primer CAGGACAGAAAGACTTTGG 91-110 45 63.0 
126 
 













 Forward Primer AGAAACGGCTACCACATCCA 56-75 50 57  
18S FAM Reverse Primer TCGTCACTACCTCCCCGG 130-113 67 58 74 
(discarded)  Probe AAGGCAGCAGGCGCGCAAA 79-97 63 68  




Reverse Primer GGCTCCAGCTTAACGATATTTGG 783-761 48 55 68 
















3.2.6 Sex determination 
The sex of mammalian embryos is determined by the presence or absence of the Y 
chromosome. Therefore, the determination of the sex of embryos is based upon detection of 
DNA sequences that are present only on the Y chromosome.  PCR of the genomic DNA 
from an embryo together with specific primers amplify sections of a Y specific gene and a 
bovine specific gene (positive control).  The PCR amplicons are detected through gel-
electrophoresis.   Two fragments indicate that the embryo is male, one fragment indicates 
that the embryo is female (Figure 22). 
 
 
Figure 22 Photograph of a representative gel produced from PCR analysis of the sex of the 
embryo.  Two bands (Y-chromoseome-specific and the cow specific genes) suggest that the 
blastocyst was male, whilst one fragment indicates that the blastocyst was female.  Gels were 
run in duplicate. 
 
Before RNA extraction, DNA was extracted from each embryo using DNA extraction 
columns (Qiagen) according to the
 
manufacturer's instructions with minor modifications.  
80% (20 µL) of the resulting volume was used for PCR using a modified version of the 
method provided by C. Wrenzycki (personal communication).  PCR was performed in a final 
volume of 50 µL
 
of 1 x PCR buffer (Qiagen) containing 1.5 mM MgCl2, 200 µM of each 
dNTP, 1 IU Taq DNA polymerase and 0. 5
 
µM of the Y-chromosome-specific primer  
(5′-CCTCCCCTTGTTCAAACGCCCGGAATCATT-3′ and 
3′-TGCTTGACTGCAGGGACCGAGAGGTTTGGG-5′; 
accession number PCT WO 86/07095) 
and 0.125 µM
 
of the cow-specific primer  
(5′-AGGTCGCGAGATTGGTCGCTAGGTCATGCA-3′ and 
3′-AAGACCTCGAGAGACCCTCTTCAACACGT-5′;  
accession number PCT WO 86/07095). 
In a heated-lid thermocycler, the PCR program involved an initial step of 97°C for 2 minutes
 
followed by 32  cycles 
 
of 15 seconds each at 95°C for DNA denaturation, 15 seconds at
 
60°C for annealing of primers, and 15 seconds at 72°C for
 
primer extension.  The last cycle 
was followed by a 5 minute extension
 








subjected to electrophoresis on a 2% agarose gel in 1× TBE buffer (90 mM Tris, 90 mM 
borate, 2 mM EDTA, pH 8.3) containing 1x SYBR-safe. The image of each gel was recorded 
using a charge couple device (CCD) camera (Gel Doc System).   
 
3.2.7 Intracellular HSP70 analysis 
Intracellular protein was extracted rom each blastocyst using the All Prep DNA/RNA/Protein 
Mini kit (Qiagen).  The flowthrough from the RNeasy spin column was mixed vigorously 
with buffer APP for 10 minutes and then centrifuged for 10 minutes at 14100 g.  The 
supernatant was decanted and 500 L of 70% ethanol added.  The sample was centrifuged 
for 1 minute at 14100g, the supernatant decanted and the protein pellet dried.  The dry 
protein pellet was stored at -20C until assayed for HSP70 protein.   
 
HSP70 was assayed using the HSP70 High sensitivity enzyme immunoassay (Assay 
Designs).  Although the samples contained higher HSP70 levels than blanks, the amount of 
HSP70 (extrapolated to be about 8 pg per embryo) were below the detection limit of the 
assay (200 pg per sample).   
 
3.2.8 Statistical Analysis 
For the serial dilutions in each plate, standard curves were plotted and a linear regression 
analysis was performed on the relationship between the log of accumulated produce and 
cycle number (Stratagene software).  The regression coefficients (r
2
), the CV between 
triplicates and the efficiencies of the standard curves were calculated using the Stratagene 
software.   
 
The variation within and between the PCR plates was calculated as the ratio of standard 
deviation to the mean and expressed as a percentage.  Sex ratios were compared with the 
50:50 ratio using Pearson chi-square analyses (Goodness-of-fit test for observed versus 
expected values, Genstat, Eighth Edition, 2005).  All parametric data were tested for 
normality before parametric analysis by visual assessment of histograms followed by 
Anderson-Darling test (Minitab, Fifteenth Edition, 2006).  Absolute transcript levels of 
YWHAZ and relative transcript levels of IFN and HSP70 to YWHAZ, were analyzed 
relative to treatment and change in morphology index using a REML-LMM (Genstat, Eighth 
Edition, 2005).   Stage of development, sex, day of blastulation and grade were checked as 
possible co-variates and included in the analysis when statistically significant.  The absolute 








transcript levels of IFN and HSP70. Whenever batch of ovaries or PCR plate were a factor, 
they were included as a random model.  Stages of embryo development were grouped as pre-
expansion (early and mid blastocysts) and post-expansion (expanding, expanded, hatching, 
hatched).  Linear regression analysis (Genstat, Eighth Edition, 2005) was used to determine 
the association between IFN and HSP70 expression levels.  To determine whether the slope 
of the regression was different between the two treatments, a two-sample t-test compared the 
ratio IFN:HSP70 in the two treatments.  In order to normalise the data prior to analysis, data 
on relative transcript levels (IFN:YWHAZ and HSP70:YWHAZ) were LOG transformed to 
account for variance bias from ratio data, whilst data on absolute transcript levels were LOG 
transformed to account for bias from exponential data due to conversion from Ct values to 
absolute values.  The effect of treatment on IFN:YWHAZ and HSP70:YWHAZ were 
assessed using student‟s two-sample t-test (one sided t-test, control < heat stressed).  
Differences were considered significant at P<0.05.  Data are presented as mean  standard 
error of the mean, unless otherwise stated.  A Maximum Likelihood Chi-square analysis 
(Genstat, Eighth Edition, 2005) was used to determine whether change in morphology index 
was affected by treatment.  The power of the effect of the treatments was estimated using the 
sample size per treatment, the standard deviation of the treatments, and the differences 










3.3.1 HSP70 expression 
Absolute HSP70 expression was upregulated (P=0.01) in heat treated (505276 fg) 
blastocysts compared to control (255 fg, Figure 23a).  HSP70 expression relative to 
YWHAZ was also increased in heat treated embryos relative to control (0.30.03 and 
0.20.02 respectively, P=0.04, Figure 23).   


































            
Figure 23 Effect of treatment (heat stressed embryos were cultured at 42ºC for 4 h, and control 
embryos were cultured at 38.5ºC) on expression of HSP70 in a) absolute terms and b) relative to 
YWHAZ, n=90.    Values are Mean  standard error.   
In the preliminary experiment (Appendix 10, page 226), there were 4 Cts difference in the 
HSP70 mRNA level in heat stressed and control blastocysts (Figure 24, page 138), whilst in 
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Figure 24 Effect of time between heat treatment (C: control, H: heat stressed) and transfer of 
blastocyst to mRNA stabilising agent on Ct value for HSP70 (Mean SEM): a comparison of the 
preliminary study (Appendix 10, page 226, 0 h, n=5) and the current chapter (Chapter 3, 20 h, 
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Absolute HSP70 transcript levels were lower (P=0.02) in blastocysts which showed signs of 
degeneration (category 3, 9658 fg) compared with blastocysts which progressed in 
development (category 1, 623482 fg) or remained unchanged in morphology (category 2, 
272241 fg) during the individual culture period (Figure 25a).  However, change in 
morphology index did not affect HSP70 expression relative to YWHAZ (P=0.6, Figure 25b).  
The smaller difference between the treatments in the relative data compared to absolute data 
suggests that changes in YWHAZ expression explain at least some of the changes in HSP70 
transcript levels, confirmed by YWHAZ being a significant factor in HSP70 absolute 
expression (P<0.001).   
 



















































Figure 25 Effect of change in morphology index (Embryo survival after 24 h of individual 
culture as assessed by change in morphology before and after individual blastocyst culture:  1 
embryo progressed in development, 2  no visual change in development, 3 signs of degradation 
or collapse) on expression of HSP70 in a) absolute terms and b) relative to YWHAZ, n=90.  
Values are mean  standard error.   
HSP70 expression was not significantly affected by the sex of the embryo (absolute or 
relative to YWHAZ, P=0.1 and P=0.9 respectively), day of blastulation (absolute or relative 
to YWHAZ, P=0.2 and P=0.05 respectively) or its stage of development (absolute or relative 
to YWHAZ, P=0.08 and P=1.0 respectively). 
 








3.3.2 IFN expression 
IFN transcript levels increased with HSP70 transcript levels (P<0.001, Figure 26), with the 
regression slope being steeper within the control group compared to the heat stressed group 
(Figure 26).  Due to the higher variation in the heat treated group (r
2
=0.2) compared to the 
control group (r
2
=0.4), the difference in the steepness of the slope of the best fit line in the 
two treatments was not significant (P=0.2).     



























Figure 26  Relationship between IFN transcript levels and HSP70 transcript levels in control 
() and heat stressed (■).  Regression line equations: within control group (y=0.8x+0.4), within 
heat stressed group (y=0.4x+1.1, n=90).        
IFN expression per YWHAZ was increased in heat treated blastocysts relative to control 
(0.540.07 and 0.300.03, P=0.006, Figure 27b, page 141), whilst the absolute IFN 
expression was not significantly affected by treatment (P=0.3, Figure 27a, page 141).   
 
IFN expression per YWHAZ expression did not vary with morphological grade before 
individual culture (P=0.7), but was lower (P=0.03, Figure 28, page 141) in blastocysts 
categorised as unchanged over the 24 h individual culture period (0.330.07) compared to 
blastocysts that progressed in development (0.460.09) or showed signs of deterioration or 
collapse (0.420.05).  The change in morphology index did not affect absolute IFN 


























a)                                                                   b) 
 
Figure 27  Effect of treatment (heat stressed embryos were cultured at 42ºC for 4 h, and control 
embryos were cultured at 38.5ºC) on expression of HSP70 in a) absolute terms and b) relative to 





















Figure 28  Relative Abundance of IFN transcript versus change in morphology index (Embryo 
survival after 24 h of individual culture as assessed by change in morphology before and after 
individual blastocyst culture:  1 embryo progressed in development n=34, 2  no visual change in 
development n=34, 3 signs of degradation or collapse n=39).  Values are mean  standard error.   
 
IFN expression was not affected by the sex of the embryo (absolute or relative to YWHAZ, 
P=0.4 and P=0.4 respectively) or its stage of development (absolute or relative to YWHAZ, 







































































3.3.3 Did the treatment affect the quality of the blastocyst? 
The proportion of blastocysts categorised as category 1 was greater in control group 
compared to the heat stressed group (Figure 29a), and the proportion of blastocysts 
categorised as category 3 was greater in heat stress group compared to the control group 
(Figure 29b).  Although a greater proportion of heat stressed embryos were categorised as 
category 3 (42%) of the change in morphology index compared to control (31%), this 
difference was not significant (P=0.3, Table 27). 
Table 27  Frequency of control and heat stressed embryos categorised as change in morphology 
index 1, 2 or 3, with percentages in brackets.      
Change in morphology index 1 2 3 
Control 18 (33) 19 (35) 17 (31) 
Heat Stressed 16 (30) 15 (28) 22 (42) 
 



















































Figure 29  Proportion of total control (C) and heat stressed (H) blastocysts categorised as a) 
category 1 (progressed in development, P=0.8) and b) category 3 (showed signs of degeneration, 

























































3.3.4 Sex Determination 
Of the 104 blastocysts for which sex was determined, a total of 51 were female and 53 were 
male, so that the average ratio of male to female was 53:51, similar to the expected 50:50 
ratio in all batches (P=0.4).  The variation between the batches was 44%.  The sexes were 
equally distributed between the treatments (Figure 30). Although a greater proportion of 
females were classified as category 3 of the change in morphology index (blastocysts showing 
signs of degeneration/collapse) compared to males (Figure 30), the difference in the 
distribution of embryos in the three categories of the change in morphology index did not 
differ between the two sexes (P=0.3).  Although day of blastulation did not vary between the 
two sexes (Figure 30), the stage of blastocyst development at day 7.75 pi did differ between 




Figure 30 Number of blastocysts of each sex in comparison with treatment (control, n=53, versus 
heat stressed, n=54), change in morphology index (1: embryos progressed in development, n=34, 
2: embryos remained unchanged, n=34, 3: embryos showed signs of degeneration/collapse, n=39), 









This is the first study to report YWHAZ, IFN and HSP70 expression levels in absolute 
terms.  Given that a blastocyst contains around 5.3 ng of total RNA (Bilodau-Goessels and 
Schultz, 1997), and around 5% of total RNA is mRNA (265 pg), the mean transcript levels for 
YWHAZ, IFN and HSP70 observed in this study (1.59 pg, 394 fg and 375 fg, respectively) 
are realistic, suggesting that the methodology used to quantify the Ct values is likely to be 
valid.  Using this methodology, the absolute transcript levels for YWHAZ, IFN and HSP70 
were corrected for loss of material due to handling and differences in efficiencies in RNA 
extraction, reverse transcription and PCR efficiencies using the -globin control.   
 
IFN and HSP70 were analysed in absolute terms and relative to YWHAZ.  Relative 
expression accounts for variation in overall mRNA levels in embryos due to differences in 
cell number (as concluded in Appendix 10, page 226, and by Vandesompele et al., 2002) 
and/or rate of transcription/ degradation, i.e. RNA degradation due to a reduction in embryo 
competence (Fair et al., 2005), or due to changes in transcription rate during developmental 
events at different stages of blastocyst development (Robert et al., 2002).  Therefore, absolute 
data refers to expression per embryo, whilst relative data refers to expression per total mRNA, 
which explains why there were differences between the two.  Since this study employs a 
novel method of quantifying mRNA expression, this is the first study to compare relative to 
absolute expression levels in embryos.   
3.4.1 Exposure to 42C for 4 h at the blastocyst stage causes stress to IVP 
bovine blastocysts 
3.4.1.1 Effect of heat stress on HSP70 transcript abundance  
HSP70 mRNA was detected in control embryos.   The primers used in this study were 
specific to the stress-inducible form of HSP70, suggesting that control embryos have also 
been stressed, although to a lesser degree than heat stressed embryos.  The stress to the 
control embryos may have been caused by the in vitro environment, since in vivo produced 
blastocysts express less HSP70 than IVP blastocysts (Wrenzycki et al., 2001a).  Since 
individually cultured embryos have inferior development to group cultured embryos (Khurana 
and Niemann, 2000b), the stress from the transfer of the embryo from group culture to 
individual culture may have also induced HSP70 expression in control embryos. 
 
HSP70 transcript levels were higher in heat stressed blastocysts compared to control, 
confirming that heat stressed blastocysts were stressed to a higher degree than control 








heat stress group.   This is not suprising given that Kawarsky and King (2001) also 
demonstrated that exposing bovine blastocysts to 42C for 4 h caused an increase in HSP70 
expression.   
 
In bovine embryos, Kawarsky and King (2001) observed a two fold increase (heat stressed 
versus control) in HSP70 expression relative to 18S expression, a higher difference than 
observed in the present study (0.5 fold increase relative to YWHAZ).  In the preliminary 
experiment (Appendix 10, page 226), there were 4 Cts difference between heat stressed and 
control (Figure 24, page 138), whilst in the current chapter (Chapter 3), there was only 1 Ct 
difference.  In the preliminary experiment (Appendix 10, page 226) and in Kawarsky and 
King (2001), embryos were removed from culture into an mRNA stabilising agent 
immediately after the heat shock treatment, whilst in Chapter 3, the embryos were cultured for 
an additional 20 h before being placed in an mRNA stabilising agent, so that a possible 
explanation for the reduced difference in HSP70 expression between treatments observed in 
Chapter 3 compared to the preliminary experiment (Appendix 10, page 226) and Kawarsky 
and King (2004) could be due to differences in the time between heat stress treatment and 
evaluation of HSP70 expression.  The HSP70 transcripts may have decayed during the 20 h 
recovery at normal temperature, thus reducing the difference in induced HSP70 expression in 
heat stressed embryos relative to control.   
 
In transcriptionally arrested human cells, the half-life of HSP70 mRNA in non-heat shocked 
cells was approximately 50 minutes, increasing at least ten-fold during heat shock 
(Theodrakis and Morimoto, 1987).  Therefore, HSP70 mRNA stability was shown to be 
affected by heat stress.  In the present study, even after 20 h recovery, HSP70 transcript levels 
were not only detected in both heat stressed and control embryos, but were also higher in heat 
stressed compared to control, suggesting that there may be a mechanism in place reducing the 
rate of decay of HSP70 mRNA in bovine embryos.   
3.4.1.2 Effect of heat treatment on embryo morphology 
The change in morphology index was a measure of the change in blastocyst development 
(size, morphological grade and stage of development) during individual culture, classifying 
blastocysts into three categories:  those that progressed in development, those that remained 
unchanged, and those that showed signs of degeneration during individual culture.  Although 
the proportion of embryos which progressed in development was greater in control embryos 
than in heat stressed embryos, and the proportion of embryos which showed signs of 
degeneration were greater in heat stressed blastocysts compared to control blastocysts, these 








categories were not significantly affected by treatment.  Therefore, heat treatment did not 
significantly affect embryo morphology.   
 
There are two possible explanations for the lack of an effect of heat treatment on embryo 
morphology.  Firstly, blastocyst stage embryos have an increased ability to resist heat stress 
compared to earlier stages of development (Kawarsky and King, 2001; Ealy et al., 1993, as 
discussed in section 1.8), so that the level of stress may have been mild enough not to affect 
embryo morphology.  Alternatively, the impact of heat treatment on embryo morphology may 
take longer to occur than 20 h, so that an effect may become evident later in development.  
This, however, was not assessed in the current study.   
3.4.1.3 Differences in response to stress by male and female blastocysts 
The stage of development on day 7.75 pi of the majority of the female blastocysts was 
classified as before expansion, whilst the majority of male blastocysts were classified as after 
expansion, suggesting that male embryos developed faster than females.   Differences in rate 
of development between male and female embryos are due to different patterns of gene 
transcription between the two sexes, so that male embryos consequently have a higher 
metabolic rate and grow faster (Gutierrez-Adan et al., 2006).  
 
The proportion of embryos classified in the three categories of the change in morphology 
index did not differ between the two sexes, suggesting that both sexes were equally able to 
resist heat stress, which contradicts the findings of Perez-Crespo et al. (2005) that female 
murine embryos have been observed to survive better than males when exposed to heat stress 
at the morula stage.  Differences between the two studies may be due to exposure of heat 
treatment at different stages of development (morulae by Perez-Crespo et al., 2005, and 
blastocyst in the present study) or species differences (murine and bovine).  Supporting the 
argument that embryos of different sexes respond to stressors in different ways, some studies 
have observed more male than female embryos cultured in vitro (~60% males in Pegoraro et 
al., 1998, Wrenzycki et al., 2002, Gutierrez-Adan et al., 2001a), and concluded that this was 
caused by stressors from in vitro culture.   
 
The overall sex ratio of blastocysts produced in vitro in the present study, however, did not 
differ from 0.5, as reported by Kimura et al. (2004a), although a high batch-to-batch variation 
in sex ratios was observed (44%), suggesting that slight variations in culture conditions and/or 
oocyte and sperm used in different batches (i.e. slight variations in manipulation, medium 
content, quality of oocytes or sperm) might have an impact on sex ratios.  In fact, stress is 








including follicular fluid steroid levels (Agung et al., 2006, Grant et al., 2008), co-culture 
(Pegoraro et al., 1998), glucose level (Gutierrez-Adan et al., 2001b), in vitro culture system 
(Gutierrez-Adan 2001a) and sperm preparation (Madrid-Bury et al., 2003, Lechniak et al., 
2003), which might explain contradictions in sex ratios observed in different studies, 
irrespective of whether embryos were exposed to stress or not.   
 
This is the first study to compare HSP70 expression between male and female embryos, and 
sex did not seem to affect HSP70 transcript levels.  One explanation is that HSP70 gene is not 
located on the X-chromosome (Ryan and Womack, 1993), and X-chromosome dosage is the 
major contributing factor to sexual dimorphism among early embryos (Wrenzycki et al., 
2002). 
 
Heat treatment affected the cellular stress response by either upregulating HSP70 expression, 
or increasing the stability of HSP70 transcripts in heat stressed blastocysts.  However, the 
stress levels were mild enough not to affect embryo morphology (and possibly viability) or 
differences in response to stress between pre- and post-compaction blastocysts, and between 
male and female blastocysts.   
3.4.2 Factors affecting IFN expression 
Blastocysts were allocated to either treatment according to grade, size and stage of 
development, to ensure that the two treatments were balanced.  Despite the sex of the 
blastocysts being determined after embryos were allocated between treatments, sex ratios 
were similar between treatments.  Therefore, differences between the treatments in expression 
of IFN, HSP70 or YWHAZ are unlikely to be due to sex, embryo grade, size, or stage of 
development, but rather due to heat stress. 
 
Absolute IFN expression was higher in heat stressed embryos compared to control, although 
not significantly higher due to the high variation in IFN expression.  IFN expression varied 
four orders of magnitude, which is comparable to the variation in protein secretion observed 
in Chapter 2, suggesting that IFN secretion is regulated at the transcriptional level.   Day of 
blastulation was a significant factor affecting IFN expression, suggesting that the increased 
IFN secretion observed in later developing blastocysts compared to earlier developing 
blastocysts in Chapter 3 is probably modulated at the transcriptional level.  The variation in 
absolute IFN expression was not accounted for by sex (P=0.4) or stage of development 
(P=0.3), suggesting that other factors caused the variation observed in this study, such as 








heat stressed embryos, suggesting that differences in overall transcript levels (possibly due to 
differences in cell number) explain at least part of the variation in absolute IFN expression.   
 
IFN correlated with YWHAZ transcript levels, a possible index of cell number, suggesting 
that IFN expression may be higher in embryos with more cells.  However, blastocysts at the 
later stages (expanded, hatched, hatching) generally have a higher number of cells than earlier 
stage blastocysts (early and mid), and IFN did not vary with stage of development or with 
blastocyst diameter. Although cell lineage was not determined in this study, this discrepancy 
may be due to embryo-to-embryo differences in the ratio of cells in the inner cell mass and 
the trophectoderm, given that IFN expression is thought to be exclusive to trophectoderm 
cells (Roberts, 2007).   
 
In the present study, IFN expression was not affected by stage of development or the 
morphological grade of the embryo, factors which have been connected with embryo quality 
(Van Soom et al., 1997).  Although there are no data in the literature on IFN expression 
relative to these variables, IFN protein secretion was shown to be affected by the stage of 
development (Kubisch et al., 1998) and the morphological grade of the embryo (Hernendez-
Ledezma et al., 1993) and discrepancies between the protein secretion in these studies and 
IFN expression variation in the present study may be due to other factors affecting rate of 
translation.   However, part of the variation in IFN transcript levels was explained by the 
change in morphology index, which takes into account changes in diameter, morphological 
grade and stage of development, and could be considered a measure of embryo viability and 
quality.   IFN expression was higher in embryos which showed signs of degeneration after 
individual culture than those that did not, suggesting that IFN is not indicative of embryo 
quality.      
 
Therefore, sex, stage of development and embryo morphology (at 0 and 24 h individual 
culture) had no significant effect on IFN expression, whilst degeneration, increased overall 
rate of expression (possibly explained by differences between blastocysts in cell proliferation) 
and heat stress upregulated IFN expression levels, suggesting that IFN expression levels 
may be indicative of stress. 
3.4.3 Relationship between IFN transcript abundance and HSP70 
transcript abundance 
This is the first study to correlate HSP70 expression with IFN expression from the same 








have assessed both IFN and HSP70 expression in bovine embryos are summarised in Figure 
31 (page 149).  In most studies, the change in HSP70 expression and IFN expression 
between treatments were in the same direction i.e. both HSP70 and IFN transcript levels 
were higher in control embryos compared to nuclear transfer embryos (Wrenzycki et al., 
2001a) and in vitro embryos compared to in vivo (Sagirkaya et al., 2007, Wrenzycki et al., 
2001b).  Similarly, IFN mRNA from in vitro cultured ovine embryos had reduced stability 
and reduced transcription compared to in vivo produced embryos (Hansen et al., 1991).   
 
The effect of serum on the relationship between HSP70 and IFN expression is contradictory.  
Rizos et al. (2003) reported higher levels of IFN transcripts in embryos cultured in the 
absence of serum, and Russell et al. (2006) observed an increase in both IFN and HSP70 
transcript levels due to serum relative to BSA, whilst Wrenzycki et al. (1999) found that 
serum caused an increase in HSP70 transcript levels and a decrease in IFN transcript levels 
relative to BSA.  Since Russell et al. (2006) also found that IFN and HSP70 transcript levels 
were not affected by lower serum concentrations (2%), discrepancies between studies may be 
due to differences in the amount of serum present in the culture.  Moreover, Russell et al. 
(2006) observed no increase in IFN or HSP70 expression in TCM supplemented with serum 
relative to SOF with 2% serum or BSA, suggesting that the increase in IFN and HSP70 
expression are not due to the protein source (BSA or Serum) or the other contents of the 
culture medium (TCM or SOF), but rather a combination of the two.  Moreover, serum 
contains growth factors which may affect IFN expression, irrespective of stress.  Therefore, 
the similar changes in HSP70 and IFN expression in different treatments in most studies 
suggest that IFN and HSP70 expression may be regulated by a similar mechanism.    
 
Figure 31  Direction of change between two treatments in the relative mRNA abundance of 
HSP70 and IFN.  Treatment 1 contains higher transcript levels than Treatment 
2,  Treatment 2 contains higher transcript levels than Treatment 1.  References: 
1: Wrenzycki et al. (1999), 2: Wrenzycki et al. (2001a), 3: Wrenzycki et al. (2001b), 4: Sagirkaya 
et al. (2007), 5: Current Study 
 Treatment 1 HSP70 IFN Treatment 2 
1 PVA   Serum 
2 Control   Nuclear Transfer 
4 In vitro   In vivo 
3 In vitro   In vivo 









Other than HSP70, IFN has also been associated with other transcripts associated with stress.  
An increase in IFN transcript level was associated with reduced transcript levels of genes 
associated with oxidative stress (MnSOD, sarcosine oxidase, SOX, apoptosis regulator box-2, 
BAX, CuZnSOD, Rizos et al., 2002, 2003, 2004, Lonergan, 2003, Gutierrez-Adan et al., 
2004a) and attachment and differentiation (LIF, Rizos et al., 2003), suggesting that IFN 
expression may be regulated by cellular stress.   
3.4.4 Possible overlapping molecular elements between IFN and HSP70 
mechanism of transcription and translation as a response to stress 
The results presented suggest that heat stress upregulates both IFN and HSP70 expression 
levels, suggesting that the mechanism for IFN production and the cellular stress response 
may have some overlapping molecular elements.  In the case of IFN, there are several 
potentially functional IFN loci coding for a number of different alleles (Ealy et al., 2001), 
suggesting that IFN is mediated by a wide range of signalling factors.   Ezashi and Roberts 
(2004) demonstrated that the transcription factor Ets2 is essential for upregulation of IFN, 
and the activation of Ets2 was shown to be mediated by the Ras/MAPK pathway as well as 
the adenosine 3′,5′-cyclic monophosphate (cAMP)/PKA signal transduction pathway (Das et 
al., 2008).   
 
A number of specific genes have been identified in bovine embryos that respond to stress, 
such as Mn/Cu/ZnSOD and glucose transporter (Glut)1 (Correa et al., 2008, Luciano et al., 
2006, Wrenzycki et al., 2001a,b).  In drosophila, Ras/MAPK signalling pathway was shown 
to be modulated by reactive oxygen species (Morey et al., 2001), so that modulation of gene 
expression by stress was observed.  Therefore, heat stress may interfere with the Ras/MAPK 
pathway, either directly or through the cellular stress response pathway, thus affecting IFN 
expression.   
3.5 Conclusion 
The effect of heat stress on change in expression of the IFN and the HSP70 genes in the 
same bovine blastocysts have been demonstrated for the first time.  The increase in IFN 
transcript levels due to heat stress and the positive correlation between IFN and HSP70 
suggest that the mechanism for IFN production and the cellular stress response may have 
some overlapping molecular elements, in agreement with suggestions by Kubisch et al. (2004) 
that IFN is an indicator of stress.  Whether IFN is necessary for HSP70 expression, or the 
other way around, or the two mechanisms share a common pathway, is unclear.  Given that 








suggests that the cellular stress response mechanism is not dependent on IFN production.  
Also, the high variation in IFN evident in this study, despite not being modulated by factors 
such as morphological grade, sex, stage of development, suggests that there are other 
unknown factors in in vitro culture affecting IFN production, so that heat stress is not the 









4 GENERAL DISCUSSION 
 
Embryo viability is defined as the probability of an embryo successfully implanting and 
developing in the uterus to term (Haiberg, 2007).  There is an ongoing debate as to whether 
IFN expression and/or secretion are indicators of embryo viability or responses to stress 
(Hernandez-Ledezma et al., 1992, 1993, Kubisch et al., 1998, 2001a, 2003).  As the 
antiluteolytic pregnancy signal, an essential embryo function for establishment of pregnancy, 
IFN would be expected to be related with embryo attachment potential and viability. 
 
Quality parameters are defined as measurements intended to reflect the viability of an embryo 
after transfer (Haiberg, 2007).  Traditionally, embryo viability is estimated using quality 
parameters based on morphology, such as blastocyst yield, embryo morphology, rate of 
development, cell proliferation and relative transcript abundance (as reviewed by Gardner and 
Sakkas, 2003). IFN secretion and expression levels were compared to quality parameters 
observed in this thesis and in the literature to determine whether IFN can be used as a 
predictor of future embryo development (summarised in Table 28, page 153).  In this thesis, 
IFN expression and secretion did not correlate with diameter or morphological grade, and 
IFN secretion did not correlate with apoptotic index or total cell number, suggesting that 
IFN is not associated with embryo quality.  Some quality parameters described in this thesis 
were related to IFN production:  higher IFN production was associated with a higher 
blastocyst yield, a progressive change in morphology and delayed blastulation. Rather than an 
indication of viability, the relationship between IFN and higher blastocyst yield may be 
indicative of more blastocysts secreting IFN, delayed blastulation may be indicative of 
increased number of cells switching on to express IFN (assuming that IFN is switched on 
genetically in a specific time window, as reviewed in section 1.5).  Therefore, although some 
quality parameters may affect IFN production, this may not necessarily suggest a 
relationship between IFN production at the blastocyst stage and viability.   
 
This lack of a consistency between comparison of quality parameters with IFN expression 
and secretion was also evident in other studies (Table 28, page 153) further suggesting that 
IFN expression and secretion in vitro do not correlate with quality parameters.  Therefore, 
either (1) there is no relationship between IFN production at the blastocyst stage and future 
embryo development and other factors mediate IFN production, or (2) quality parameters are 









Table 28  Direction of change in IFN production (protein secretion or transcript concentration) in 
‘good’ compared with ‘poor’ quality embryos in a range of studies.   : ‘Good’ produced more 
IFN than ‘Poor’.  =:  No significant change between ‘good’ and ‘poor’.  :  ‘Poor’ produced 
more IFN than ‘Good’.  
Quality Parameter „Poor‟  „Good‟ Reference 
Pregnancy Rate  Kubisch et al., 2004 
   
Morphology  Hernandez-Ledezma et al., 1993 
Neira et al., 2007 
 





Kubisch et al., 1998 
  






   
Age at blastulation  Chapter 2 
Chapter 3 
Kubisch et al., 1998, 2001a 
  Gutierrez-Adan et al., 2004a 
   
Age of hatching  Stojkovic et al., 1995 
   





Larson et al., 2001 
   
Pyruvate oxidation  Chapter 2 
   
Apoptosis = Chapter 2 
   
Cell Count = Chapter 2 
Kubisch et al., 1998, 2001a 
Larson and Kubisch, 1999 
Stojkovic et al., 1999 
Neira et al., 2007 
   
  Chapter 3* 
   





Stojkovic et al., 1999 
Lo and Summers et al., 2002 
   
Relative transcript abundance (SOX, Glut-1 or Cx)  Wrenzycki et al., 2001a,b 
Rizos et al., 2002, 2004 
Lonergan et al., 2003a 
Gutierrez-Adan et al., 2004a  
   
                                         Rizos et al., 2003 
   
Relative transcript abundance (HSP)  Chapter 3 









There have been several attempts to link mRNA transcript abundance of genes thought to be 
important for bovine embryo development with embryo quality.  The references in Table 29, 
(page 158) compared embryos from different treatments and, using other quality parameters, 
concluded that embryos from the first treatment had lower viability compared to embryos 
from the second treatment.  „Low‟ quality embryos consistently expressed higher levels of 
sarcosine oxidase (SOX) than „high‟ quality embryos, so that SOX may be an indication of 
reduced quality.  SOX is an enzyme that catalyses oxidation reactions of lipids of more than 
18-carbon long chains (Koyama et al., 1996).  Increase in the transcription of SOX are related 
with high levels of H2O2, high levels of glycine and glucose, high levels of lipid peroxidation 
and lipid metabolism.  As such, upregulation of SOX tends to be associated with increased 
ROS levels and increased oxidative stress (Koyama et al., 1996).  Therefore, poor quality 
embryos have increased SOX expression levels due to increased rate of oxidation.  
Differences in IFN mRNA levels between „low‟ and „high‟ quality embryos have also been 
significantly repeatable across different studies (according to the chi-square test demonstrated 
in Table 29, page 158).  Most papers (9 out of 13) found that IFN decreased with quality, 
suggesting that IFN may be negatively associated with quality.  Comparing IFN expression 
with expression of SOX, a consistent marker of reduced viability (Table 29, page 158), IFN 
transcript levels correlated with expression of SOX in most papers (Rizos et al., 2002, 2004, 
Lonergan et al., 2003a,b, Gutierrez-Adan et al., 2004a), suggesting that IFN expression is 
enhanced in conditions of oxidative stress.   
 
Oxidative stress leads to increased lipid peroxidation which in turn cause mitochondrial 
dysfunction in embryos (Guerin et al., 2001).  Mitochondrial manganese superoxide 
dismutase (MnSOD) is associated with increased mitochondrial activity and detoxification of 
ROS, whilst HSP70 has a protective role during stress.  The relationship between transcript 
levels for genes associated with stress recovery (HSP70 and MnSOD) and quality was not 
significant (Table 29, page 158), possibly due to varied levels of stress affecting quality in 
different ways.  Therefore, there seems to be no relationship between quality and ability to 
activate a cellular stress response mechanism.   
 
In Chapter 3, exposure of bovine blastocysts to 42C for four h increased transcript levels of 
IFN relative to control blastocysts, demonstrating that detrimental environmental factors 
may regulate IFN expression.  IFN and HSP70 transcript levels were evaluated in the same 
blastocyst, and it was observed that IFN transcript levels increased with HSP70 transcript 








between treatments have observed similar changes in HSP70 and IFN transcript levels in 
different treatments (discussed in section 3.4.3, summarised in Figure 31, page 149), 
suggesting that IFN and HSP70 expression may be regulated by a similar mechanism.  Heat 
treatment caused an increase in HSP70 transcript levels but did not affect the change of the 
morphology of the blastocyst during 24 h individual culture, suggesting that the level of stress 
caused by the heat treatment was high enough to activate the cellular stress response, but mild 
enough not to cause a change in morphological quality, suggesting that the stress may have 
been mild enough not to cause an increase in apoptosis and necrosis.  Therefore, mild heat 
stress upregulated IFN expression, suggesting that IFN is an index of stress, as first 
suggested by Kubisch et al. (1998).    
 
Therefore, the results from this thesis suggest that IFN expression and secretion are not 
associated with overall quality parameters, and, instead, IFN expression seems to be related 
to cellular stress. 
 
4.1 Quality, metabolism, stress and viability 
4.1.1 Quality 
Although quality parameters tend to be predictors of future embryo development in vitro 
(Fujino et al., 2007), they do not necessarily correlate positively with future embryo 
development in vivo, such as rate of attachment, pregnancy rate and development to full term.  
Therefore, quality parameters are not sensitive enough to predict viability.  Quality 
parameters are likely to be a reflection of the success of embryo development up to the point 
when embryos were assessed which may not necessarily relate to the success of future 
embryo development (as discussed by McEvoy et al., 1997).   
4.1.2 Metabolism 
In Chapter 3, IFN correlated positively with YWHAZ transcript levels, a possible index of 
total expression level which is mediated by cell number (Sirard et al., 2005, amongst other 
factors), suggesting that IFN expression may be higher in embryos with more cells.  In 
agreement, Stojkovic et al. (1999) estimated trophoblast growth by calculating the surface 
areas of embryos based on diameters and observed a significant positive correlation between 
trophoblast area and IFN secretion.  Using ovine embryos, Lo and Summers (2002) also 
observed that embryo diameter was positively correlated with IFN secretion, suggesting that 
IFN secretion may be positively correlated to embryo size and number of trophoblast cells.  








3) or secretion (Chapter 2), maybe because blastocyst diameter is only a crude estimation of 
trophoblast cell number since embryos may collapse and re-expand.  Cell number is a 
consequence of a balance between increase in cell proliferation fuelled by an increase in 
metabolism, and a decrease in cell death by apoptosis or necrosis.  According to Chapter 2, 
apoptosis was not related to IFN secretion (in agreement with Russell et al., 2006), but the 
positive relationship (which approached significance, P=0.07) between IFN secretion per cell 
and pyruvate oxidation per cell observed in Chapter 2,  suggesting that IFN secretion is 
related to metabolism, but not apoptosis.  Ealy et al. (1993) previously demonstrated that mild 
heat treatment enhanced the growth rate of embryos, suggesting an increase in metabolism.  
In this thesis, heat treatment increased IFN expression, further suggesting that IFN 
expression may be positively associated with rate of metabolism.  Therefore, the lack of a 
correlation between IFN production and quality parameters observed in this thesis, and the 
positive relationship between IFN expression and stress may be due to IFN being related to 
metabolism as opposed to quality parameters.   
 
The „Quiet embryo hypothesis‟ proposes that metabolism of an embryo is indicative of its 
viability, with viable preimplantation embryos operating at metabolite or nutrient turnover 
rates which are lower than those of their less viable counterparts (Leese et al., 2008).  
Therefore, following the principles of the quiet embryo hypothesis, the positive relationship 
between IFN secretion and metabolism suggests a negative relationship between IFN and 
embryo viability.   
 
All cells will use energy as required by the normal cellular and developmental processes 
necessary to maintain survival.  The embryo has an intrinsic ability to compensate for stress 
which involves processes such as mRNA damage surveillance and ribosomal recovery, 
protein degradation and amino acid recycling, nucleotide, polynucleotide, peptide, 
polypeptide synthesis (Baumann et al., 2007).  As an embryo becomes stressed, energy is 
used in an attempt to accommodate the necessary repair system to repair the damage to the 
genome, transcriptome and proteome caused by stress.  According to the quiet embryo 
hypothesis, the increased energy usage leads to an increased metabolism (and increased 
consumption of oxygen and nutrients, Leese et al., 2007) likely to generate increased levels of 
reactive oxygen species which are also deleterious to the cell (Guerin et al., 2001), which 
explains why the most viable cells, which need to use less energy repairing damage to the 
cell, exhibit a „quieter‟ metabolism (Leese et al., 2002).  As such, stress may lead to a 
reduction in embryo viability.  Following this philosophy, Lane and Gardner (2005) observed 








adequate levels of ATP, which eventually lead to disturbed cellular function, disturbed 
epigenetic regulation and abnormal foetal and placental development.  The association 
between stress and reduced embryo viability has therefore lead to the hypothesis that early 
embryos should be maintained in systems designed to minimize stress.  As such, stress may 
lead to a reduction in embryo viability.   
 
The quiet embryo hypothesis suggests that the cellular stress response takes precedence over 
other developmental events, so that the normal programs of gene activity are altered.  
However, non-teratogenic doses of heat can produce a strong cellular stress response 
(Edwards, 1998) which does not fit this proposal.  Therefore, on top of having a quiet 
metabolism, a viable embryo must also be able to respond to stress with minimum disruption 
to the metabolism in order to ensure a non-teratogenic consequence to the embryo.   
 
In mice, the trophectoderm consumed significantly more oxygen, produced more ATP 
(trophectoderm produced 80% of the ATP generated by the embryo), contained greater 
number of mitochondria, had greater amino acid turnover (trophectoderm responsible for 90% 
of the amino acid turnover by the embryo) compared to the inner cell mass (Houghton et al., 
2006).  Therefore, the trophectoderm is more metabolically active than the inner cell mass.  
Given that the trophectoderm is the site of IFN production suggests that IFN production 
may be associated with increased metabolism and, following the quiet embryo hypothesis, 










Table 29  Direction of change in relative mRNA abundance of several candidate genes in ‘good’ compared with ‘poor’ quality embryos in a range of bovine studies 
(updated and expanded from Rizos et al., 2004).  In each comparison, the latter is considered ‘Poorer’ than the former.   : ‘Good’ contain more mRNA than 
‘Poor’.   :  No significant change between ‘Good’ and ‘Poor’.  :  ‘Poor’ contain more mRNA than ‘Good’.  1. Wrenzycki et al., 1999, 2. Wrenzycki et al. 2001a, 3. 
Wrenzycki et al. 2001b, 4. Bertolini et al., 2002, 5. Rizos et al., 2002, 6. Rizos et al., 2003, 7. Lonergan et al., 2003a, 8. Rizos et al., 2004, 9.  Gutierrez-Adan et al., 
2004a, 10. Lim et al., 2007, 11. Sagirkaya et al., 2007, 12. Correa et al., 2008.  SOX is involved in oxidative stress; MnSOD, oxidative stress ; HSP70, heat stress.  B: 
Bovine, O: Ovine, S: SOF, viv: in vivo, vit: in vitro, S1 and S2 are modified recipes of SOF, -: serum absent, +: serum present, PVA: polyvinyl alcohol, NT: nuclear 
transfer, BSA: bovine serum albumin, IVP: in vitro produced, High: high oxygen level, Low: low oxygen level.  Majority of papers show a negative, positive or 
inconsistent relationship between the expression of the gene of interest and quality.  Summary:  number of studies showing a negative () and positive () per total 
number of studies assessing that gene.  Probability (P) refers to the chi-square test compared to a third of the papers showing a negative, positive or inconsistent 














































  Overall 
IFN               9/13 3/13    P=0.01  
SOX               7/7 0/7  P<0.001 
Glut-1               2/11 7/11     P=0.1 
HSP70               1/4 2/4     P=0.8 
MnSOD               4/9 4/9     P=0.4 









An embryo in vivo is exposed to environmental stimuli and intrinsic signals which ensure 
embryo survival.  In this thesis, a stressed embryo is defined as an embryo which is exposed 
to any factor (or lack of) which causes an unfavourable deviation from the normal function of 
an embryo.  If the in vivo environment is considered normal, then an in vitro embryo is 
always exposed to stressors.  Moreover, heat denaturation of proteins proceeds at a slow rate 
even at normal body temperature (Johnson and Pavelec, 1972), so that all embryos (including 
in vivo embryos) must suffer some degree of thermal stress.   
 
The stressor threatens the viability of an embryo and requires a response to ensure survival.  
There are several potential pathways in which stress may modulate cellular function.  A 
stressor may cause modified gene expression, leading to modified metabolism, causing a 
subsequent change in developmental kinetics, causing cell death, and affecting a range of 
quality parameters (ability to blastulate and hatch, cell proliferation, rate of development, 
etc…) and the successful establishment of pregnancy (Fleming et al., 2004).  The dose of 
stress and the ability of the embryo to respond to the stressor will impact on whether the 
stressor affects embryo viability.   
4.1.3.1 Dose of stress 
As reviewed in section 1.8.5, maternal heat stress leads to foetal loss (Garcia-Ispierto et al., 
2006).  Exposure of heifers to hyperthermic conditions (daily exposure to 16 h at 30C and 8 
h at 42C) caused a 2.5–fold increase in the number of abnormal and retarded embryos and 
unfertilized ova compared to heifers kept at thermal neutrality (20C, Putney et al., 1988a).  
Exposure of in vitro bovine embryos to 43C for 18 h caused a reduction in intracellular 
incorporation of proteins (indicative of decreased viability) and decreased IFN secretion 
(Putney et al., 1988b).  However, exposure of pregnant cows to 37C for nine days (which 
would cause an in utero temperature of around 39.8C) caused an increase in IFN secretion 
compared to control (21C, Geisert et al., 1988).  Therefore, the varied effect of hyperthermia 
on IFN secretion reported in different studies may be explained by differences in the dose of 
heat exposed to the embryos.  The „dose‟ is the produce of the extent and duration of elevated 
temperature.   
 
In rats, as the temperature exposed to pregnant rats increased, the time required to cause a 
defect was reduced logarithmically (Germain et al., 1985).  In mice, Edwards (1998) also 








heat.  Therefore, a high dose of hyperthermia leads to an increase in abortion and conceptus 
abnormality, reduced dose leads to a high prevalence of abnormality with low rates of 
abortion, and lower doses leads to no abnormality or abortion.   
 
Non-teratogenic doses were associated with a minor increase in the incidence of apoptosis, 
whilst teratogenic doses caused severe apoptosis, suggesting that there is a threshold level of 
apoptosis required to cause teratogenesis.  Therefore, Edwards (1998) concluded that an 
embryo must be exposed to a threshold „dose‟ of heat if rate of apoptosis is to increase, and a 
higher dose if teratogenic effects are to be caused.  Although Edwards (1998) reviewed the 
effect of hyperthermia in post-implantation rodents, it is possible that the threshold dose 
concept may be applicable to bovine pre-implantation embryos as well.  
 
Based on the rodent models, it is hypothesised that in cattle, increased doses of stress cause 
increasing deviations from normality in bovine pre-implantation embryos, as outlined in the 
model proposed in Table 30 (page165).  At mild doses of stress, there is some modification in 
gene expression and cell death by controlled apoptosis, but changes to metabolism, 
developmental kinetics, necrosis and reduced quality and short term survival do not occur.  At 
higher doses of stress, the embryo is not able to cope with the stress through the cellular stress 
response and apoptotic pathways alone and, instead, gene expression is modified further, 
leading to modified metabolism, developmental kinetics, cell death by apoptosis as well as 
necrosis, leading to deteriorated quality and reduced attachment and pregnancy, and a greater 
decrease in short term as well as long term survivability compared to milder stress doses.  
Lethal doses of stress overwhelm the ability of the embryo to respond to stress so that the 
stress defence mechanisms (such as cellular stress response and apoptosis) are not activated 
correctly, leading to decreased quality of the embryos and, ultimately, abortion.  Therefore, 
quality parameters are not affected at lower degrees of stress (0 or 1, Table 30, page165).  
Quality markers attempt to predict survivability, and a reduction of survivability is a possible 
consequence of high doses of stress, whilst exposing embryos to mild doses of stress may not 
affect the ability of the embryo to survive.    
 
In agreement with the quiet embryo hypothesis, this model suggests that viability will be 
determined by the effect of the stressor on the metabolism of the embryo, but also considers 
that the embryo may be able to tolerate or even recover from the stress insults if the dose of 
the stress is below a threshold.  Therefore, IFN may be related to stress and not with quality, 








4.1.3.2 Ability of an embryo to respond to a stressor 
The stress dose that leads to mild, teratogenic or lethal levels of stress is likely to vary 
between different embryos according to the variability between embryos in their ability to 
respond to a stressor.  In this thesis, blastocysts were evaluated before and after 24h 
individual culture.  Some blastocysts progressed in development, some remained unchanged 
and some regressed in development.  Such differences in change in morphology index 
between different embryos cultured in the same conditions suggest that different embryos 
have different levels of ability to respond to a stressor.  
4.1.3.2.1 Reasons for different embryos to have varied abilities to respond to stress 
Embryos from Brahman and Romosinuano breeds are more resistant to elevated temperature 
than embryos from Angus (Hernandez-Ceron et al., 2004). In another study, embryos from 
Brahman cows were more resistant to heat shock than embryos from Holstein or Angus, and 
embryos from Senepol cows had even lower resistance to heat shock (Paula-Lopes et al., 
2003).  Therefore, different breeds of cattle have adapted to different environmental 
temperatures, so that the normal basal temperature varies between breeds.  Therefore, the 
threshold dose that leads to mild stress, teratogenic stress or abortion is likely to vary between 
different embryos according to the variability between embryos in their normal basal level.   
 
Using pregnant mice, Edwards (1998) observed that the periods of high susceptibility to 
embryonic stress occurred during organogenesis, with the type of malformation depending 
mainly on the stage of embryonic development.  The authors speculated that at this stage, 
HSP expression is at its highest level, possibly to protect the embryo and the increased 
susceptibility might be due to gene activity being concentrated in heat shock response, so that 
the normal protein synthesis necessary for organogenesis becomes suspended.  Therefore, 
protective HSPs are produced, but survival is achieved at the expense of normal development.  
The same principle could be applied to pre-implantation embryos, with certain stages of 
embryo development having increased sensitivity due to the gene activity sequestering greater 
proportion of HSPs for certain processes in embryo development, leaving less for protection 
against environmental insults.  Alternatively, the production of induced proteins may be 
delayed due to certain processes requiring extensive gene activity.  Lane and Gardner (2005) 
observed that post-compaction embryos are better able to regulate their physiology and are, 
therefore, less vulnerable to stress than pre-compaction embryos.  In this thesis, IFN and 
HSP70 expression were upregulated in post-expansion blastocysts compared to blastocysts 
before expansion (Appendix 11), suggesting that post-expansion blastocysts are less 









In guinea pig, rat and mice embryos, the M-phase cells appeared to be the most susceptible to 
hyperthermic stress, with higher stress doses leading to S-phase cell deaths.  Similarly in pig 
embryos, low doses of hyperthermia affected cells in mitosis phase of the cell cycle, and other 
cells became affected after more severe doses (Edwards, 1998).  The reason for the increased 
susceptibility of mitotic cells is unclear, but could be due to irreversible denaturation of some 
proteins associated with M-phase chromosomes.  In the initial M-phase cell death, the 
chromosomes shortened, thickened and aggregated into clumps which later fragmented.  Cells 
then became vacuolated and disintegrated and normal mitotic activity was suspended. Blocks 
to progression through mitosis occurred before prophase and during metaphase (Edwards et 
al., 1974).  Therefore, the stage of the cell cycle will also affect the susceptibility of 
blastomeres to stress.   
 
Therefore, factors likely to contribute to variation between embryos in their ability to respond 
to a stressor include breed, stage of development, number of cells and rate of metabolism, 
inherent genetics and stage of the cell cycle.  Moreover, it is possible that the ability of an 
embryo to respond to stress may be indicative of its viability. 
4.1.3.3 The ability to respond to stress may be an indication of viability 
Acquiring thermotolerance involves increasing the capacity of the embryo to produce 
molecules involved in thermoprotection (Arechiga et al., 1995).  Therefore, exposing embryos 
to a mild stress treatment may enhance its survival by enhancing its tolerance to future 
stressors.  In this thesis, the blastocysts were not cultured on after heat treatment, so that it 
was not possible to assess whether mild heat treatment improved viability.  There are few 
studies on acquisition of thermotolerance by bovine embryos, all of which are interested in 
establishing the stage of development that thermotolerance is possible, and none of which 
actually transferred the embryos back in vivo to determine whether thermotolerance leads to 
improved viability.  Ealy et al. (1993) demonstrated that mild heat treatment enhanced the 
growth rate of embryos and concluded that mild heat treatment may benefit the embryo 
through acquisition of thermotolerance.  However, the enhanced growth rate is more likely to 
be indicative of an increase in metabolism, so that further studies are necessary to determine 
whether increased tolerance to stress improves bovine embryo viability.   
 
High hydrostatic pressure is a stressor for biological materials by inhibiting growth (Abe et 
al., 1999), altering the membrane functionality and therefore perturbing the physico-chemical 
balance of the cell (Palou et al., 1997) and perturbing DNA replication (Abe et al., 1999).   
High hydrostatic pressure has also been shown to increase HSP expression in human 








stressor to cells.  Higher pressure dose (90MPa for 2 h or 30MPa for 5h) caused irreversible 
changes to the murine blastocysts, which disintegrated after 2 h of in vitro culture or 
immediately after decompression (Pribenszky et al., 2005a).  Sublethal levels of hydrostatic 
pressure (90MPa for 30 minutes, or 30MPa for 3 h), significantly improved the post-thaw 
survival of frozen mouse blastocysts, as well as live birth rate after transfer (Pribenszky et al., 
2005a).  Similarly, pig oocytes exposed to high hydrostatic pressure also demonstrated 
increased cleavage rate compared to control (Prisbenzsky et al., 2008).  Exposure to high 
hydrostatic pressure prior to freeze-thawing has been shown to result in improved motility, 
viability and fertility parameters of frozen bull and boar semen (Huang et al., 2009, 
Pribenszky et al., 2005b), suggesting that exposing gametes and embryos (including bovine) 
to a mild stress may improve their viability due to increased stress tolerance.   
 
4.1.4 Viability 
As outlined in Figure 32 (page 166), the model postulates that there are three main factors that 
will determine the viability of an embryo:  rate of metabolism, ability to respond to stress and 
dose of stress exposed to the embryo.  For maximum viability, the embryo will have a quiet 
metabolism and will not be exposed to a stressor.  Since all embryos are stressed to some 
degree, then an embryo must be able to respond to stress in order to be viable.  The extent of 
the ability to respond to stress required for survival will depend on the dose of stress that will 
be faced by the embryo during its future development. If quality parameters are indicative of 
the success in past embryo development, and rate of metabolism is indicative of the present 
success in embryo development, then ability to respond to stress is indicative of future 
embryo development, pending only on the dose of stress to be exposed to the embryo by the 
environment. 
 
The model postulates that in the absence of stress, the viable embryo is likely to have a „good‟ 
morphological quality, quiet metabolism and basal levels of IFN expression.  At different 
doses of stress, the relationship between embryo viability and metabolism, quality parameters 
and IFN production is likely to change, as summarised in Figure 33 (page 166).  According 
to the quiet embryo hypothesis, there is a negative relationship between rate of metabolism 
and viability.  However, the quiet embryo hypothesis takes no account of either the extent of 
the stress or the ability of the embryo to respond to the stressor, which will impact on how the 
stressor affects embryo viability.  Therefore, when stress levels are below the threshold to 
affect rate of metabolism, then rate of metabolism cannot be predictive of embryo viability.  








„quiet‟ embryos may have a low metabolism due to the gradual shut-down of the embryo as it 
ceases to function.  Since quality parameters are indicative of the past success of embryo 
development, then if the embryo is not exposed to any stressors, it will continue to develop as 
in the past, so that quality parameters will be indicative of embryo viability.  At sub-lethal 
levels of stress, quality parameters cannot account for the variation between embryos in their 
ability to respond to stress, so that quality parameters will not be predictive of embryo 
viability.  Lethal levels of stress cause extensive necrosis and fragmentation, and thus affect 
the morphology of the embryo and its quality parameters.  Therefore, low quality parameters 
would indicate that embryos have been exposed to lethal levels of stress and/or are genetically 
uncapable of normal development irregardless of stress  and, therefore, can predict that these 
embryos are not viable.   
 
If IFN production is associated with a stress response, as suggested by the results from this 
thesis, then if the stress dose is below the level necessary to activate the cellular stress 
response mechanism, then it follows that IFN production will not be indicative of embryo 
viability.  At mild stress levels, increase in IFN production will be indicative of activation of 
the cellular stress response (and increase in stress tolerance), and indicative of ability to 
respond to stress.  Therefore, at mild stress levels, increased IFN production would suggest 
increased viability.  Due to the protective role of the cellular stress response, quality 
parameters are not affected at mild stress dose, so that the relationship between IFN 
expression and quality parameters become inconsistent.  At higher stress doses, embryo 
viability becomes compromised, so that increased IFN production would be indicative of 
increased stress levels and reduced embryo viability.  At lethal stress levels, IFN expression 
levels and quality parameters deteriorate, and are indicative of the shut down of the genetic 
regulation of the dying embryo.   
 
Therefore, because the relationship between embryo viability and quality parameters, 
metabolism and IFN production will vary depending on the level of stress incurred on the 
embryo, then it follows that none of these factors may accurately predict embryo viability 










Table 30  A proposed stress induced causal model.  Different degrees of change (inherent or environmental) cause different degrees of stress.  At lower degrees of 
stress, quality parameters are not affected.  +: some increase, ++: a lot of increase, -: decrease, : causal relationship.  An in vivo embryo would have closer to 0 
stress, whilst an in vitro embryo would have higher stress levels.  GM-CSF would improve the in vitro environment, making it more similar to the in vivo 
environment and, therefore, lower in stress than the in vitro embryo not exposed to GM-CSF.  The heat shock level used in this thesis was mild, as quality 
parameters were not affected.  Embryos that had a change in morphology index that showed deterioration or no change had lower thresholds to stress and 
therefore had lethal levels of stress.   
Change  None Mild High Lethal 
Degree of Stress  0 1 2 3 
      
Modified gene expression 
overall  None + ++ - 
HSP70 and IFN None + ++ None 
      
Modified metabolism  None None ++ - 
      
Modified developmental kinetics  None None ++ - 
      
Cell death 
Apoptosis None + ++ None 
Necrosis None None + ++ 
Fragmentation None + ++ +++ 
      
Quality parameters  Normal Normal Deteriorated Deteriorated 
      
attachment and establishment of pregnancy  Normal Normal Reduced Not occur 
      
Survival 
Short term Not affected Not affected May be affected Affected 
Long term Not affected May be affected Probably affected Affected 









   
Figure 32 Factors affecting viability.  *according to the quiet embryo hypothesis. 
 
 
Figure 33  According to the quiet embryo hypothesis and the assumption that IFN is 
related to cellular stress response, hypothetical relationship between embryo viability 
and rate of metabolism, quality parameters and IFN production at different levels of 
stress (none, mild, high and lethal).  When no stressors are present, IFN levels and 
metabolism are not affected by viability whilst quality parameters reflect viability.  At 
mild stress levels, the cellular stress response is activated, and the viability is 
determined by the aility of the embryo to respond to stress.  Therefore, IFN levels 








affected by viability.  Since stress levels are below the threshold for metabolism to be 
affected, metabolism is not indicative of viability.  High stress levels are detrimental to 
viability, so that metabolism becomes affected.  At lethal levels of stress, IFN 
synthesis and rate of metabolism decrease as the embryo shuts down, so that IFN is 
then positively related with viability.   
4.2 IFN production by stressed embryos and the 
maternal recognition of pregnancy 
The relationship between IFN and cellular stress response suggests (1) a role for 
IFN in cellular stress response, and/or (2) an evolutionary adaptation of bovine 
embryos to increase their communication with the maternal system when 
threatened by a stressor, thus improving the chances of establishing a pregnancy 
(discussed further in section 4.2).  In these circumstances, increased IFN 
expression may be associated with increased embryo viability (discussed further in 
section 4.1.3.3).  If the ability to respond to mild doses of stress is an indication of 
viability, then IFN expression as a response to stress may be an evolutionary 
adaptation to promote establishment of pregnancy.  In vivo, there is a positive 
feedback loop between the maternally derived cytokines and the embryonic derived 
IFN (discussed in section 1.7.1.4).  Therefore, if the embryo does not receive a 
response from the maternal system, which is absent in vitro, then the embryo may 
increase its IFN expression levels in an attempt to increase the effectiveness of the 
maternal recognition of pregnancy signal, which may explain why in vitro cultured 
embryos express higher levels of IFN than in vivo produced embryos (Wrenzycki 










In Chapter 2, bovine embryos were unresponsive to a cytokine shown to be 
beneficial to embryo development (roGM-CSF) in terms of IFN secretion, 
metabolism (pyruvate oxidation and rate of development), apoptosis, cell number, 
blastocyst yield and morphological quality in the concentrations and periods of 
exposure tested.  In Chapter 3, IFN expression was upregulated in embryos 
exposed to a mild heat stress compared to control.  Moreover, there was a positive 
correlation between IFN and HSP70 transcript levels, suggesting a connection 
between IFN expression and the cellular stress response.   
 
Although some quality parameters were identified as modulators of IFN 
expression and secretion (day of blastulation and change in morphology over 24 h 
culture), the relationship between IFN expression and secretion and different 
quality parameters was inconclusive.  Embryo metabolism, as outlined by the quiet 
embryo hypothesis, may be a better predictor of embryo viability than quality 
parameters.  The lack of a correlation between IFN production and quality 
parameters observed in this thesis, and the positive relationship between IFN 
expression and stress is likely to be due to IFN production being positively related 
to rate of metabolism.   The quiet embryo hypothesis, however, does not account 
for differences in the doses of stress exposed to the embryo or differences between 
embryos in tolerance to stress.  Therefore, the viability of an embryo is likely to be 
determined based on a combination of the following factors 
(1) Morphological quality parameters (indicative of how well the embryo has 
responded to stressors to date) 
(2) Rate of metabolism  (indicative of inherent viability, as outlined by the 
quiet embryo hypothesis) 
(3) Ability to respond to stress through the cellular stress response pathways 
(which may be enhanced through exposure to mild stress leading to stress 
tolerance) 
(4) Dose (amount and duration) of stress exposed to the emryo.  
These factors may explain, at least in part, why not all embryos with quiet 
metabolism and with good morphological grading lead to a pregnancy.  If the 
embryo cannot be quiet then it needs to be able to make an appropriate response to 








relationship between IFN expression, quality parameters and metabolism will vary 
depending on the degree of stress exposed to the embryo.  Further studies are 
necessary to confirm whether IFN production, rate of metabolism and stress dose 
could be used together as consistent biomarkers indicating embryo viability, which 
would be indispensable for obtaining higher reproductive efficiency in cattle 








6  SUGGESTIONS FOR FUTURE WORK 
 
The results from this thesis have lead to four hypotheses that would require further 
work to become established.  In the discussion, it was hypothesised that: 
(1) IFN production is not related to quality parameters; 
(2) IFN production is associated with metabolism; 
(3) IFN production is associated with cellular stress response;  
(4) Embryos with a higher ability to tolerate stress have higher embryo 
viability.   
The purpose of this chapter is to explore ways to test these hypotheses.   
6.1  IFN production is not related to quality 
parameters 
One way to determine whether IFN production is associated with quality 
parameters is by exposing embryos to a factor that improves quality parameters.  In 
this study, the beneficial environmental factor (GM-CSF) had no effect on IFN 
secretion, so that the effect of other beneficial factors (rbGM-CSF, natural GM-
CSF, or other growth factors previously demonstrated to improve embryo quality 
parameters) would have to be assessed.  However, it is hard to identify a factor to 
improve embryo quality.  Several studies have observed IFN expression and 
secretion relative to a range of quality parameters (Table 28, page 153), so that the 
inconsistent relationship between IFN production and quality parameters is well 
established.  Given that IFN production was not associated with embryo quality 
parameters, and that quality parameters are poor predictors of embryo viability, 
future studies should not focus on the relationship between IFN production and 
quality parameters.   
6.2 IFN production is associated with metabolism 
In this thesis, the relationship between IFN secretion per cell and pyruvate 
oxidation per cell approached significance (P=0.07), suggesting a possible 
relationship between IFN secretion and rate of metabolism.  It would be 
interesting to know whether the relationship has higher significance between IFN 
expression and pyruvate oxidation (without the  post-transcriptional variation) .  To 
determine whether IFN production is associated with rate of metabolism, different 








secretion, such as turnover of amino acids, lactate production, measurements of 
oxygen, pyruvate and glucose consumption.  The problem with using whole 
embryos for these studies is that IFN production is primarily localised to the 
trophectoderm, so that variation in the rate of metabolism of the inner cell mass 
would add variability to the data.  Therefore, further studies should also assess rate 
of metabolism on biopsies from the trophectoderm, with the embryo being 
transferred back to assess embryo implantation potential (as a measure of viability).  
Mosaicism and reduced viability due to the biopsy technique are obvious 
disadvantages.  However, a combination of whole embryos and trophectoderm cell 
biopsies would provide a clear picture as to whether IFN production is associated 
with rate of metabolism.   
 
It would also be interesting to know whether the bovine trophectoderm has 
increased rate of metabolism compared to the inner cell mass, as reported in the 
murine (Houghton et al., 2006). 
6.3 IFN production is associated with cellular stress 
As discussed in section 1.2.1, not all IFN mRNA isoforms are transcribed and 
post-transcriptional and translational regulation may affect the correlation between 
total IFN expression and secretion levels, as observed by Robertson et al. (1996).  
Unfortunately, samples of media where the embryos were cultured in were 
destroyed in transit, so that it was not possible to assess IFN secretion levels in 
Chapter 3.  Therefore, further work is required to determine whether heat treatment 
affects IFN secretion levels in the same way as it affects IFN expression levels.    
 
Increased transcript levels of a gene are caused either by an increase in expression 
or an increase in mRNA stability.  One way to assess mRNA decay is to expose 
pools of embryos to actinomycin or -amanitin (which cause transcription arrest) 
and then assess mRNA levels using RT-PCR at 0, 1 and 2 h post-exposure to the 
transcription inhibitor.  Although this method was performed in Hela cells 
(Theodrakis and Morimoto, 1987), the embryo-to–embryo genetic variation within 
the pool of embryos may be too high for this method to be feasible, in which case it 
might be better to use cell cultures derived from embryos rather than pools of 
embryos.  The HSP70 and IFN mRNA stability in heat shocked embyonic cells 
could then be compared to that of controls to determine whether heat shock affects 









IFN expression in bovine blastocysts was associated with heat (Chapter 3), 
oxidative (Kubisch and Johnson, 2007), and physical (embryo manipulation, 
Wrenzycki et al., 2001a) stress, so that other stressors need to be evaluated, such as 
glucose levels, osmolarity, pathogenic (bacterial or viral infections) or cryogenic 
stress. 
 
Furthermore, it would be interesting to examine the effect of stress in ovine 
blastocysts, to determine whether IFN expression by ovine blastocysts respond to 
heat stress in a similar way to bovine blastocysts.   
 
Once the relationship between cellular stress and IFN production becomes 
established, it would be interesting to determine whether this association is 
mechanistically related or controlled at the molecular level.  Increased expression 
of a gene may be caused either by direct upregulation of transcription of the gene 
of interest, or activation of additional factors associated with transcription of the 
gene of interest.  Although a mechanism was proposed for the relationship between 
IFN, HSP70 and heat stress (section 3.4.4), further work is necessary to clarify the 
molecular signalling by which heat stress causes upregulation of IFN and HSP70.  
Different IFN and HSP70 gene control constructs may be transfected into cell 
lines and mutations of different elements in different pathways may be mutated and 
the effect observed in order to determine which molecular pathways may be 
mediated by IFN and HSP70.  There is also a need to further understand the 
promoter region of IFN, in order to identify a region on the promoter where a 
factor associated with the cellular stress response may bind to.    
 
Further experiments assessing  IFN expression in a third treatment whereby the 
embryo is exposed to an alleviated stress, such as exposure to an antioxidant (i.e. 
glutathione), or exposure to a milder heat stress (1 h at 40C) prior to heat 
treatment to induce thermotolerance, may clarify whether IFN is regulated 
differently at different doses of stress.  HSP70 expression was not upregulated 
when thermotolerated embryos were exposed to a more severe stress (Al-Katanani 
and Hansen, 2002).  An increase in IFN expression in thermoregulated embryos 
would therefore suggest an environmental alteration in gene expression, rejecting 









Varied effect of hyperthermia on IFN secretion reported in different studies may 
be due to differences in dose of stress.  A model of how different degrees of stress 
have different outcomes in terms of embryo viability, quality parameters, 
metabolism and IFN expression is summarised inTable 30 (page165).   IFN 
production in embryos stressed at mild, high and lethal doses compared to control 
blastocysts should be compared in a microarray to genes related with metabolism 
(glucose 6 phosphate dehydrogenase is a potential indicator of the PPP pathway, 
Glucose transporters are associated with nucleotide synthesis, arachidonate 
lipoxygenase gene 15 are associated with carbohydrate metabolism), apoptosis 
(BCl-2 and BAX are regulators of apoptosis), necrosis (inflammatory cytokines 
such as TNF), compaction and blastocyst formation (Cx), implantation (COX2 and 
CDX2, El-Sayed, 2006), placenta formation (placenta-specific gene 8) and SOX (a 
stress sensitive gene),  in order to determine whether the stress induced causal 
model proposed in section 4.1.3 is accurate.  Transferring these embryos back 
would then provide an indication of embryo viability. 
6.4 Embryos with higher ability to tolerate stress have 
higher embryo viability 
Embryos with induced thermotolerance will have a higher ability to tolerate stress.  
Therefore, by comparing pregnancy rates (determined by progesterone levels and 
foetal heart beat) of thermotolerated and control embryos, it would be possible to 
determine whether embryos with higher ablity to tolerate stress have a higher 
embryo viability.  The problem with this simple experiment is that the level of 
stress exposed to the embryos will differ in different uteri.  Therefore, sibling 
embryos could be used, and a genetic profile determined by embryo biopsy prior to 
transfer.  Then a thermotolerated and a control embryo are then transferred into the 
same uterus to determine which embryo is most likely to attach and lead to a 
successful pregnancy.  If twin pregnancies occur, then the health of the offspring 
and the placenta may be compared.   
 
Also, embryos could be exposed to increasing amounts of stress to determine a 
correlation between teratogenesis and abortion and stress at the blastocyst stage.  It 
would be interesting to observe how stressed embryos recover, and whether there is 
a legacy of stress in previously stressed embryos that survive.  Can the stressed 








6.5 Improvements to current methodologies  
The RT-PCR method validated in Chapter 3 was an improved method compared to 
previous techniques for detecting bovine mRNA in that it allowed for 
quantification of mRNA in absolute terms, corrected for variation in overall mRNA 
levels (due to changes in cell number, embryonic genome activation and viability) 
with an endogenous control, and variation in enzymatic efficiencies with an 
exogenous control, and used sequence specific probes allowing for multiplex 
reactions for detection of mRNA levels in single bovine embryos (discussed in 
section 1.2.1).   
 
As discussed in section 1.2.2.2, the cell cytopathic assay used to detect IFN 
protein levels in culture medium detects IFN through its antiviral activity as 
opposed to the biological activity relevant to the role of IFN, through binding to 
IFNR on the uterine endometrium.  Therefore, the biological activity as 
determined by the cell cytopathic assay may not correspond to the biological 
activity relevant to the role of IFN.  Moreover, the cell cytopathic assay is not 
specific to IFN, as other IFNs may also have biological activity, and, because 
different IFN isoforms vary in antiviral activity, then the biological activity 
determined by the cell cytopathic assay may not correspond to the amount of 
protein present.  These limitations to the cell cytopathic assay suggest that 
improvements are necessary to the current techniques available for detecting IFN 
secretion.   
 
In rats, normal protein synthesis is diminished during a heat shock response (Walsh 
et al., 1987).  In this thesis, only mRNA levels for HSP70 and IFN were assessed, 
so that further studies would be required to determine whether the protein levels 
mimic the mRNA levels for HSP70 and IFN during a cellular stress response.  If 
IFN protein levels are increased during a cellular stress response, this would be 
the opposite of what happens to other proteins and would further suggest a control 
for IFN production related to the cellular stress response, as opposed to 
metabolism.  However, there are currently no methods available which are 
sensitive enough to assess HSP70 protein levels in individual bovine blastocysts.  
Therefore there is a need for a higher sensitivity detection method for bovine 
HSP70 to determine whether HSP70 protein synthesis is increased during a cellular 
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Equipment and Chemicals 
In vitro embryo production  
Equipment Supplier 
Needles, 18-gauge Sherwood Medical, Hampshire, UK 
Syringes, 5 ml Sherwood Medical, Hampshire, UK 
Petri dishes, 60 and 30 mm diameter, sterile Bibby Sterilin, Staffs, UK 
Petri dishes, 60 mm, sterile Nalge Nunc International, Hereford, UK 
Universal containers, 30 ml, sterile Fisher Scientific, Loughborogh, UK 
Multidishes 4-well plates, sterile Nalge Nunc International, Hereford, UK 
Swim-up tubes, sterile Bibby Sterilin, Stone, UK 
Filters, 0.2 µm, 150 and 500 ml, sterile Sartorius, Gottingen, Germany 
Filters Minisart, 0.2 µm, sterile Sartorius, Gottingen, Germany 
Microtubes, 0.5 and 1.5 ml Fisher Scientific, Loughborogh, UK 
Micro-pipettes and tips Gilson, WI, USA 
Incubators, 5% CO2 in air Heraeus Instruments, Bishop‟s Storford, UK 
Incubators, 5% CO2, 5% O2, 90% N2 Heraeus Instruments, Bishop‟s Storford, UK 
Microscopes Wild M3Z, Heerbrugg, Switzerland 
Inverted microscope Labovert FS, Leitz Wetzlar, Germany 
Autoclave BA852 Sovereign, Dendley instruments 
Limited, Sussex, UK 
Osmometer Model 3MO, Advanced instruments Inc., 
Needham Heights, Massachusetts, USA 
Hood HF72, Flow laboratories 










Chemicals Supplier Cat. No. 
Bovine Serum Albumin – Fraction V Sigma, Poole, Dorset, UK A3311 
Bovine Serum Albumin – Fatty acid free (F.A.F.) Sigma A8806 
Taurine Sigma T8691 
D-(+)-Glucose Sigma G6152 
Medium 199 – HEPES buffer Sigma M7528 
Medium 199 – bicarbonate buffer (Chapter 5 and 8) Sigma M4530 
Medium 199 – bicarbonate buffer Sigma M2154 
L-glutamine Sigma G8540 
Alanyl-glutamine Sigma A8185 
Polyvinyl alcohol (PVA) Sigma P8136 
Hyaluronic acid (sodium salt) Fluka, Biochemika 53747 
Trolox Fisher Scientific 21894 
α-Tocopherol (Vitamin E) Sigma T3251 
Sodium citrate tribasic dihydrate Sigma S4641 
Sodium DL-lactate Sigma L7900 
Sodium pyruvate Sigma P4562 
Ethylene glycol (EG) Sigma E9129 
Dimethyl sulfoxide (DMSO) Sigma D8779 
Foetal calf serum (FCS) Sigma F7524 
Acetic acid BDH Chemicals Ltd 27013 BVl 
Ethanol (99.7%) BDH Chemicals Ltd 10107.7Y 
Phenol red solution (0.5% in D-PBS) Sigma P0290 
Etylenediaminetetraacetic acid (EDTA) Sigma E6758 
BME Essential amino acids (50x) Sigma B6766 
MEM Non-essential amino acid solution (100x) Sigma M7145 
Kanamycin monosulfate Sigma K1377 
Heparin (sodium salt) Sigma H3149 
Luteinizing hormone (LH) Sigma L9773 
FSH Sigma 4520 
Hydrochloric acid 1.0 N solution (HCl) Sigma H9892 
Sodium hydroxide 1.0 N solution (NaOH) Sigma S2770 
Sucrose Sigma S1888 
Sodium bicarbonate (NaHCO3) Sigma S5761 
HEPES Sigma H4034 
Potassium chloride (KCl) Sigma P5405 
Sodium chloride (NaCl) Sigma S5886 
Sodium phosphate (NaH2PO4) Sigma S5011 
Magnesium chloride hexahydrate (MgCl2.6H2O) Sigma M2393 
Calcium chloride dihydrate (CaCl2.2H2O) Sigma C7902 
Hypotaurine Sigma H1384 
D-Penicillamine Sigma P4875 
Sodium bisulphite (NaHSO3) Sigma S9000 
(±)-Adrenaline Sigma E1635 









Cell counts and apoptosis assay 
Equipment Supplier 
Microscope Wang 600, Wang Biomedicals, 
Wageningen, The Netherlands 
Digital camera Olympus C-5050 zoom 
 
Chemicals Supplier Cat. No. 
Apoptag Red In Situ Apoptosis Detection kit Chemicon International S7165 
Hoechst 33342 Sigma B2261 
 
Pyruvate metabolism assay 
Equipment Supplier 
Scintillation vials, 6 ml Zinsser Analytic, Germany 
Filtered tips Gilson, Middleton, WI, USA 
Liquid scintillation analyser Tri-carb 2300TR, Packard BioScience, 
Meriden, CT, USA 
 
Chemicals Supplier Cat. No. 
NaOH, 1 M Analar BDH 191483R 
HCl, 1 M Analar BDH 190686W 
Emulsifier Safe scintillation fluid Packard BioScience 6013389 
[1-
14
C]-pyruvic acid American Radiolabeled 
Chemicals 
 
Cell cytopathic assay  
Equipment Supplier 
Multipipettor  
Biosafety hood  
96-well cell culture cluster – Flat bottom 
with lid 
Corning Inc. (3599) 
 
Chemicals Supplier Cat. No. 
Dulbecco‟s modified Eagle medium Invitrogen 11960-051 
Sodium Pyruvate 100mM Invitrogen 11360-070 
Foetal Bovine Serum Invitrogen  
L-glutamine Invitrogen  
Pen/Strep Invitrogen  
IFN standard Dr. Ealy, University of 
Florida 
 
Gentian Violet Stain Fisher G12-100 
Ethanol BD Biosciences  
Dulbecco‟s Phosphate-Buffered saline Gibco 14190-144 











0.5mL PCR tubes thin wall Roslin Stores, LM40G 
Non-stick RNase-free Microfuge tubes Ambion, 12475 
Stratagene MX3000P Stratagene 
Bioanalyzer 2100 Agilent 
Primer Express 1.0 Primer Express® 
Stratagene software Stratagene 
Gel Doc Kapelan 
 
Chemicals Supplier Cat. No. 
RNeasy Micro Kit Qiagen 74004 
Quantitect Reverse Transcription kit Qiagen 205313 
Quantitect Custom Assay  Qiagen 241009 
RNase ZAP Ambion 9780 
Quantitect Multiplex PCR kit Qiagen 204543 
Ribonucleic acid, messenger from rabbit globin Sigma R1253 
Gene Ruler DNA ladder, ultra low range Fermentas SM1213 
Top Vision LE GQ Agarose  Fermentas R0491 
10X TBE Electrophoresis Buffer Fermentas B52 
RNAlater Ambion 7020-7024 










Pyruvate Oxidation Assay 
 
All eukaryotic cells undergo four metabolic pathways involved in carbohydrate 
catabolism and ATP production:  glycolysis, pyruvate decarboxylation, 
tricarboxylic acid (TCA) cycle and respiratory chain.  The pyruvate oxidation assay 
monitors the pyruvate decarboxylation reaction, which links glycolysis to the TCA 
cycle by converting pyruvate, the endproduct of glycolysis, into acetyl-coenzyme 
A, a reactant for the TCA cycle, as described in the following reaction:   




 + CoA + NAD
+
   CH3-C=O-CoA + CO2 + NADH 
            3     2       1  
 
The highlighted carbon (1) represents the radiolabelled carbon which was 
converted into carbon dioxide during the pyruvate oxidation assay in this study.  
The pyruvate oxidation assay involved incubating the blastocyst in a closed 
chamber in the presence of radioactive pyruvate, and the carbon dioxide released 
was continuously collected in a sodium hydroxide trap.  The amount of 
radiolabelled carbon dioxide trapped in the sodium hydroxide trap was therefore 
proportional to the amount of pyruvate oxidised and was therefore a measurement 
of the metabolic rate of the blastocyst.  The methodology used for measuring 
oxidative metabolism of embryos was similar to that previously used, with slight 
modifications.  Rieger and Guay (1988), Rieger and Loskutoff (1994) and Rieger et 
al., (1992) used [2-
14
C] pyruvate, which was only converted into carbon dioxide 
after the TCA cycle.  In contrast, the current study, as well as Khurana and 
Niemann (2000), Thompson et al. (1993) and Rooke et al. (2005), used the [1-
14
C] 
pyruvate which quantified specifically the pyruvate decarboxylation reaction. 
Therefore, use of [2-
14
C] pyruvate and [1-
14
C] pyruvate reflect the relative 
















) detected in individual culture media as reported in different 
studies observing ruminant blastocysts.  1:  Hernandez-Ledezma et al. (1992, 
1993), 2:  Kubisch et al. (1998, 2001a,b, 2004),  3: Kimura et al. (2004), 4: Rooke 















































Single stranded sequence for -globin DNA (X04751, 
http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=1466) and 
location of the primers and probes used in this study:  primer and probe. 
       1 gcggggccgg gtcccaggca gacgccgcga gggcgccccc agcggtggcg gccgccgccg 
       61 cgccccgccg cgccggccaa tgagcggggc cccgctgggc gtgcccgcag cacctcgggc 
      121 ttaaaagcgc cgcgcagtct gggctccgca cacttctggt ccagtccgac tgagaaggaa 
      181 ccaccatggt gctgtctccc gctgacaaga ccaacatcaa gactgcctgg gaaaagatcg 
      241 gcagccacgg tggcgagtat ggcgccgagg ccgtggagag gtgaggaccc ccgccccgcc 
      301 ccgccccgcc cgagcccgcc ggcgccgcgc cccgctcacg gcctcctgtc cccgcaggat 
      361 gttcttgggc ttccccacca ccaagaccta cttcccccac ttcgacttca cccacggctc 
      421 tgagcagatc aaagcccacg gcaagaaggt gtccgaagcc ctgaccaagg ccgtgggcca 
      481 cctggacgac ctgcccggcg ccctgtctac tctcagcgac ctgcacgcgc acaagctgcg 
      541 ggtggacccg gtgaatttca aggtgagccc gcagcccggc tgggagcgtc gcgggggtcg 
      601 gcggtccccg accacaccca ccgacgtccg cccctctctc tgcagctcct gtcccactgc 
      661 ctgctggtga ccctggccaa ccaccacccc agtgaattca cccctgcggt gcacgcctcc 
     721 ctggacaagttcctggccaacgtgagcaccgtgctgacctccaaatatcgttaagctgga 
     781 gcctgggagc cggcctggcc ctccgccccc cccacccccg cagcccaccc ctggtctttg 
      841 aataaagtct gagtgagtgg ccgacagtgc ccgtggagtt ctcgtgacct gaggtgcagg 
      901 gccggcctag ggacacgtcc gtgcacgtgc cgaggccccc tgtgcagctg caagggacag 
      961 gagtgggcaa ccggctggtt ccttccttcc tgcttgcaag tccacgaggg gctgctgaaa 
     1021 gaacccccca cacacacatg cacacactcg tgccactcgg ctgcctccag cctgggtccc 
     1081 cggctccccc agatctcggg ggggcactgg ctctccctca gcctcccaaa cgtacccacc 
     1141 cacccaccca cccacggtgc agacaaaacc ggaggtcgag tgcaggctgc agatcccagc 
     1201 agcacccggg gacgctcact cctaagaccc ttaggtcgcg cttggggcca gtgaggccca 
     1261 gtgcccacgt ggccaccctg gggctggcac ccctgccttg aggcagcggg ggcccggggt 
     1321 ggacagtgcc cgcggcaggc ttccttcctg aagagggagg tttgccgtgc catccagccc 
     1381 ctggctaaca ccagtgtcct ctcacgccca gtctggggct cctccttgga ggacaccgtg 
     1441 gcagcccctt gggcacctcg ggggcagtgg gagccgtggg aaggggctgt cttcgctcct 
     1501 tgagaggaag ggagacaggt gagggtgggg cgggacaggt gcacctgagc aggtgaatgg 
     1561 gcagactgtg gtgccaccgt agccaggaat ggtggagcac cgccgtagcc gggaatggtg 
     1621 gggcaccgcc gtagccggga atggtggggc accgccgtag ccgggaatgg tggggcacgg 
     1681 ctgaacctgc aacactgcct gctgaggagc agccgggcgc aggagcccac ccactggggt 
     1741 ggagaccccg cttctccaac cagacgccca gctccgtgca gctcaggttg gggagcagtg 
     1801 gtcatcgatg accaggctgg agactcggct tcttagccgc tggcttgctt cctctgctcc 
     1861 cgcctgggtt ttgtggtcag tcagcagaag ggcggggggg gggggctcca gtgcccaggt 
     1921 ctgtgggagg ggtggaggca ctgtgagggg accacttggg ggtgcggctg gcagggcgtg 
     1981 accccatgtg ctctgtgggt ctcctggagt tccattcagg gacgtggccc ccacaagtgc 
     2041 cagggctcag cagtgggaga cacactgccc ggaggcggca cacccacatt aggtggacca 
     2101 cagacgccag tcctctgctg gccccggctg tgtccggctt cccctgaccc ccgcgtgccc 
     2161 tctcgggtct agggccacct ctgcagcaag cagaggcgct cacttgcctg agaatcacgg 
     2221 caggccagtc ctgcttggtt taacccagag tggacactga taagtgtcat aagtagaaag 
     2281 tatagctaat tggcgtcatg ggtatacagc tgctatttag taggttagga atttgtgtgt 
     2341 gtggctgtct ctgtaattac aattacaacc tcagtgcctt aagtcatcaa cactcagctt 
     2401 ataatgtctg tgtgcatctt gtttcataat tggataatga atctatattc aaattaatgt 
     2461 aacgttgatt tctgtccaag aaaaataaat gcaagcattt aaaaaatcta tgactttttt 
     2521 ttaaaagtcc acatgttgaa taatcccatt tattaaacac acacacacac acacaacaag 
     2581 caaatccgtg gaaacagaga ggaggttggt gggctggagg aggggctgga ggcactgccc 
     2641 cggcagtttg ggagtagagg tggggagggt cgcacgcgct ggcttgacag ctcagtgtgg 
     2701 gagctgcaag gctcggctag gcactcagca ggtgcaggtg ttggccgccc gcaacggaac 
     2761 tcctgctgcg agccaccccg accggccgcg cggcggccca gcccgggagt cgctgtcacc 
     2821 atctcgcgca gcgcccgcgc tctgccgggg ttccgcgtcc tgtccaggtc tccctctgcg 
     2881 cgtgtgcata acatgtgtct ccactgaatg tttcaaatgt gtgttttgct gaaaggcctg 
     2941 gggttcagag cgagcccgaa agtggcggac cgagactgcg tgcgtgcgcg ggcctccggg 
     3001 tgcgcgcggc ggcacacgtg tcgggaacgg gcctgcgcca cgcccccaga ggcccgcggg 
     3061 gacccggccc gccgcgcccg ccgcgcccgc cgcgcccgcc gctgcccgcc gctgcccgcc 
     3121 gctgcccgcc gctgcgggat ggcgctgtcg gcggcggagc gggcgctgct gcgcgccctg 
     3181 tggaagaagc tggggagcaa cgtgggcgtc tacgcgaccg aggccctgga gaggtgcgca 
     3241 ccgggagggc gcccccggcc cgccgcgccc cgcgccgcgg ggcccccaca cgcaccacat 
     3301 ccccctcctc ccgcagaacc ttggaggcct tcccgcgcac caagatctac ttctcccaca 
     3361 tggacctgag cccgggctcc gccaggtcag agcccacggc cgcaaggtgg ccgacgcgct 
     3421 gaccctcgcc gcagaccacc tggacgacct gcccggcgcc ctgtccgctc tgagcgacct 
     3481 gcacgtgcgc acgctgcgcg tggaccccca ccacttcggg gtgagcgccg ggaaccttcc 
     3541 accggggagg gggctcccct aggcggggtg ggggaggaga atcgatggac cgcgagcggg 
     3601 aacgacccct ccctgcagct gctgggccac tgtctgctgg tgaccctcgc ccggcactac 
     3661 cctggagact tcggccccgc catgcacgcc tcggtggaca aattcctgca ccacgtgatc 
     3721 tcggcgctga cctccaagta ccgctgaatg gagggtggga ggtcgtggga cgccccgccc 
     3781 cccgtcgacg ccgtcggctt ggagtaaagc cccggggcag cagcctgaac cgagtgctcc 
     3841 ctggggattg cgtgtgtggg gatggcctcg ggtccgcaaa ccaaggggct ggcgggtttg 
     3901 gggcgtccag gtcccaaatt ccaattcctt ggccttggcc aggagggtgg caggcgggag 
     3961 gtggtcgggg ggctgttgat gcccagtcca ggcccttcgc agtactgctc gcttagtcct 








Single stranded sequence for IFN mRNA (AF196320, 
http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=6513854) and 
location of the primers and probes used in this study:  primer and probe. 
 
        1 tgttacctgt ctgaggacca catgctaggt gccagggaga acctcaggct cctggcccga 
       61 atgaacagac tctctcctca tccctgtctg caggacagaa aagactttgg tcttcctcag 
      121 gagatggtggagggcaacca gctccagaag gatcaggcta tctctgtgct ccatgagatg 
      181 ctccagcagt gcttcaacct cttctacaca gagcactcgt ctgctgcctg gaacaccacc 
      241 ctcctggagc agctctgcac tgggctccaa cagcagctgg aggacctgga cgcctgcctg 
      301 ggcccagtga tgggagagaa agactctgac atgggaagga tgggccccat tctgactgtg 
      361 aagaagtact tccagggcat ccatgtctac ctgaaagaaa aagaatacag tgactgcgcc 
      421 tgggaaatca tcagaatgga gatgatgaga gccctctctt catcaaccac cttgcaaaaa 
      481 aggttaagaa agatgggtgg agatctgaac tcactt 
 
Single stranded sequence for HSP70 mRNA (U09861, 
http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=497937) and 
location of the primers and probes used in this study:  primer and probe. 
        1 cccataaaaa cttgcggctt agtccgtgag aacagcttcc gcagacccgc tatctccaag 
       61 gaccgccccg agggcaccag agcttcacga tgttgatcct gtgggccgtt ttcaggtttg 
      121 aagcttatct cggagccgaa aaggcagggc accggcatgg cgaaaaacat ggctatcggc 
      181 atcgacctgg gcaccaccta ctcctgcgta ggggtgttcc agcacggcaa ggtggagatc 
      241 atcgccaacg accagggcaa ccgcaccacc cccagctacg tggccttcac cgataccgag 
      301 cggctcatcg gcgatgcggc caagaaccag gtggcgctga acccgcagaa cacggtgttc 
      361 gacgcgaagc ggctgatcgg ccgcaagttc ggagacccgg tggtgcagtc ggacatgaag 
      421 gagtggcctt tccgcgtcatcaacgacggagacaagcctaaggtgcaggtgagctacaaa 
      481 ggggagacca aggcgttcta cccggaggag atctcgtcga tggtgctgac caagatgaag 
      541 gagatcgccg aggcgtacct gggccacccg gtgaccaacg cggtgatcac cgtgccggcc 
      601 tacttcaacg actcgcagcg gcaggccacc aaggacgcgg gggtgatcgc ggggctgaac 
      661 gtgctgagga tcatcaacga gcccacggcc gccgccatcg cctacggcct ggacaggacg 
      721 ggcaaggggg agcgcaacgt gctcatcttt gatctgggag ggggcacgtt cgacgtgtcc 
      781 atcctgacga tcgacgacgg catcttcgag gtgaaggcca cggccgggga cacgcacctg 
      841 ggcggggagg acttcgacaa caggctggtg aaccacttcg tggaggagtt caagaggaag 
      901 cacaagaagg acatcagcca gaacaagcgg gccgtgaggc ggctgcgcac cgcatgcgag 
      961 cgggccaaga gaaccttgtc gtccagcacc caggccagcc tggagatcga ctccctgttc 
     1021 gagggcatcg acttctacac gtccatcacc agggcgcggt tcgaggagct gtgctccgac 
     1081 ctgttccgga gcaccctaga gcccgtggag aaggcgctac gcgacgccaa gctggacaag 
     1141 gcgcagatcc acgacctggt cctggtgggg ggctccaccc gcatccccaa ggtgcagaag 
     1201 ctgctgcagg acttcttcaa cgggcgcgac ctcaacaaga gcatcaaccc cgacgaggcg 
     1261 gtggcgtacg gggcggcggt gcaggcggcc atcctgatgg gggacaagtc ggagaacgtg 
     1321 caggacctgc tgttgctgga cgtggctccc ctgtcgctgg gactggagac ggccggaggc 
     1381 gtgatgaccg ccctgatcaa gcgcaactcc accatcccca cgaagcagac gcagatcttc 
     1441 accacctact cggacaacca gccgggcgtg ctgatccagg tgtacgaggg cgagagggcc 
     1501 atgacgcggg acaacaacct gctggggcgc ttcgagctga gcggcatccc gccggccccg 
     1561 cggggggtgc cccagatcga ggtgaccttc gacatcgacg ccaatggcat cctgaacgtc 
     1621 acggccacgg acaagagcac gggcaaggcc aacaagatca ccatcaccaa cgacaagggc 
     1681 cggctgagca aggaggagat cgagcgcatg gtgcaggagg cggaaaagta caaggcggag 
     1741 gacgaggtgc agcgcgagag ggtgtctgcc aagaacgcgc tggagtcgta cgccttcaac 
     1801 atgaagagcg ccgtggagga tgaggggctg aagggcaaga tcagcgaggc ggacaagaag 
     1861 aaggtgctgg acaagtgcca ggaggtgatt tcctggctgg acgccaacac cttggcggag 
     1921 aaggacgagt ttgagcacaa gaggaaggag ctggagcagg tgtgtaaccc catcatcagc 
     1981 agactgtacc agggggcggg cggccccggg gctggcggct ttggggctca gggccctaaa 
     2041 gggggctctg ggtctggccc caccattgag gaggtggatt aggaatcctt ccctggattg 
     2101 ctcatgtttg ttatggagac tgttgggatc caaggctttg cattgcctta tatatctgcc 
     2161 tttcatcagc catcagctat gcaagctgtt tgagatgttg aactgtccct tttatgaaat 
     2221 taggaactct tttttccaga gtcttaagta tagagctgaa tgtatagtgc catcttttgt 
     2281 cagtttcttt ttgtagtatt catgccaaac tcaagctatt tttcacccgt ttctgtttac 








Single stranded sequence for YWHAZ mRNA (BM446307, 
http://www.ncbi.nlm.nih.gov/nucest/BM446307?ordinalpos=1&itool=EntrezSyste
m2.PEntrez.Sequence.Sequence_ResultsPanel.Sequence_RVDocSum) and location 
of the primers and probes used in this study:  primer and probe. 
       1 GCTGTTCCCA ACCATGTCCT ATACTCCCTC CTCCCCCTGA AAATTTTTTT CAGAGACGGG 
         61  GAGTTGATTG AAAAAAGTAA TGTTATTCCA TTTAAAATTT TGGTATATGG CATTTTCTAA 
        121  CTTAGGAAGC CACAGTGTTC TTGGCCCATC ATGACATTGG GTAGCATTAA CTGTAAGTTT 
        181  TGTGCTTCCA AATCACTTTT GTTTTTAAGA ATTTCTTGGT ATTCTTTAGC CTGTCTTCAA 
        241  TTTTGATCCT TTCTTCTTTC TATTTGTCAG GTGCACAGGA TTACCTTTTT TAGCCTCTGT 
        301  CTTGTCACCA ACCATTCCTAC TTGGTGGCC ATGTACTTGG GGAAAAGGCC GCATGATCTT 
        361  TCTGGCTCCA CTCAATGTCT AAGGACACCC TGCTTCCTTT GCTTGCATCC CACAGACTAT 
        421  TTCCCTCTTC CTATTCACTG CAGCTAATCT CTCCTGAGTTGATGAGATTGTGTTATCTCC 
        481  CTATACACCC TACCCTATCC TGAATGGTCT GTCATTGTCT TTGCCTTTAA ATTCCTTCCC 











Results from BLAST analysis of the amplicons.  Expectation values refer to the 
number of different alignments with scores equivalent to or better than similarity 
that are expected to occur in a database search by chance. The lower the 
expectation value, the more significant the score 
 
Amplicon Blast hits Genome Hit (% identical, %gap, Expectation values) 
-globin 2 
Similar to Hemoglobin alpha chain in chromosome 25 (97%, 0%, 2e
-25
) 
Similar to Recombinant Hemoglobin (97%, 0%, 2e
-25
) 
   
IFN 13 
trophoblast protein-1 in chromosome 8 (99%, 0%, 3e
-25
) 
IFN tau in chromosome 8 (96%, 0%, 3e
-25
) 
IFN tau in chromosome 8 (96%, 1%, 3e
-25
) 
IFN tau c1 in chromosome 8 (93%, 3%, 3e
-25
) 
Similar to IFN tau in chromosome 8 (89%, 3%, 3e
-25
) 
Similar to IFN tau in chromosome 8 (89%, 3%, 3e
-25
) 
Similar to IFN tau in chromosome 8 (89%, 1%, 3e
-25
) 
Similar to IFN tau in chromosome 8 (87%, 3%, 3e
-25
) 
Similar to IFN tau in chromosome 8 (87%, 3%, 3e
-25
) 
Similar to IFN tau in chromosome 8 (86%, 0%, 3e
-25
) 
Similar to IFN tau in chromosome 8 (88%, 1%, 3e
-25
) 
Similar to IFN tau in chromosome 8 (89%, 4%, 2e
-37
) 
Similar to IFN alpha in chromosome 8 (86%, 4%, 2e
-37
) 
   
HSP70 2 
Heat Shock 70 kd protein 2 in chromosome 23 (97%, 0%, 2e
-24
) 
Protein sequence spanning the HSP in chromosome 23 (97%, 0%, 2e
-24
)  
   
YWHAZ 2 
YWHAZ in chromosome 14 (100%, 0%, 2e
-25
) 












Validating the RT-PCR methodology 
To validate an RT-PCR method, there is a need to validate: 
 (1) the primers and probes in terms of compatibility with the gene of 
interest, specificity and amplicon identity verification (Appendix 8, page 
219); 
(2) the RT-PCR methodology in terms of the kinetics of the PCR reactions 
for the transcript of interest (Appendix 8, page 219); 
(3)  the efficacy of the RNA extraction method in terms of the quantity as 
well as the quality of RNA templates (Appendix 7 ,page 215);  
(4) the RT-PCR methodology in terms of a standard curve generated by 
serial dilution (ten-fold) of a positive cDNA template (Appendix 9, page 
222);   
(5) -globin as the exogenous housekeeping gene in a multiplex reaction 
with the gene of interest (Appendix 10, page 226); 
(6) the inter-assay and intra-assay variation (Appendix 10, page 226); 
(7) YWHAZ as an endogenous housekeeping gene to monitor variation in 
amount of total RNA  in the original sample (Appendix 11, page 233). 
 
Blastocysts used for validating the RT-PCR method were produced using the 
standard method of IVP at our laboratory at the time of study (as described in 
section 2.2.1).  The average cleavage rate and blastocyst rate among the batches 
was 639% (mean  standard deviation) and 187 % respectively (Table 31, page 
214).  On days 7, 8 and 9 pi blastocysts were evaluated in terms of their stage of 
development (as described in Table 11, page 87) and given a quality score based on 
morphological assessment (grade 1=embryos free of fragmented cells; grade 2= 
some granulation and initial signs of fragmentation; grade 3=collapsed or badly 










Table 31  In vitro culture efficiency for all 9 batches used to produce blastocysts for 













V 9/8/6 1 40 147 113 (77%) 20 (18%) 
V 22/8/6 2 27 104 61 (60%) 11 (18%) 
3 3 8 22 15 (68%) 1 (7%) 
4 4 52 71 50 (70%) 9 (18%) 
5 5 60 270 175 (65%) 20 (11%) 
8 6 25 109 72 (66%) 21 (29%) 
10 7 34 143 86 (60%) 19 (22%) 
12 8 52 267 137 (51%) 33 (24%) 











Assessment of the efficacy of the RNA extraction method 
 
In order to obtain reliable RT-PCR data, it is important to ensure that the RNA in 
the samples is of high quality (Imbeaud et al., 2005). The collection and storage of 
samples and the process of RNA isolation affect the quality of RNA that is used for 
expression analyses. Therefore, the first step in optimising a Real Time RT-PCR 
method is to ensure that the RNA extraction method of choice and the storage of 
sample RNA provide high yield of good quality RNA.   
Methodology 
The bioanalyzer is an automated bio-analytical device which uses microcapillary 
electrophoresis to separate tiny amounts of RNA in the channels of a 
microfabricated chip according to molecular weight (Mueller et al., 2000).   The 
separated RNA is detected via laser-induced fluorescence and presented as 
electropherograms and gel-like images which can be visually evaluated. Four 
samples were used to assess RNA integrity.  Sample 1 contained a pool of 11 
blastocysts which blastulated between day 7 and 9 pi, were categorised as grade 1 
or 2, and ranged from early to hatched blastocysts (details of individual blastocysts 
are outlined in Table 32).   














1 7 Expanding 2 
1 8 Expanding 2 
1 8 Early 2 
1 7 Expanding 2 
1 8 Mid 2 
1 7 Hatched 2 
1 9 Early 1 
1 9 Early 2 
1 8 Expanding 2 
1 8 Expanding 2 
1 8 Early 2 
 
2 Single 1 8 Hatched 2 
3 Single 1 7 Hatched 1 









Samples 2 and 4 each contained a single hatched blastocyst which blastulated on 
day 8 pi and were categorised as grade 2.  Sample 3 contained a single hatched 
blastocyst which blastulated on day 7 pi and was categorised as grade 1.  The 
extracted RNA from samples 1 to 4 were assessed using an Agilent Bioanalyzer 
2100 and Agilent RNA 6000 Pico Assay, according to manufacturer‟s instructions.  
Briefly, 9 l of gel-dye mix and 1 l of extracted RNA (out of a total of 12 µl) 
were allocated into each well of an RNA 6000 Pico LabChip.  1 l of ladder was 
added instead of sample RNA into one of the wells. The chip was run in the 
Agilent 2100 bioanalyzer and the results were analysed using the Agilent 2100 
bioanalyzer software.  The integrity and the purity of the RNA were determined 
based on the ratio of 28S:18S bands and the RNA integrity number (RIN).  The 
RIN (Schroeder et al., 2006), is an alogarithm based on six regions of the 
electropherogram, including the conventional 28S rRNA to 18S rRNA ratio and 
ranges from 0 (totally degraded) to 10 (intact).  Since the Agilent 2100 software 
does not contain this algorithm, the RIN was determined by visual assessment of 
the electropherograms compared to Figure 34. 
 
 
Figure 34 Categorisation of the RNA Integrity Number (RIN) based on the 
electropherogram of the sample produced by the Agilent 2100 Bioanalyzer, from 









The isolated RNA samples derived from four blastocyst samples were analysed 
using the Agilent 2100 Bioanalyzer with regard to their concentration and quality 
(Table 33, page 218).  
 
Samples containing single blastocysts were very close to the detection limit of the 
RNA 6000 Pico LabChip (200 pg µL
-1
, Agilent, 2006) so that the amount of total 
RNA estimated in the single blastocysts (particularly samples 2 and 4) may not be 
accurate. Nevertheless, the amount detected are in the same order of magnitude as 
observed by Bilodeau-Goessels and Schultz (1997a,b) in bovine blastocysts using 
northern blot analysis to assess total RNA in pools of embryos of the same stage.  
Using pools of blastocysts between the stages early and expanded, Bilodeau-
Goessels and Schultz (1997a) determined that blastocysts contained 5.30.6 ng 
(meanSEM) of total RNA, compared to 2.51.7 ng in the current study.  
Interestingly, the blastocyst with the best morphological grade (grade 1) contained 
more RNA than those with lower morphological grade (grade 2).  However, more 
blastocysts would have to be examined to determine whether morphological grade 
affects total RNA content in a blastocyst.   
 
The quality of the RNA content of a sample is determined by its purity and 
integrity.    The electropherogram of all four samples (Table 33, page 218) 
displayed characteristics of high quality RNA: there were clear, well defined 28S 
and 18S peaks, there was low noise between the peaks, and there was minimal low 
molecular weight noise suggesting limited contamination.  RNA is considered of 
high quality when the ratio of 28S:18S bands are about 2.0 and higher (Schroeder 
et al., 2006) and the rRNA ratio was greater than two for all samples (Table 33, 
page 218).  According to Jung et al. (2007), RNA samples should have RIN values 
greater than 7.0.  The RIN from the three single blastocyst samples had an RIN of 
9, and the pool of 11 blastocysts had an RIN of 10, suggesting that the integrity of 
the samples was above adequate.   
Conclusion 
The amount of RNA detected, its purity and integrity in both single or pool of 
blastocysts suggests that the samples had adequate RNA quality.  Therefore, the 
method of RNA extraction and sample storage is adequate for downstream gene 








Table 33  Electropherogram, RNA concentration and rRNA ratio for each sample, as determined by the Agilent 2100 Bioanalyzer software.  Day refers to 





















2 Single 8 2 36 2.5 432 9 
 
 
3 Single 7 1 625 2.4 7500 9 
 
 









Appendix 8  
Amplicon identity verification 
 
To validate an RT-PCR method, there is a need to validate the primers and probes in terms 
of compatibility with the gene of interest, specificity and amplicon identity verification.   
Methodology 
Gel electrophoresis allows for the verification of the amplicon size in order to ensure that the 
primers and probes are detecting the right product.  cDNA derived from a sample containing 
a single hatched blastocyst (sample 1) and a pool of expanded/hatched blastocysts (sample 
2,Table 34) underwent RT-PCR and the amplicons were run on a gel to determine amplicon 
size.  0.01 and 0.02 BRU of cDNA from the pool of blastocysts and 0.01 BRU from the 
single blastocyst were assessed by RT-PCR.  Details of the blastocysts contained in samples 
1 and 2 are provided in Table 34. 
 
Table 34 The following samples underwent PCR and the RT-PCR amplicons were run in a gel 













1 Single 6 8 7 Hatched 1 
       
2  Pool 3 9 8 Expanding 2 
  4 8 7 Hatched 1 
4 8 7 Hatching 1 
5 8 7 Hatched 1 
5 8 7 Hatched 1 
5 8 7 Hatched 1 
       
 
The gel (3% agarose in Tris/Borate/EDTA) was heated and 0.003% ethidium bromide added 
to the gel.  The gel was poured into a tank with the comb and allowed to set for 45 minutes.  
5 l of each sample and 2 l of loading buffer (Gel loading solution, Sigma, G2526) were 
loaded into wells.  6 l of DNA Ladder (Fermentas, SM0371) was added into each of the 
outer wells.   The gel was run at 25V for 5 minutes, followed by 50V for 1 h.  The gel was 










PCR quality and yield can be assessed from gel electrophoresis of PCR amplicons (Figure 
35d, page 221).  The specificity of the primers and probes in the duplex reactions are 
represented by the double strong bands of the correct size for the YWHAZ gene and each 
gene of interest, as determined by comparison with size markers (lane 9) run on the same 
gel.  There were faint triple bands below the 50 base pair marker (not shown) and between 
the IFN bands which probably corresponded to PCR artefacts.  PCR artefact bands were 
very faint in comparison to the correct size bands, so were not of concern.     
 
The fluorescence reference dye (ROX) profile was flat suggesting that reagent amounts and 
concentration did not vary during the PCR reaction (Figure 35a, page 221).  The 
amplification curve for IFN, HSP70 and YWHAZ (Figure 35b,c, page 221) include a lag 
phase, an exponential phase and a plateau phase, the kinetics expected from a valid PCR run.  
Therefore, the length of the amplicons produced by the primers, although long enough to 
ensure specificity, were short enough to ensure that reagents did not become limiting.   
 
The profiles for NTC and NRT controls were flat.  One in every ten controls did contain 
spikes in the fluorescence, probably due to RT-PCR artefacts, although these did not occur 
before cycle 40 (used as the detection limit in the current study).  Therefore, the primer sets 
and probes are specific to the genes of interest and the fluorescence detected in the 
amplification curves (Figure 35, page 221) refer to the respective genes of interest.   
 
Conclusion 
As determined by BLAST, gel electrophoresis and the kinetics of the PCR reaction, the 
primers and probe sequences were compatible with the GOI, were specific to the GOI and 
led to amplicons of the correct size, confirming the identity of the amplicon and the validity 



















1 2 3 4 5 6 7 8 9
 
Figure 35  Amplification plots and gel electrophoresis for single blastocyst (0.1 BRU) and pool of 
blastocyst (0.1 BRU and 0.2 BRU) and No Template Control and No Reverse Transcriptase.  
a)Fluorescence (nm) of the dyes ROX (reference dye), FAM (IFN and HSP70) and YY 
(YWHAZ), b,c) Fluorescence corrected for baseline fluorescence and for reference dye 
fluorescence  for the genes b) IFN and YWHAZ and c) HSP70 and YWHAZ.   d) Photograph 
of a gel produced from PCR end-products.  1,5: Single blastocyst, 2,6: pool of blastocysts (0.1 
BRU), 3,7: pool of blastocysts (0.2 BRU), 4,8: NTC, 9:Ladder showing bands for 100, 150 and 
200 base pairs.  1-4: IFN multiplexed with YWHAZ, and 5-8: HSP70 multiplexed with 

















Appendix 9  
Serial dilution of the template cDNA 
Methodology 
In order to test the primers and overall assay performance, standards consisting of serial 
dilutions (ten fold) of cDNA derived from a pool of 24 blastocysts (details of blastocysts are 
outlined in Table 35) were amplified in duplicate in the same singleplex PCR run against 
negative controls to produce a standard curve.  The standard curve was plotted as the 
threshold cycles (Ct) versus the log of the dilution of cDNA. The efficiency of the PCR 
reaction was obtained by compairing the threshold cycles and slopes of the amplification 













1 4 8 Expanding 3 
2 4 8 Early 2 
3 4 8 Early 2 
4 4 8 Hatching 2 
5 4 8 Hatched 1 
6 4 8 Hatched 1 
7 4 7 Expanding 3 
8 5 9 Early 2 
9 5 9 Mid 2 
10 5 9 Expanding 2 
11 5 8 Hatching 1 
12 5 9 Early 2 
13 5 9 Expanding 1 
14 5 9 Mid 2 
15 5 7 Expanding 1 
16 5 8 Hatched 1 
17 5 9 Hatching 1 
18 5 9 Expanding 1 
19 5 9 Expanding 1 
20 5 9 Mid 2 
21 5 8 Expanding 1 
22 5 9 Expanding 2 
23 5 9 Expanding 1 











As demonstrated in Table 36, the PCR system for YWHAZ, IFN and HSP70 produced 
normal PCR curves: the amplified template accumulated exponentially with each cycle until 
the reaction components became limiting, reaching the plateau stage of the PCR kinetic 
curve.  The thresholds were set so that the Ct values were derived from the exponential 
amplification phase, when the abundance of cDNA was related to the amount of starting 
material.  Normal PCR kinetics were also observed when YWHAZ, IFN and HSP70 were 
multiplexed with -globin (Table 40, page 230).    
Standard Curves 
The linear relationship between the log of accumulated product and the PCR cycle number in 
the standard curves (Table 36 and Table 40, page 230) suggest that the Ct value is related to 
the amount of cDNA present, thus validating the RT-PCR method used.  As is ideal, the 
dynamic range of all standard curves were between three and five logs and the best fit line of 
the standard curves had a high linear fit (r
2
 > 0.98) with less than 2% CV variation between 
triplicates (Table 36 and Table 40, page 230).  The coefficient of variance ranged from 0.42 
to 1.59 for IFN, between 0.40 and 2.00 for HSP70 and between 0.39 and 1.70 for YWHAZ, 
suggesting low variation between replicate PCRs for the same sample for all genes of 
interest.  The PCR reactions had adequate efficiency levels, ranging from 82 to 101%, within 
the range suggested by Tichopad et al. (2003, between 65 and 100%).    
 
When YWHAZ, IFN and HSP70 were multiplexed with -globin, the slope of the standard 
curves was similar between the two genes in each multiplex reaction (Table 40, page 230).   
Conclusion 
Therefore, the linear relationship between log of accumulated produce and cycle number, the 
low variation between triplicates and the high efficiency of the PCR reactions, further 









Table 36  (next page) Serial Dilution of a pool of 24 blastocysts.  BRU = Blastocyst 
RNA Unit.  Amplification plots plotted as the log of fluorescence versus cycle number 
in order to define the log-linear phase of the cycle.  The threshold is set above noise 
level:  165 dR for FAM, and  15 dR for YY.  10 fold serial dilution of 1, 0.1, 0.01, 0.001, 
0.0001, 0.00001, NTC, NRT. The standard curve plotted as the threshold cycle numbers of 
titrated cDNA pool serial dilutions versus the log of the concentration of template 



















Amplification Plots Standard Curve 
IFN 4 2.4e
-3  2.4 94 0.994 29.5  40.0 
  
HSP70 3 2.4e-2  2.4 88 0.999 32.0  38.6 
  









Appendix 10  
Validation of -globin as the exogenous control 
Methodology 
An exogenous standard is required to control for differences between samples in RNA 
recovery, RT and PCR.  An exogenous standard will also control for variation within samples 
due to pipetting error and variations in PCR efficiencies between wells.  Since bovine 
embryos do not express globin mRNA (Donnison and Pfeffer, 2004), synthetic rabbit -
globin mRNA is an appropriate exogenous control for studies involving bovine embryos.   
 
RNA was extracted from a pool of six blastocysts (Table 37) which were equally distributed 
into five tubes containing 1.4 ng, 140 pg, 14 pg, 1.4 pg and 0 pg of rabbit -globin mRNA 
(Table 38).  Following RT, samples were assessed for -globin mRNA levels multiplexed 
with IFN or HSP70.  The Stratagene software was used to plot standard curves.    
 







1 6 8 Mid 2 
2 6 8 Mid 2 
3 6 9 Early 1 
4 6 9 Early 2 
5 6 9 Mid 2 
6 6 9 Expanding 2 
 
Table 38  Sample contents for -globin validation.  The blastocyst template was constant in all 
samples whilst the -globin was serially diluted (ten fold) three times.  BRU:  Blastocyst RNA 
Unit.   
Sample Number 
 






RT (ng) PCR (pg) 
1  1 0.1  1.4 14 
2  1 0.1  0.14 1.4 
3  1 0.1  0.014 0.1 
4  1 0.1  0.0014 0.01 
Blastocyst Positive Control  1 0.1  0 0 










Validation of -globin as the exogenous control gene involved a serial dilution of -globin 
duplexed with the genes of interest to determine whether the genes were compatible in a 
duplex reaction, a serial dilution of -globin mRNA with a fixed amount of blastocyst cDNA 
to determine the optimum amount of -globin to spike the samples with, determination of 
plate to plate variation using an -globin positive control and determination of the efficiencies 
of the standard curves for -globin and the genes of interest to determine whether the genes of 
interest may be quantified relative to the -globin standard curve.   
Deterimining the amount of -globin to spike the samples with 
The amount of -globin mRNA spiked per sample in the literature varies between 0.1 pg 
(Donisson and Pfeffer, 2004, de Oliveira et al., 2006, Wrenzycki et al., 2000) to 3 pg (Russell 
et al., 2006) to 5 pg (Somers et al., 2006).  Russell et al. (2006) assessed pools of blastocysts, 
whilst Donisson and Pfeffer (2004) assessed pools of oocytes.  Blastocysts have a higher 
expression level than oocytes (Bilodeau-Goessels et al., 1997a,b), so that the variation in 
amount of initial exogenous RNA added between studies may depend on expression levels of 
target genes.  The RT-PCR methodology may also affect the ideal amount of -globin to 
spike the samples with.  Too little input may not generate enough signal, whilst too much may 
lead to an early PCR plateau which uses up the reagents in the PCR reaction and therefore 
may affect the PCR reaction of the duplexed gene.  Therefore, optimisation is required in 
order to determine the optimum amount of exogenous RNA.   
 
According to the standard curves for -globin multiplexed with YWHAZ, IFN and HSP70, 
whether with a serial dilution (Table 39, page 228) or fixed amount (Figure 36, page 230 and 
Table 40, page 230) of blastocyst cDNA, the serial dilution of -globin had a dynamic range 
of four orders of magnitude, and the low variation within the standards for -globin, HSP70 
and IFN (CV less than 1.7%) would imply that HSP70 and IFN are compatible in a 
multiplex reaction with -globin in any amount of -globin within the range tested.  The CV 
for the -globin Ct was highest within the higher (1.7%,Table 40 , page 230) compared to the 
lower (0.4 to 0.8%) -globin concentrations, suggesting that there may have been some level 
of limiting factors due to the high concentration of amplicons.  Moreover, the Ct values for 
the -globin cDNA were closest to the Ct value for IFN cDNA at the lower -globin 
concentrations (Figure 36, page 230).  Therefore, the amount of -globin added to the 
samples in Chapter 3 was 20 pg of mRNA (equivalent to 1.4 pg of -globin cDNA per PCR 









Table 39  (next page) Serial Dilution of a pool of 19 blastocysts spiked with 20 pg of -globin 
mRNA.  BRU = Blastocyst RNA Unit.  10 fold serial dilution of 1.9, 0.19, 0.019, 0.0019, 0.00019 
BRU.  The standard curve plotted as the threshold cycle numbers of titrated cDNA pool serial 
dilutions versus the log of the concentration of template cDNA.  The Stratagene software 
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a)                                                                  b) 
   
Figure 36 Serial Dilution of -globin mRNA against a constant blastocyst total RNA.  
-globin was multiplexed with HSP70 or IFN.  a) Amplification plots plotted as the 
log of fluorescence versus cycle number in order to define the log-linear phase of the 
cycle.  The threshold is set above noise level.  10 fold serial dilution of -globin cDNA 
14pg, 1.4pg, 0.14pg, 1.4pg, 0, NTC, NRT.  b) The standard curve plotted as the threshold cycle 
numbers of titrated cDNA pool serial dilutions versus the log of the concentration of 
template cDNA.  The Stratagene software generates a best fit line. Triplicate HSP70 
and IFN (black) expression in the constant blastocyst RNA. 
Table 40  Serial Dilution of -globin mRNA against a constant blastocyst total RNA.  
-globin was multiplexed with HSP70 or IFN. 
-globin cDNA (pg) GOI 
-globin  GOI 
Mean CV  Mean CV 
14 HSP70 18.0 1.7  34.3 0.4 
1.4 HSP70 21.8 0.8  34.4 0.4 
0.1 HSP70 25.8 0.4  34.2 0.5 
0.01 HSP70 29.8 0.4  34.2 0.8 
0 HSP70 No Ct   34.2 0.4 
       
14 IFN 18.1 1.7  32.1 0.8 
1.4 IFN 22.2 0.4  31.5 0.2 
0.1 IFN 25.5 0.6  30.8 0.5 
0.01 IFN 29.4 0.7  31.2 0.4 
0 IFN No Ct   31.3 0.3 
Plate-to-Plate variation in the exogenous control 
In Chapter 3, seven RT-PCR plates were assessed containing a standard curve for 
-globin in each plate, and duplicate positive -globin controls.  The within-plate 
variation in the control -globin Ct value ranged between 0.2 and 2.2% (Table 41, 
page 231) and the inter-assay variation in the positive control was 6%.  The low 









Table 41  The intra-assay variation on Ct values from the positive -globin controls 
(in duplicate) from each plate.   
Ct 1 Ct 2 Intra-assay variation (%) 
20.9 21.1 0.8 
21.1 21.8 2.1 
19.7 19.6 0.1 
19.6 19.0 2.2 
18.6 18.5 0.5 
19.3 19.3 0.2 
21.7 21.7 0.2 
 
In Chapter 3, the standard curves for -globin from different plates had similar 
slopes, suggesting similar efficiencies averaging 974% (Figure 37a).  The y-
intercept of the standard curves varied from plate to plate, correlating with the 
average Ct value for the samples on the plate (P<0.001, Figure 37b).  Therefore, 
the quantitation method used in Chapter 3, which employs y-intercepts and slopes 
in the equation, corrects for such variation between plates.  The high variation in 
the average Ct for the samples on each plate (wide standard deviation bars 
demonstrated in Figure 37b) are due to sample variation, minor pipetting error 
(accounted for by the -globin control), and due to slight differences between the 
two fluorescent dyes used in the multiplex reaction.    
 
The low plate-to-plate variation in the -globin positive control and -globin 
standard curve efficiency further suggest the validity of using -globin as the 
exogenous control. 
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Figure 37  a) Standard Curve for different plates.  X-axis: amount of -globin mRNA 
(in pg), Y-axis: Ct. b)  X-axis: Average Ct for the samples on the plate (for both dyes 
in the multiplex reaction),Y-axis: Standard Curve Y-intercept.  The error bars refer 
to standard deviation, as a measure of the variation in each plate.  The best fit line is 








Validation of using the -globin standard curve to quantify GOI in absolute 
terms 
In all PCR plates in section Chapter 3, the standard curves were linear across the 
whole range of template concentrations, with the efficiency between 80 and 110%, 
R
2
 above 0.985 and the slope between -2 and -4, suggesting that the Ct values 
represented the true representation of amount of -globin mRNA.    
 
Quantification of the GOI using the -globin standard curve in each plate is only 
valid because -globin and the GOI are multiplexed in the same well, because -
globin, YWHAZ, HSP70 and IFN had similar efficiencies (Figure 38) and similar 


















Figure 38 Variation in efficiency derived from standard curves (Appendix 9, page 222, 
Appendix 10, page 226 and Chapter 3).  Efficiency for the -globin sequence was not 
significantly different to that of IFN (P=0.4), HSP70 (P=0.3) and YWHAZ (P=0.4).  
Mean  standard deviation. 
 
As demonstrated, the RT-PCR method was optimised for the amount of -globin 
mRNA to be added to the samples, and validated by serial dilution of the -globin 
cDNA when multiplexed with YWHAZ, IFN and HSP70 (discussed in Appendix 
10, page 226, and summarised inTable 40, page 230).  Therefore, the use of -
globin as the exogenous control gene in a multiplex reaction with the genes of 










Validating YWHAZ as the endogenous house-keeping 
gene 
 
Several studies have determined that the expression levels of house keeping genes 
vary between treatments, which explain why different normalization approaches 
have lead to opposing results (Bonefeld et al., 2008).  Because of this, there have 
been a number of studies comparing the stability of a range of house keeping genes 
in the hope of finding one which is unanimously stable.  For instance, Bonefeld et 
al. (2008) compared a panel of eight common housekeeping genes (including 
YWHAZ, 18S, -actin and GAPDH) and found that YWHAZ was the most stably 
expressed gene in rat brain tissue.  Using pools of 20 pre-attachment bovine 
embryos of similar stage and quality, Goosens et al. (2005) found that the most 
stable of eight commonly used reference genes tested was also YWHAZ.  Because 
of this stability, YWHAZ is being increasingly used as an endogenous house 
keeping gene in a range of studies using blood cells (Carroll et al., 2007) or 
leukocytes (De Ketelaere et al., 2006) and its stability in bovine embryos (Goosens 
et al. 2005) is the reason why YWHAZ was the chosen endogenous house keeping 
gene in this thesis.  However, Toegel et al. (2007) compared the stability in 
expression of six common housekeeping genes and in human cartilage cells for 
three different treatments, and found that although the ranking of the stability of the 
genes changed between treatments, YWHAZ was among the three least stable 
genes in all three treatments assessed.  Ayers et al. (2007) pointed out that although 
YWHAZ was the most stable house-keeping gene for some canine tissues 
(ligament tissues), it was regulated in other tissues (fat tissues), suggesting that no 
single reference gene can be identified as having stable expression in all different 
tissue types.  In fact, YWHAZ was implicated with initiating a cellular 
communication system in two-cell murine embryos (Li et al., 2003), so that 
expression varied with stage of development.  Due to this lack of a standard house 
keeping gene in all tissues, Bonefeld et al. (2008) suggested that, ideally, a large 
battery of possible house keeping genes should be tested before an experiment to 
ensure that the house keeping gene is stably expressed in the tissue being studied 
and for the treatments being assessed.  However, this suggestion is time-consuming 
and expensive so that it is not practical for qPCR work.  Instead, two preliminary 








relative to heat treatment and stage of blastocyst development to determine whether 
YWHAZ was appropriate as an endogenous house-keeping gene for Chapter 3 
(expressed either as Ct or in absolute terms) were also used to assess the variation 
in YWHAZ expression relative to heat treatment, stage of blastocyst development, 
change in morphology index, day of blastulation and sex.   
 
Therefore, the objectives were:  
(1) to determine whether stage of blastocyst development affects expression of 
YWHAZ, IFN and HSP70, and  
(2) to determine whether heat treatment affected expression of YWHAZ, IFN 
and HSP70.   
Methodology 
Effect of stage of blastocyst development on mRNA yield 
21 blastocysts from the same batch (details of blastocysts are outlined inAppendix 
5, page 212) were categorised as early, mid, expanding and expanded (according to 
criteria set in Table 12, page 87) and pooled together according to stage and 
underwent RT-PCR in two separate PCR plates.   
Effect of heat stress on mRNA yield 
Six hatching blastocysts were transferred from group culture to individual culture 
(5 µL drops) and allocated to either the control or heat stress group. Embryos 
remained for 4 h at 5% CO2, 5% O2 plus 90% N2 at either 38.5C (control) or 42C 
(heat).  Only blastocysts which had progressed in development during the 4 h 
treatment (i.e. category 1 of the change in morphology index) were selected.  After 
storage in Buffer RLT at -80ºC, samples underwent RNA extraction and 
quantitative singleplex RT-PCR.  Samples were assessed in triplicate for each gene 
of interest (IFN, HSP70) and in duplicate for YWHAZ.   
Quantification of mRNA levels 
Transcript levels were assessed as Ct values and as relative to the endogenous 
control (YWHAZ) as calculated by the Strategene software using the following 
















Ct values for IFN, HSP70 and YWHAZ were analyzed relative to treatment (heat 
stressed versus control) and relative to stage of development (early, mid, 
expanding, expanded) using a REML-LMM (Genstat, Eleventh edition, 2008), 
with replicate blastocyst as a random factor.  Stages of development were also 
analysed as before (early and mid) and after (expanding, expanded) expansion 
using a two-sample t-test.  Ct values for YWHAZ were analyzed relative to the 
gene that it was multiplexed with (IFN or HSP70) using a REML-LMM (Genstat, 
Eleventh edition, 2008), with replicate blastocyst as a random factor.  Efficiency 
derived from standard curves for YWHAZ, IFN and HSP70 were compared to the 
efficiencies for -globin derived from all the standard curves for -globin in 
Chapter 3, Appendix 9 (page 222) and Appendix 10 (page 226) using a two-sample 
t-test (Genstat, eleventh edition, 2008).  Stages of embryo development were 
grouped as pre-expansion (early and mid blastocysts) and post-expansion 
(expanding, expanded, hatching, hatched).  Linear regression analysis (Genstat, 
Eighth Edition, 2005) was used to determine the association between YWHAZ, 
IFN and HSP70 expression levels.   
Results 
Effect of heat treatment on YWHAZ transcript levels 
In the preliminary experiment, heat treatment caused an approximately 100-fold 
increase in HSP70 expression relative to control (7 Ct difference in Figure 39f, 
page 238, P<0.001), and a four-fold increase in IFN expression relative to control 
(2 Ct difference in Figure 39d, page238, P<0.001).  Meanwhile, YWHAZ was not 
affected by heat treatment (P=0.9, Figure 39b, page 238).  In the main experiment, 
YWHAZ transcript levels were also not affected by heat treatment (954428 fg and 
2056939 fg, for control and heat treated blastocysts respectively, P=0.6), 
suggesting that YWHAZ is an appropriate endogenous housekeeping gene for 
assessing expression levels in heat stressed embryos relative to control.    
 
Variation in YWHAZ expression between blastocysts was observed in the 
preliminary experiments (Appendix 11)  and in the chapter 3.  The overall variation 
in YWHAZ within each plate was comparable to that reported in other studies.  In 
this study, the average range in Ct in all plates was 3.7, similar to the 3.5 range in 
Ct for YWHAZ observed by Toegel et al. (2007) in cartilage cells treated with 








explained by differences in the sex of the blastocyst (24101044 fg for males and 
785353 fg for females, P=0.08) or the day it blastulated (17961215 fg for day 
7.75 blastocysts and 1215762 fg for day 8.75 blastocysts, P=0.2).   
Effect of Stage of Blastocyst Development on YWHAZ expression 
In the preliminary experiment (Appendix 11, n=21) YWHAZ expression was 
similar in early, mid, expanding and expanded blastocysts (P=0.5, Figure 39f) and 
in before (early and mid) and after (expanding and expanded) expansion (P=0.3 
Figure 39a, page238).  However, in Chapter 3, where more blastocysts were 
evaluated (n=110), blastocysts before compaction had higher YWHAZ transcript 
levels than after compaction in terms of Ct (P=0.001 Figure 41b, page239).  
Therefore, YWHAZ expression was affected by stage of blastocyst development in 
Chapter 3, but not in the preliminary experiment (Appendix 11, page 233).   
 
In contrast to YWHAZ, IFN and HSP70 were upregulated in post-expansion 
blastocysts compared to blastocysts before expansion (P<0.001, Figure 42a, b, page 
240), whilst the effect of stage of development on IFN:YWHAZ and 
HSP70:YWHAZ expression approached significance (P=0.07 and P=0.06 
respectively, Figure 42c,d, page 240).  Moreover, in Chapter 3, absolute IFN and 
HSP70 were also upregulated in post-expansion blastocysts compared to 
blastocysts before expansion, although not significantly (P=0.08 and P=0.1, Figure 
43a,b, page 241).  Therefore, although stage of blastocyst development did not 













































































































































































Figure 39  (previous page) Effect of treatment on a-b) YWHAZ expression, c-d,g) 
IFN expression and e-f,h) HSP70 expression.  Samples were measured in triplicate in 
a total of 6 embryos (3 Control, 3 Heat Stress).  a,c,e) Amplification plots plotted as 
the log of fluorescence vs cycle number in order to define the log-linear phase of the 
cycle.  The threshold is set above noise level:  185 dR for FAM, and  25 dR for YY. 
Heat Stressed, Control, NTC, NRT.  b,d,f) Expression measured as Ct: threshold 
cycle.  I:  multiplexed with IFN, H: multiplexed with HSP70.  
Stage
Replicate



















Figure 40  Individual value plot per blastocyst showing the effect of stage of blastocyst 
development (Early, Mid, Expanding, Expanded) on YWHAZ expression.  Expression 
is measured as the raw data (Ct).  Samples were measured in triplicate in a total of 21 
embryos (6 Early, 6 Mid, 5 Expanding, 4 Expanded).  I:  multiplexed with IFN, H: 
























































Figure 41  The effect of stage of blastocyst development (before and after expansion) 
on YWHAZ expression in a) the preliminary experiment (n=21, Appendix 11) and in 
b-c) Chapter 3  (n=110).  In a-b) transcript levels are measured as the raw data (Ct), 
whilst in c) transcript levels are expressed in absolute terms.  Values are mean±SEM.  
 
 Differences in the CV expressed as Ct or relative to YWHAZ in the two 
preliminary experiments (heat treatment and stage of development) are summarised 
in Table 42 (page239).   The variation was higher at the Ct level than relative to 
YWHAZ, suggesting that YWHAZ may be correcting for some of the variation in 
YWHAZ expression, thus, further supporting the use of YWHAZ as the 
endogenous housekeeping gene.   
 
Table 42  Differences in coefficient of variation in the Ct values and in the relative to 
YWHAZ values for the genes of interest (GOI) in two validation experiments.   
Treatment GOI Absolute (Ct) Relative to YWHAZ 
Heat Stress HSP70 14.7 4.7 
 IFN 1.65 0.02 
    
Stage HSP70 1.65 0.06 
 IFN 2.67 0.27 
 
Some of the within sample variation in YWHAZ expression was due to which gene 
(HSP70 or IFN) was being multiplexed with YWHAZ.  Although the Ct values 
for YWHAZ for the same sample were comparable irrespective of what gene 
YWHAZ was multiplexed with, the Ct value for YWHAZ was consistently higher 
when multiplexed with HSP70 than with IFN (P<0.001, paired t-test, Minitab).  
This may be due to slight differences in the conditions of the PCR reaction due to 









Stage of blastocyst development only accounts for some of the variation between 
samples, so that other factors, such as variation in viability, may explain the 
remainder variation in YWHAZ expression between samples.    
 
 










































Figure 42  Results from the preliminary experiment (Appendix 11) on the effect of 
stage of blastocyst development (before and after expansion) on a) IFN expression 
before n=30, after n=27), b) HSP70 expression (before n=29, after n=27).  Expression 

























Figure 43  Results from Chapter 3 on the effect of stage of blastocyst development 
(before and after expansion, after hatching and collapsed, n=43, 29, 8 and 29 
respectively) on a) IFN expression and b) HSP70 expression.  Expression is measured 
as the raw data (Ct).  Values are mean±SEM.  
Effect of change of morphology index on YWHAZ expression 
Embryo viability may explain some of the variation in total gene expression 
between samples.   Blastocyst 12 had high Ct values in all genes assessed, 
suggesting RNA degeneration.   
 
In Chapter 3, YWHAZ transcript levels were lower (P=0.009) in blastocysts which 
showed signs of degeneration (category 3, 26786 fg) compared with blastocysts 
which progressed in development (category 1, 25931361 fg) or remained 
unchanged in morphology (category 2, 20441008 fg) during the individual culture 
period (Figure 44, page 242).  Therefore, YWHAZ expression may decrease with a 
decrease in embryo viability, possibly due to an increase in RNA degradation in 











Figure 44  Transcript levels of YWHAZ versus change in morphology index (embryo 
survival after 24 h of individual culture as assessed by change in morphology before 
and after individual blastocyst culture:  1 embryo progressed in development, 2  no 
visual change in development, 3 signs of degradation or collapse).  Values are mean  
standard error.   
The relationship between YWHAZ and other genes 
As expected from a housekeeping gene, YWHAZ transcript levels were not 
affected by treatment (mean  standard error, 954428 fg and 2056939 fg, for 
control and heat treated blastocysts respectively, P=0.6).  YWHAZ transcript levels 
correlated with IFN transcript levels (P=0.004, Figure 45b), and with HSP70 
transcript levels (P<0.001, Figure 45a).  The higher variation in IFN expression 
compared with HSP70 expression meant that the probability of a relationship with 
YWHAZ expression was greater with HSP70 than with IFN.   






















































Figure 45  Relationship between YWHAZ and a) HSP70 (y=0.8-0.4) and b) IFN 
(y=0.7+0.2) transcript levels.   
Change in morphology index 



































YWHAZ gene expression was not affected by factors which should not affect the 
number of cells in an embryo (treatment, sex or day of development), but was 
regulated by factors which affect the number of viable cells in an embryo (stage, 
change in morphology index, IFN and HSP70 expression).  YWHAZ gene 
expression was upregulated (three-fold) after expansion (associated with higher 
number of cells) compared with before expansion, suggesting that some of the 
variation in YWHAZ expression can be explained by differences between samples 
in cell number.  Given that YWHAZ is stable and ubiquitous in all embryo cell 
types in similar amounts (Goossens et al., 2005), it is plausible that YWHAZ 
correlates with total cell number.  It is not possible to correlate cell count and cell 
viability with gene expression in the same embryo, since the process of counting 
cells and the apoptosis assay may cause mRNA deterioration.  However, the 
relationship between YWHAZ expression and stage of development and change in 
morphology index indicate a relationship between YWHAZ expression and total 
mRNA.  Therefore, it is justifiable to use YWHAZ expression as a control for 








Appendix 12  
 
Criteria used to reject data for analysis and the reasons for disregarding data.    
RFU: relative fluorescence unit. 
Criteria Reason 
Wells with loose caps Allow reagents to be lost due to 
evaporation 
 
Replicates containing reference dye 
profiles which were noisy (not flat or 
containing spiking) or saturated 
(>35000 RFU) 
 
Indicate fluctuations in reagent 
amount and concentration due to 
evaporation or loading error   
 
Replicates containing baseline signals 
for amplification plots below 3000 
RFU 
 
Above 3000 RFU, signals are 
significantly above background 
 
Replicates containing the exponential 
phase of the amplification curve 
above 35000 RFU 
 
Above 35000 RFU, the signal is too 
saturated, which may cause poor 
signal uniformity 
 
Replicates with Ct coming up too late 
(above 40 cycles)  or not at all 
 
Signals above 40 cycles could be due 
to PCR artefacts, such as primer 
dimers   
 
Standard curves with efficiencies 
below 75% 
 
Suggests contamination or reagent 
evaporation.   
Standard Curves with efficiencies 
above 110% 
Suggests contamination or reagent 
evaporation.   
 
Replicates with excessive spiking 
 
Excessive spiking suggest that the 
signal is not due to an amplified PCR 
reaction 
 
